Application of phage display to the study of toxin-receptor interactions by McLean, Hector Alexander
 
 
 
 
 
 
 
https://theses.gla.ac.uk/ 
 
 
 
 
Theses Digitisation: 
https://www.gla.ac.uk/myglasgow/research/enlighten/theses/digitisation/ 
This is a digitised version of the original print thesis. 
 
 
 
 
 
 
 
 
Copyright and moral rights for this work are retained by the author 
 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
 
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author 
 
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten: Theses 
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
APPLICATION OF PHAGE DISPLAY TO THE 
STUDY OF TOXIN-RECEPTOR INTERACTIONS
HECTOR ALEXANDER McLEAN
Thesis submitted for the degree of Doctor of Philosophy
Division of Infection and Immunity, University of Glasgow
September 1999
ProQuest Number: 10391479
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 10391479
Published by ProQuest LLO (2017). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLO.
ProQuest LLO.
789 East Eisenhower Parkway 
P.Q. Box 1346 
Ann Arbor, Ml 48106- 1346
1 GLASGOW I1u --.'æ r s i t y |Uiii^Y
n
SUMMARY
111
îIV
In causing disease, most bacterial toxins must firstly interact specifically with one or 
more host receptors. Thus, discovery of the identity of these receptors is an important 
step towards elucidating a toxin's mode of action.
This project aimed to assess whether the technique known as phage display had any 
role to play in the identification of toxin receptors.
Libraries of DNA were supplied for this work. These libraries had degenerate DNA of 
defined sequence length cloned into genes encoding major or minor components of 
the capsid of filamentous phage of the Ff family. This resulted in random peptides 
being 'displayed' in the outer envelope of the phage.
Libraries of such phage were exposed to surfaces of immobilised toxin, with those
' • : rcarrying a random peptide sequence complementary to the receptor binding site 
interacting with, and being bound to, the toxin. Unbound phage were washed away 
and bound phage were removed by elution with a specific or non-specific agent.
The toxin used as a model in this work was the heat-labile toxin of enterotoxigenic 
Escherichia coli (LT), for which the natural receptor is already known. A diarrhoeal 
toxin almost identical to that from Vibrio cholerae, it recognises a glycolipid, 
ganglioside Gmi- This assessment therefore called for the peptide extension of the 
phage to mimic a natural carbohydrate moiety.
The structure of LT is designated AB5, signifying that it has one Active and five 
Binding subunits. As this work was primarily concerned with binding, isolated LT-B 
pentamers, secreted by a genetically-modified marine Vibrio were used in the 
experimental work in preference to whole toxin. After examining the growth pattern 
of this strain, and relating it to B subunit production, the pentamers were purified by 
affinity chromatography using a galactose column, then biotinylated to facilitate 
attachment to streptavidin-coated plastic. The biotinylated product was tested for 
integrity and activity.
Three phage display libraries were assessed. After exposure to the toxin, the eluted 
phage were tested in binding assays and, where appropriate, were sequenced to 
determine the amino acid composition of the random insert.
1
The first library tested, the 'Smith hexamer', carried a six amino acid extension to 
minor capsid protein III and performed poorly: the selected clones showed no specific
binding to the toxin. The second library, the 'Liizzago nonamer', which carried a nine
.
amino acid extension to protein VIII , was an example of a library carried on a 
phagemid vector. It apparently had suffered a flaw in construction and appeared 
unable to synthesise eoat protein. The third library, the 'Smith pentadecamer', carried 
a fifteen amino acid extension to protein VIII. Successive rounds of exposure to the
■■
toxin and amplification of binding phage demonstrated that, although selection of 
phage carrying specific peptides was occmx : , the affinity was for elements of the
test system other than LT-B itself.
Thus, these experiments were unable to identify peptides from a random, phage-borne 
library able to mimic the natural receptor for LT-B.
:
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INTRODUCTION
PA R T  1 : P H A G E  D ISPL A Y  T E C H N O L O G Y  
Methods for identification of ligands
The ability to determine the relationship between the amino acid sequence of an 
active protein and the functionality of that protein in mature configuration has long 
been recognised as being critical to the study of protein - ligand interactions.
For example, the quest for a deeper understanding of the nature of individual 
antibodies, hormones or bacterially-derived toxins requires knowledge of whether 
their natural ligands are peptides in which the critical binding portion (epitope) is a 
linear amino acid sequence {ie. continuous) or is a structural feature created by 
separated amino acids being brought together by convoluted folding of the protein {ie. 
discontinuous). In an attempt to ascertain this information, procedures such as 
assaying a bank of individual variants {eg. mutants) for the desired property, followed 
by sequencing of the variant, have proved useful. However, the practicality of this 
method is compromised by the vast number of variants that must be considered. Of 
more practical value are selective methods, in which a collection of variants are 
simultaneously exposed to the protein, and then treated in such a way as to eliminate 
those which are reacting only weakly and to isolate those that are reacting in a 
specific manner. The major difficulty that exists with this approach is the requirement 
to then identify conclusively the selected species. In recent years, however, this 
problem has been overcome by the development of selection systems in which the 
protein being tested is physically linked to the carrier of the DNA that encodes it. 
After selection for the protein, the DNA can be sequenced, thus giving valuable 
insight into the nature of the reactive protein, and, by implication, of the site that 
selected it (Clackson and Wells, 1994; Stephen et a i, 1995).
General principles of phage display
In 1988, Parmley and Smith introduced the idea of directly identifying receptor 
ligands by expressing them in bacteriophage vectors. Their work was inspired by the
variation of Geysen et al. (1986) to the traditional’ method of screening for epitopes - 
digestion of the antigen with a range of specific proteases, the individual testing of 
each fragment for reactivity, and the piecing together of the sequences of the 
overlapping reactive fragments to reveal the peptide structure. In their method, 
Geysen et a l  used random chemical synthesis to extend peptides which had bound 
monoclonal antibodies weakly, in order to generate peptides that were bound with 
higher affinity by the monoclonal antibody under investigation. This was done 
without knowledge of either the sequence or the conformation of the epitope. As well 
as simply duplicating the natural ligand, unrelated peptides ('mimotopes') were also 
discovered that were mimics of the discontinuous antigenic epitopes.
In the phage display technique that will be of concern in this project, such peptide 
mimics are generated not chemically but genetically, by the insertion of foreign DNA 
into those bacteriophage genes which encode external features of the phage capsid. 
On expression therefore, foreign proteins or peptides will be 'co-displayed'; fused 
within the capsid protein on the outer surface of the virion. Those which mimic 
important epitopes will therefore be antibody (and otherwise) selectable. If the 
displayed peptide is a specific ligand for a receptor, antibody, or other such molecule, 
that natural molecule can be used to capture the peptide and the phage displaying it. 
The captured phage can be used to reinfect a suitable host facilitating the cloning of 
sequences encoding peptides with interesting properties. The physical linkage of the 
peptide to the gene which encodes it represents one great advantage that phage 
display has over chemical synthesis techniques.
Ff class filamentous phage
The bacteriophage chosen as a display vector in phage display must remain infective 
despite the insertion of a foreign peptide. Equally, it must not kill the infected cell but 
rather should permit it to keep dividing thereby producing a high yield of phage.
Most of the phage display reported thus far has been carried out in the Ff (F-pilus 
specific) class of filamentous phage (reviewed by Smith, 1988b; Scott, 1992;
Makowski, 1993; Webster, 1996; Rodi and Makowski, 1999). This class comprises 
the f l , fd and M l3 strains, which demonstrate 98% sequence homology, with few of 
the sequence differences resulting in the coding of alternative amino acids; those 
which are different are thought unlikely to affect biological function.
The wild-type phage has a tubular capsid, 7nm wide and 900 to 2000 nm long, that 
encloses a single-stranded DNA genome of 6407 or 6408 bases (strain dependent) 
encoding eleven proteins (pi - pXI), A list of the genes and gene products of Ff phage 
is given in Table 1 whilst a representation of the structure is shown in Figure 1.
The capsid primarily comprises 2700 molecules of the major coat protein pVIII (it 
constitutes 88% of the weight of the phage particle) arranged in a helical array. 
Translated with a 23 amino acid signal peptide, pVIII is cleaved to yield a mature 
molecule 50 amino acids in length, with a molecular weight of approximately 5235 
Daltons (Da), that consists of three major domains. During phage assembly when the 
pVIII molecules assemble around the DNA strand, the first 1 0 - 1 3  residues of the 
carboxyl-terminal domain, four of which are lysine, interact with the sugar phosphate 
backbone of the chromosome. The hydrophobic central domain separates this region 
from the acidic amino-terminal domain which is exposed to the outer environment. 
Felici et a l  (1991) report the amino-terminal sequence of the protein (for single letter 
coding see Appendix 5, page 188) to be ;
A E G D D P A K A . . . .
All insertions of foreign protein into pVIIl, thus far, have been into the A^ to D-^  
amino-terminal sequence that constitutes a mobile surface segment that is distinct 
from the alpha-helices that make up the rest of the protein (the full base and amino 
acid sequences of gene VIII are shown as Appendix 8, page 192). Site-directed 
mutagenesis (Felici et a l, 1991; lannolo et a l,  1995) has shown that these residues 
play no role in either protein translocation or phage assembly.
At the 'proximal' end of the capsid (i.e. that end of the virus which is extruded last 
from the host during phage assembly) are clusters of five molecules of each of two 
minor capsid proteins pIII and pVI. The specificity of the Ff class of phage, all of
4
GENE AMINO ACIDS =!= MOL, W EIGHT ^ FUNCTION
I 348 39502 Assembly
II 410 46137 DNA replication
III 406 42522 Capsid protein
IV 405 43476 Assembly
V 87 9682 Binding ssDNA
VI 112 12342 Capsid protein
VII 33 3599 Capsid protein
VIII 50 5235 Capsid protein
IX 32 3650 Capsid protein
X 111 12672 DNA replication
XI 108 12424 Assembly
* Given for mature protein excluding, where applicable, the signal peptide.
TABLE 1 : Size, weight and function of gene products of the Ff class of 
filamentous phage.
Adapted from Webster (1996).
5 copies each 
of pVil, piX
5 copies each of 
pVI, pill -
2 700  copies of 
pVIII
/
/
FIGURE 1: Structure of filamentous bacteriophage.
Adapted from Kishchenko et a l, 1994.
which infect Escherichia coli cells displaying F-pili, is a function of pIIL The largest 
protein in the virion, it is responsible for binding the F-pilus and thus initiating 
infection of E. coli hosts. The requirement for an F+ host has been shown to be 
purely a function of the infection process, as phage DNA artificially introduced to the 
host by other routes was just as capable of establishing infection. Despite its vital 
role, pin is nonetheless the most commonly used capsid protein for phage display, 
being able to tolerate large insertions with no loss of function. Like pVIII, it is 
translated with a signal peptide, in this case of 18 amino acids. The 406 amino acid 
mature protein is divided into three domains. The carboxyl-terminal domain acts as an 
anchor, holding the phage to the host membrane during virion assembly (Boeke and 
Model, 1982). It is thought that pIII is attached to the capsid via its C terminus and 
via pVI, which acts as a bridge, whilst its N terminus protrudes outwards. Proteins III 
and VI also serve to stabilise the phage against dissociation, remaining associated 
despite disruption of the phage by detergent (Hill and Stockley, 1996; Webster, 1996, 
Holliger and Riechmann, 1997). In 1995, Jespers et a l reported the first, and so far 
only, demonstration of a phage display fusion to pVI.
Five copies of each of two other minor capsid proteins pVII and pIX, which have 
roles in the initiation of phage assembly, form a highly hydrophobic plug at the 'distal' 
end.
Two factors make these phage particularly useful as cloning vectors: (a) Their great 
resistance to extremes of heat (70“C) and pH (2.0). This is exploited in the use of acid 
elution buffer to break the non-covalent bonds between peptide and ligate thus 
allowing recovery, without loss of function, of captured phage after affinity 
purification, (b) The fact that the length of the capsid is simply a function of the 
length of the DNA it contains. As there is no defined size, the genome can be 
lengthened by insertion in the knowledge that the helical array of pVIII will simply 
extend to cover this extra DNA, with an extra copy of pVIII being added for every 
additional 2.3 nucleotides.
Insertions into both pIII and pVIII are made at, or close to, the amino terminus of the 
mature protein. This terminus tends to be the most exposed part, thus increasing 
access for agents intended to select particular inserted sequences. This physical 
separation of the insert from the capsid also lessens the chances of cross-interference.
Infection cycle of Ff class of phage
Infection of E. coli by Ff phage (reviewed by Smith, 1988b; Webster, 1996; Model 
and Russel, 1988; Reichmann and Holliger, 1997; Rodi and Makowski, 1999) is a 
process which has only recently become defined with any clarity.
Infection is initiated by the interaction of the extreme amino terminal portion of pIII 
with the bacterial cell surface protein TolA, one of a group of membrane-spanning 
proteins (the products of the host tolQRA genes) that are also involved in the 
translocation of colicins; in mutants lacking them, phage and colicins are still able to 
bind to the host, but are unable to infect (the mutant host is therefore to/erant of the 
infecting agents). This interaction releases the next domain upstream of the terminus 
to bind to the F-pilus of the bacterium. The phage then commences disassembly as it 
is being drawn towards the host cell surface by retraction of the piliis. Whether this 
retraction is promoted by the attachment of the phage, or is the result of the regular 
cycle of pilus polymerisation and depolymerisation, is unknown. Trans location of the 
DNA genome through the membrane and into the cell is mediated by TolQ, Toi R and 
Toi A. Once in the cell, replication takes place thus :
Firstly, the host RNA polymerase and DNA synthesis apparatus combine to convert 
the single-stranded viral DNA to a supercoiled, double-stranded replicating form (RF) 
in a process that is independent of any virally-encoded proteins. This RF viral DNA 
will serve as a template for production of mRNAs for all viral proteins.
Then, nicking of the plus strand of the RF molecule by pll initiates rolling circle 
replication which results in the production of many circularised daughter RFs. Phage 
protein pH, and possibly the associated pX, in conjunction with host enzymes, 
mediate this stage of replication. The increasing number of RF's leads to a rapid
increase in production of all viral proteins. Those which aid DNA production are 
located in the cytoplasm, whilst those involved in phage assembly are integrated into 
the cell membrane.
The final stage occurs when the cytoplasmic concentration of phage protein pV 
reaches a critical level. Newly synthesised single stranded viral DNA is not replicated 
to form RFs, but rather individually associates with pV molecules to form virion-like 
precursors of the progeny phage.
The process by which these progeny are assembled and released, though still not 
completely understood, is seen as unique to filamentous phage in that assembly 
occurs not in the cytoplasm but rather at a specific site formed by pi, pIV and pXI at a 
point where the inner membrane is in close contact with the outer membrane. The 
DNA is passed through the membranes, distal end first, releasing the pV molecules 
which are recycled. The only capsid structural proteins with signal peptides, procoat 
pin and pVIII, which, like pVI, pYII and pIX, exist as integral membrane proteins, 
are at this point cleaved by signal peptidase and all these mature proteins associate 
with the DNA. Phage assembly slows the growth rate of the host cell by about 50% 
while it proceeds. Typically, each first generation host cell will produce around 1000 
phage, whilst each cell in subsequent generations will yield 100 - 200 particles.
First uses of filamentous fusion phage
Smith (1985) was the first investigator to report production of a fusion based upon the 
coat protein of a filamentous phage. Using wild-type fl phage he inserted small 
fragments of DNA from a plasmid encoding the restriction endonuclease EcoRl into a 
Bam HI site in gene III to create a fusion protein with foreign amino acids between 
the two domains of pIII. The phage retained their infectivity and as E c o R l  
endonuclease, the expressed peptide, was accessible, they were also antibody 
selectable. The major problems with this system were that the phage could only be 
maintained by continual cycles of infection and that infectivity was severely 
depressed, with plaque forming (ie. infectious) units representing less than 1 in 50 of
the total virion content (as ascertained by spectrophotometry) compared with 1 in 2 
for wild-type. Thus, possession of a fusion protein was clearly disadvantageous to the 
phage.
Parmiey and Smith (1988) developed from this initial work many of the principal 
elements of phage display. They used a new vector, phage fd-tet, into which they 
inserted foreign protein near to the signal peptide at the amino-terminal of pIII. This 
is the exposed terminus of pIII (responsible for binding to the F-pilus), thus the 
resulting fusion protein was more accessible. They also found that this fusion had a 
less deleterious effect on phage function. A more detailed account of the development 
of fd-tet, and its uses in library work is given on page 51.
In assaying for the fusion, they developed the technique of 'biopanning' (described 
later) and proposed the construction of gene libraries by phage display of random 
oligonucleotides.
Classification of phage display vectors
Smith (1993) outlines six possible systems for displaying foreign proteins on the 
surface of filamentous phage. The type 3 vector has a single recombinant gene III 
with a foreign DNA insert. On expression, all five pIII molecules will carry the 
foreign insert. However a major problem with large insertions in pIII is that they can 
promote periplasmic degradation of the fusion protein and can interfere with its 
normal function of adsorption to the F-pilus, thus rendering the phage non-infective. 
This problem is overcome in the type 33 vector in which both a recombinant, and a 
wild-type gene III are present, resulting in a capsid displaying a mixture of pIII 
molecules, only some of which have foreign proteins fused. The presence of wild- 
type infective pIII on the capsid surface compensates for the presence of any non- 
infective fusion pin. The recombinant gene is inducible, and careful control of 
expression level can produce monovalent display of pIII; McConnell et a l  (1994) 
reported an average of 0.74 recombinant proteins per virion in their work. Whilst this 
does mean that a subset of virions will carry no recombinant protein, these wild-type
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capsids will not feature in the selection process. The type 3 + 3 vector also has 
recombinant and wild-type genes present, however in this case the recombinant DNA 
is carried by a phagemid - a plasmid bearing antibiotic resistance markers with origins 
of replication both for the plasmid itself and for filamentous phage. Infection of 
phagemid-carrying host cells with a helper phage that carries all the genes to form a 
capsid but is defective in replication, results in both the helper genome and that of the 
phagemid being separately packaged into virions. The excess of wild-type pIII 
supplied by the helper means that around 10% of resulting virions will carry a fusion 
protein (Clackson and Wells, 1994).
Types 8, 88 and 8 + 8 are the gene VIII equivalents of these gene III types. It has been 
shown by Greenwood et a l (1991) that insertions greater in length than six amino 
acids, the typical size of a continuous peptide epitope, fail to produce viable phage 
using type 8 vectors. This is possibly due to disruption of the necessary interaction 
between pVIII and pVII and IX at the initiation stage of phage assembly (Makowski, 
1993). If types 88 or 8+8 are used, each of the fusion proteins is probably locally 
monovalent, i.e. surrounded by wild-type proteins, as this has been shown to be 
necessary for capsid stabilisation.
An advantage in using pVIII for insertions, proposed by Folgori et a l (1994), is that 
10 to 100 pVIII will display the protein on a single phage capsid as compared with a 
maximum of 5 copies when pIII is used.
The epitope library
As suggested by Parmley and Smith (1988), phage display has been widely used for 
the generation of libraries of random oligopeptides. A library can be created by 
synthesising degenerate oligonucleotides using random mixtures of nucleotides and 
cloning them into the appropriate coat protein genes of the phage or phagemid vector 
(Scott, 1992). Library size is probably determined by the efficiency with which the 
ligated mixture is transformed and by the length and composition of the inserted 
peptide (Folgori et a l, 1994), but will typically contain 10'^  to 10% clones that each
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display a unique peptide sequence. The size of library required to contain every 
possible combination of amino acids can be calculated as 20%, 20 being the number of 
amino acids and n being the length of the insert. A table showing the number of 
theoretical combinations for various insert sizes is shown as Table 2. It can be seen 
from this that a library of inserts of up to six amino acids could be 'complete' i.e. could 
contain every possible combination of amino acids, if 10^ variants were produced. 
Although libraries of longer peptide insertions will be incomplete, each long peptide 
will contain within it several short epitopes. Thus, a library of long peptides may well 
contain more epitopes than an equivalently sized library of shorter peptides. For 
example, Kay et al. (1993) report that a 36 amino acid insert will, because of a sliding 
reading frame, contain 31 different hexamers (the formula {X - N)-\- 1, can be used to 
calculate how many V-mers an X-mer insert will contain). Longer inserts are also 
advantageous in that they may assume tertiary structure independent of the protein to 
which they are fused, thus providing multiple contact sites which may be required for 
ligand binding. However, it has been suggested that, even when enough variants have 
been generated to cover every theoretical combination, there will nonetheless remain 
some peptides which cannot feature in the library. Any inserts which exhibit toxicity 
towards the host, prevent the proper folding of host or phage proteins or which cannot 
be translated, secreted or processed by the host will necessarily be absent; for example, 
peptides that include codons not regularly used by E. coli have been seen to be under­
represented in pVIII libraries produced using that host, possibly because the 
appropriate tRNAs are not present in sufficient numbers (Clackson and Wells, 1994; 
Rodi and Makowski, 1999).
Scott and Smith (1990) suggest that peptides encoded by DNA sequences that represent 
restriction sites of the endonucleases used in construction of the library will be missing. 
Any peptide that replicates the cutting sequence for the signal peptidase that releases the 
mature pIII or pVIII may also be eliminated. Moreover, it has been recognised that, as 
at least the first two amino acids of the mature protein exert some influence over signal 
peptidase action, then libraries where the insert commences at the extreme tip of the
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Size of insert
tamino acidsi______________Number of combinations
4 1.60 X 105
5 3.20  X 10Ô
6 6.40  X 107
7 L 2 8 x l 09
8 2.56  X 10^0
9 5.12  X 1011
10 1.02 X 1013
15 3.28 X 1019
TABLE 2 : Number of different amino acid combinations in complete phage 
display libraries with various lengths of insert.
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mature protein may also be subject to considerable bias in regard to the first few 
residues (Wilson and Finlay, 1998; Rodi and Makowski, 1999).
Selection of ligate-binding fusion phage by biopanning
'Biopanning' is the term coined by Parmley and Smith (1988) for the most widely 
used and adapted method for selection of ligate-binding phage (see Figure 2). In the 
original method, a dilution of biotinylated monoclonal antibody (MAb), which had 
previously been exposed to UV-irradiated phage (to block non-specific phage binding 
sites) was reacted with the library. This mixture was then applied onto a streptavidin I
coated petri dish where phage carrying fusion proteins which specifically reacted with
the MAb were immobilised by the biotin-streptavidin bridge. Unreacted phage were 
removed by extensive washing of the plate, after which the bound phage were eluted 
with acidic buffer. These captured phage were amplified by infection of a fresh 
culture of the bacterial host and then subjected to a second round of panning, i.e. were
exposed to a fresh surface of bound MAb. Only a small percentage of the phage in a 
library carrying random fusions would recognise and bind to the MAb. However, 
after eluting these few phage and amplifying them to high titre, a much higher 
number would be expected to bind on re-exposure. The ability, in this way, to enrich 
peptides with sequences of interest, represents the single greatest advantage that this 
technique has over manual synthesis of peptides. Theoretically, successive rounds of 
selective enrichment and amplification could be carried out indefinitely, but there is a 
danger that only the fastest growing phage are favoured by too much repetition. Scott 
and Smith (1990) report that a single round of panning resulted in a 10  ^enrichment in 
their application whilst Kay et a l  (1993) used an excess of phage in a second round to 
increase competition and ensure selection of only those phage that bound with highest 
affinity. Individual clones can be isolated and the gene encoding the associated 
epitope sequenced.
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FIGURE 2 : Principle of biopanning.
Biotinylated antibody, captured by plate-bound streptavidin, can capture phage which 
display peptides compatible with the antibody. After washing to remove unbound 
phage, the captured material can be eluted off with acid. (After Parmley and Smith, 
1988)
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PART 2 : BACTERIAL PROTEIN TOXINS AND 
DIARRHOEAL DISEASE
The aim of this project was to assess whether phage display could be conveniently 
applied to the identification of receptors for bacterial protein toxins.
The diversity of bacterial protein toxins
Toxin is a difficult term to define comprehensively, but it is the enduring word for 
those important virulence factors of bacteria, the 'poisons' with which they damage 
their hosts. Toxins have been described as the 'smart weapons in the biological 
warfare waged between species, being precisely targeted against specific molecules' 
(Read and Stein, 1993).
The existence of toxins was first suggested, on purely speculative grounds, by Klebs 
in 1882 who gave them the name 'sepsins'. Koch, after isolating the causative 
organism of cholera in 1884, suggested that the diarrhoea! effect may be the result of 
an extracellular product of the bacterium. Finally, in 1886, Roux and Yersin 
precipitated pure diphtheria toxin, which they took to be 'a kind of enzyme' and for 
which the term toxin was first coined. Soon after this came the discoveries of tetanus 
toxin (1890) and botulinum toxin (1896). Toxin discovery continued through 
succeeding years; e.g. the dreadful consequences of gas gangrene in the First World 
War prompted investigation into the clostridial toxins. By the start of the 1950's, some 
60 bacterial toxins had been identified, (van Heyningen, 1970; Stephen and 
Pietrowski, 1981 ; Alouf, 1994). A particularly important advance in the field of 
toxinology at this time came when Macfarlane and Knight (1941) showed that the a- 
toxin of Clostridium welchii (now Clostridium perfringens ) type A had lecithinase 
(phospholipase C) activity which was specifically inhibited by Clostridium welchii 
type A antitoxic serum. For the first time a bacterial toxin in pure form was shown to 
be an enzyme, thus confirming Roux and Yersin’s proposal of 55 years earlier.
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Since the 1950's, knowledge in the field of toxinology has continued to increase. The 
most recent major advance in the field has been the elucidation of the 3-dimensional 
structures of various toxins, starting, in 1986, with Pseudomonas aeruginosa  
Exotoxin A. As to the present state of affairs, Alouf (1994) reported the following 
statistics in regard to protein and peptide toxins.
TOTAL No. OF TOXINS KNOWN 290 
47% from gram +ve bacteria 53% from gram -ve bacteria
Of these, 75 % are extracellular, 25 % are intracellular.
At this stage, 6 had been characterised by crystallography.
Satisfactory classification of these toxins is rendered difficult by the lack of a single 
defining characteristic. They may be grouped according to the originating species of 
bacterium, the toxin's structure or its mode of action. E. coli strains alone produce a  
haemolysins, enterohaemolysins, verotoxins, cytotoxins and enterotoxins (Gyles, 
1992). These include some toxins with the structural designation A:B5 (explained 
later), a feature of those produced by, amongst others, Bordetella pertussis or V. 
cholerae strains. There are in excess of ten different species that produce toxins with 
ADP-ribosylating activity. Intoxication by a bacterial protein toxin may lead to 
effects which are cytotoxic, necrotic, haemolytic, neurotoxic, which may cause 
oedema of tissue, may affect protein synthesis or may have enteric effects. The toxins 
will act either at the plasma membrane of the host, from whence they affect trans­
membrane signalling and /or membrane permeability, or within the cell, where they 
exhibit enzymatic effects on cytosolic functions of the cell (Montecucco et a l, 1994). 
Toxin genes may be chromosomal, phage-borne, plasmid-borne, or transposon-borne 
(Alouf, 1994). Lethality ranges from negligible to, in the case of botulinum D, an 
estimated 3,000,000 times more potent than strychnine (van Heyningen, 1970).
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Host receptors for bacterial protein toxins.
An important step towards elucidating the mechanism of action of a toxin is to 
discover the host receptor to which it preferentially binds. As the concentrations of 
toxin at the binding site may be very low, and as that site may be in an environment 
that legislates against prolonged contact, such as the gut with its flowing content, it 
would therefore be most favourable to the toxin to be able to rapidly bind with high 
affinity (Gill, 1982). Given that it is unlikely that host cells possess receptors 
exclusively for the binding of toxins that will ultimately kill them (so-called 'suicide 
receptors'), it is therefore more likely that the toxins must bind to existing receptors 
normally utilised in host cellular processes. If these receptors trigger uptake by the 
cell of the binding protein, the entry of the toxin to the cell is thereby facilitated. 
Ledley et al. (1976) presented evidence that the B subunit of cholera toxin shares 
sequence similarity with some glycoprotein hormones, the suggestion being that this 
represents shared recognition mechanisms for host cell receptors. In addition, the 
process of binding to the receptor may actually trigger uptake into the cell. Among 
known receptors, gangliosides (ceramide-linked oligosaccharides, discussed in detail 
on page 35) feature strongly, as do proteins and glycoproteins. Diphtheria toxin has 
been positively identified as binding to a heparin-binding EGF-like growth factor 
precursor. The diversity of receptor types and the extent of the gaps in our knowledge 
are illustrated in a short list of some toxins, and their receptors, shown as Table 3.
The role of toxins in diarrhoeal disease
Enteric pathogens producing one or more toxins are one of the principal aetiologies of 
diarrhoeal disease. Sears and Kaper (1996) list some 60 clearly identifiable 
enterotoxins, produced by 21 bacterial species. Toxins have been related to disease by 
monitoring the effect of ingestion on volunteers and / or the presence of toxin in stool 
samples, or by identifying intestinal or serum antibody responses to toxins. Another 
frequently applied technique in enteric toxin research is injection into the exposed
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TOXIN RECEPTOR
Cholera
C. perfringens b 
Diphtheria
E. coli Heat-labile (LT) I
E. coli Heat-labile (LT) II
E. coli Heat-stable (ST) I
E. coli Heat-stable (ST) II
Pertussis
Shiga
Shiga-like
Pseudomonas exotoxin A
GmL'
GM2*
heparin-binding EGF-like 
growth factor precursor
Gm I *
Go la*
guaiiylate cyclase type C (GC-C) 
unknown 
glycoprotein receptor 
Gb3*
Gb3 or Gb4 (strain dependent) 
c(2MR / LRP '
I = oc2"iTiacroglobulin receptor / low density lipoprotein receptor-related protein
TABLE 3 : Diversity of toxin receptors.
Ganglioside receptors (marked ='=) are discussed later (page 35).
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ileal loops of experimental animals; this was, for example, used when De et al. 
demonstrated that net secretion could be induced by cell-free culture supernatant fluids 
of V. cholerae, a finding which led to the discovery of cholera toxin (discussed in 
greater detail below).
Sears and Kaper also define four distinct diarrhoeal activities.
A strict enterotoxin is defined as one capable of stimulating either (a) net secretion in 
intestinal models, in the absence of cellular damage, or (b) ion secretion in an Ussing 
chamber. A cytoskeleton-altering toxin produces net secretion via the non-lethal 
alteration of cell shape, usually as a result of rearrangement of F-actin filaments. A 
cytotoxin lethally damages the cell or tissue, while a neurotoxin alters intestinal smooth 
muscle activity. Few toxins, however, can be neatly slotted into any one of these 
categories as it seems increasingly likely that amongst those acting enterically, there are 
toxins with the capability of simultaneously subverting more than one cellular 
mechanism in order to create the intestinal secretion characteristic of disease.
Significance and occurrence of diarrhoeal disease
Despite a century of progress in understanding the causes of dianhoea, and advances in 
treatment, it remains responsible for around 25% of infant deaths annually (3.7 - 4.6 
million). As well as being potentially fatal, the disease is a major contributory factor to 
the widespread malnutrition in the 'developing' world, where a 5 year old child may 
have suffered episodes of diarrhoea for up to 15% of his or her life. The most 
vulnerable are the youngest, with the frequency of attack declining thereafter if the child 
reaches the age of two. An incidence of five attacks, per child under two yeai's old, per 
year was observed in Africa. Even in the developed world, infant diarrhoea is a public 
health issue; in the U.S.A., an estimated 38 million cases requiring medical attention 
are seen annually in patients under five years of age, resulting in some 425 deaths 
(Black, 1993).
Another factor adding to the total annual incidence of diarrhoea world-wide is 
traveller's diarrhoea. This is defined as an individual from a 'low risk' aiea suffering a
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sudden increase, by two-fold or greater, in the frequency of unformed bowel 
movements, often with associated abdominal cramps, nausea and malaise, during, or 
immediately after, a visit of up to one months duration to a 'high risk' area. High risk 
areas are taken to be the developing countries of Latin America, Africa, the Middle 
East and Asia, whilst low risk countries are those of Northern Europe, North America 
and Australasia. Traveller's diarrhoea may strike up to 40% of the 12 million or so 
who travel annually, although in only around 1% of cases will the symptoms persist 
longer than a few days and only extremely rarely will it ever lead to death 
(Anonymous, 1986; Black, 1990; 1993).
History and epidemiology of cholera
Cholera, the most severe diarrhoeal disease, has been known since ancient times. 
Initially restricted mainly to Asia and India, it gradually spread along trade routes into 
Europe and thence to the New World in the early years of the 19th Century. 
Commerce and colonisation in succeeding years resulted in frequent epidemics 
throughout the world. Manifestations range from Cholera gravis (severe dehydration, 
cramps and ruptured blood vessels which can result in death just 6h after onset) to 
mild or even asymptomatic infection. The shrivelled appearance and skin 
discoloration characteristic of the most severe manifestation of the disease meant that 
cholera was feared as much in the 19th Century as the bubonic plague had been 
before it. Since 1817 there have been seven pandemics, the most recent of which 
commenced in 1961 (McNeill, 1976; Black, 1986; Hirst, 1995).
Cholera is contracted primarily through ingestion of faecally-contaminated water, a 
fact first demonstrated in 1854 by Dr. John Snow who, by preventing the use of the 
Broad Street water pump in London, arrested the spread of the disease in the locality 
(McNeill, 1976). Cholera remains endemic to this day in areas where water supplies 
are susceptible to contamination such as coastal areas of the Indian sub-continent. 
Although practically unknown in the developed world for most of this century, a 
recent surge of isolated outbreaks have been reported in 17 Mediterranean and
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Eastern European countries (Anonymous, 1994b). In South America a major 
epidemic commenced in 1991. At its peak in 1992, this resulted in 354000 cases 
being notified to the World Health Organisation (WHO) (Anonymous, 1994a). 
Although there is a long-proven link with contaminated drinking water, the use of 
dirty water for purposes such as bathing, food preparation, utensil cleaning, etc. can 
continue the spread of the disease even amongst those to whom clean drinking water 
is available. Seafood too is a notorious vector for this disease. The WHO, in 1995, 
issued the following guidelines for travellers to cholera-affected areas (Anonymous, 
1995a).
• Drink only water that has been boiled or disinfected with chlorine or iodine.
• Avoid ice, unless you are sure that it is made from safe water.
• Eat food that has been thoroughly cooked and is still hot when served.
• Avoid raw seafood and other raw foods.
• Boil unpasteurised milk before drinking it.
• lee cream from unreliable sources is frequently contaminated and can cause
illness. If in doubt, avoid it.
• Be sure that meals bought from street vendors are thoroughly cooked in your
presence and do not contain any uncooked foods.
If contracted, cholera can result in the loss of up to 1.25 litres of fluid diarrhoea per 
hour and up to a total of 60 litres in the course of a severe intoxication. The stool is 
low in protein and high in Na+, K+, CT and HCOg" (Levine et a l, 1983).
In the absence of counteractive measures, case fatality rates can exceed 20%. 
However, cholera is treatable with antibiotics and, more importantly, with oral 
rehydration therapy (ORT), in which isotonic solutions of glucose and salts are 
continually fed to the victim, replacing those lost through diarrhoea. This simple 
remedy is estimated to save the lives of one million infants each year and is thought 
to be responsible for the relatively low death rate in the South American outbreak of 
thel990’s. In Tanzania in 1977, ease fatality rates were reduced from 55% to 1.6% by
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the introduction of ORT, whilst WHO figures show a fall in world-wide case fatality 
rates from 49.3% in 1961 to 1.7% in 1993 (Black, 1986; Hirschhorn and Greenough, 
1991; Anonymous, 1994b).
Vibrio cholerae
Snow's demonstration of the source of cholera in 1854 (see above) did not lead to 
isolation of the causative organism until advances in bacteriological technique made 
such breakthroughs possible. Robert Koch, the originator of many such technical 
improvements, turned his attention to cholera in 1883, being appointed leader of an 
investigation into the disease by a German government alarmed at the prospect of an 
Egyptian outbreak spreading to mainland Europe. Having arrived in Egypt as the 
epidemic was receding, he moved on to Calcutta in order to continue his work 
(Brock, 1988). It was here that he isolated an organism which, he said, was 'not quite 
straight, as other bacilli are, but slightly curved, comma-like' As these organisms 
were present only in the stool or intestines of cholera victims and not in healthy 
people, nor those suffering any other illness, he concluded that Vibrio cholerae was 
the causative organism of the disease (Anonymous, 1884).
The epidemic and pandemic outbreaks of cholera seen thus far are due to the strain V. 
cholerae 01 for which man is the only natural host. Two distinct biotypes of G1 have 
been identified, namely Classical and El Tor (named after the field station where it 
was first isolated), each of which has Ogawa and Inaba serotypes. The ratio of mild to 
severe cases with the Classical biotypes is 4 or 5 : 1 whilst that with El Tor is 40 or 50 
: 1. The normal infective inoculum is thought to be around 10^ to 103 organisms, and 
in fully healthy volunteers 10  ^ organisms of the less severe El Tor Inaba strain, when 
administered with bicarbonate to neutralise stomach acid, caused a mild diarrhoeal 
disease in four out of six subjects. Administration of 10^ organisms of the same 
biotype and serotype without bicarbonate failed to infect (Levine et a l, 1983; Black, 
1986).
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A new serogroup of V. cholerae which is immunologically unrelated to either the 01 
biotypes or to any of the non-Ol serotypes, and designated 0139, emerged in India at 
the end of 1992. Although still centred in Asia, the WHO express the fear that, should 
it spread, it may cause an excess of deaths amongst adults in those areas where V. 
cholerae 01 is presently endemic, and may reverse the trend of ever-decreasing case 
fatality rates. A vaccine against this strain is thus one of their major research priorities 
(Anonymous, 1994b; 1995b; Hirst, 1995).
Escherichia coli diarrhoeal disease
All cases of diarrhoea displaying the classic symptoms of cholera were recorded as 
such regardless of the absence of V. cholerae from stool samples until, in the decade 
following the Second World War, E. coli strains (today called enterotoxigenic E. coli 
or ETEC strains) were seen to be associated with similar diarrhoeal disease (Sack, 
1975). De et al. (1956) demonstrated that such strains were capable of inducing 
identical symptoms to cholera in ileal loops of rabbits.
E. coli strains are responsible for around 20% of severe diarrhoeal cases in infants and 
were found in studies in Bangladesh, Zaire, Brazil and Thailand, to be the most 
frequent pathogen in samples taken from 2-year-olds receiving clinical treatment for 
diarrhoea (Hirschhorn and Greenough, 1991; Black, 1993).
The major syndrome attributable to ETEC in numerical if not pathological terms, is 
the aforementioned traveller's diarrhoea. The cause of the most common 
manifestation, a watery stool containing no blood or body tissue (i.e. non-dysenteric 
diarrhoea) of three to four days duration (Gorbach et a l, 1986) had remained a matter 
of speculation until E. coli was implicated by Kranendonk (1960). Being part of the 
normal gut flora, it had, until then, been overlooked as a potential cause of disease. 
ETEC strains have now been identified, in all countries where epidemiological 
surveying has been done, as the most common cause of the syndrome. In twenty- 
seven studies of visitors to Latin America, Asia and Africa, diarrhoea was shown to 
have affected 50% either during or immediately after their visit. Staying in a higher
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standard of accommodation did nothing to lessen the incidence of disease. ETEC 
strains are thought to be responsible for at least 50% of these cases. Aside from 
drinking water, salads, uncooked vegetables and ice cubes are the most frequent 
sources of contamination. E. co/i-mediated diarrhoea ranges in severity from eholera- 
like to mild. In terms of case numbers it is far more significant than cholera, afflicting 
650 million people annually and resulting in 800000 deaths. (Black, 1986; 1990; 
Kean, 1986; Spangler, 1992; Hirst, 1995).
Role of toxins in cholera-like diarrhoeal disease
As already stated, Robert Koch had proposed that the symptoms of cholera were the 
result of a toxin released by the causative organism when he first related V. cholerae 
to diarrhoeal disease in 1884. This theory was not proved until 1959 when Dutta et 
al., using oral administration to infant rabbits previously subjected to gastric lavage, 
and De, using rabbit ileal loops, independently demonstrated toxic activity by cell- 
free culture supernates. The enzymically-active toxin is released into the gut lumen by 
organisms which attach to the mucosa of the proximal small intestine. No damage to, 
nor invasion of, the mucosa by the organism accompanies toxin production, the 
bacteria remaining in the intervillus spaces or crypts until washed out by natural flow. 
Cholera toxin (CT) was isolated in pure form by Finkelstein and LoSpalluto (1970). 
As little as 5|Ug of pure CT (administered with bicarbonate) was shown to be 
sufficient to cause mild diarrhoea in four out of five adult volunteers in just 6 - 14h 
while a dose of 25qg resulted in the loss of around 20 litres of fluid (Levine et al., 
1983).
In the 1960's E. coli was also shown to be a cause of diarrhoea in young animals and 
Smith and Halls (1967), using the ileal loop method of De (1959), were able to show 
that eell-free filtrate of a porcine strain was capable of causing loop distension, thus 
implying the production of a toxin by this bacterium too. A 'heat-labile, non- 
dialysable, immunogenic enterotoxin’ was the first to be identified, from an E. coli 
human strain, by Sack et al. (1971), and was named 'heat labile toxin' (LT),
25
CT or LT intoxication causes massive loss of water and electrolytes from affected cells 
into the lumen of the small intestine thus producing the characteristic 'rice water’ 
diarrhoea and potentially leading to the death of the host from dehydration.
Types of E. coli en terotoxins
Purification of ETEC toxins was to prove a difficult process because of the 
simultaneous production of both heat-labile and a heat-stable enterotoxin (ST) by E. 
coli strains (Smith and Gyles, 1970), and because, unlike CT, these toxins are not 
secreted but are retained within the bacterial periplasm. Sack (1975) defined ST as 
being able to withstand a temperature of 100°C for 15 minutes while LT is destroyed by 
treatment at 60°C for 30 minutes. Around 35% of strains isolated worldwide cause 
severe diarrhoea, through the production of both ST and LT. Less severe symptoms are 
caused by the 30% of strains that are LT + / ST - and by the 35% that are LT " / ST+.
As this work will primarily be concerned with LT, ST will be briefly summarised here. 
There ai*e two types, designated ST-I and ST-II which are related only in that they are 
both heat-stable, plasmid-encoded, low relative mass peptides capable of causing 
diarrhoea. ST-I is a single peptide of 18 or 19 amino acids (depending on host) with a 
relative molecular mass (Mr) of around 2000 which recognises a host intestinal 
epithelial receptor, localised in the brush border membrane. After attachment to this 
guanylate cyclase type C receptor, diarrhoea results from the raising of cellular levels of 
cGMP, a cellular signal molecule. ST-II is 48 amino acids in length and appears to be 
produced by porcine ETEC only. The receptor and mechanism are as yet unknown 
although diarrhoeal effects may be produced by raising levels of cellular bicarbonate. 
ST types are not antigenically related to either CT or to LT (Acheson, 1992; Gyles, 
1992; Sears and Kaper, 1996).
Green et al. (1983) identified a second distinct serotype of LT and Pickett et a l (1986) 
proposed the names LT-I for the classical type and LT-II for the new type. Despite 
sharing a similar structure and mode of enzymic action, LT-II is not
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neutralised by antisera against either LT-I or CT, while its active portion shows only 
around 56% sequence homology. Its binding portion shows no homology with those 
of CT and LT-I and recognises a different receptor. It is thus probably only distantly 
related to CT and will not be given further coverage in this report.
Comparison of LT and CT
Since De et a l (1956) reported that ETEC strains were capable of inducing cholera­
like symptoms, substantial similarities between LT-I and CT have been demonstrated. 
Both porcine LT-I (LTp-I) and human LT-I (LTh-I) were shown to be antigenically 
related to cholera toxin (CT) (Gyles and Barnum, 1969; Smith and Sack, 1973) and to 
each other. Although not identical, LTh-I and LTp-I show 95% (Honda et a l,  1981) 
or 96% (Yamamoto and Yokota, 1983) sequence similarity and for the purposes of 
this report will be considered, unless otherwise specified, as the single entity 'LT-I'. E. 
coli -mediated diarrhoeal diseases of other animals have been reported; for example, 
Inoue et a l (1993) sequenced a chicken strain (LTc-I); however, they concluded that 
this was in fact identical to LTh-I.
Clements and Finkelstein (1978a; 1978b) demonstrated immunologically that LT 
shared identity with both choleragen (the cholera holotoxin) and choleragenoid (the 
non-enzymic binding portion of cholera toxin) suggesting that LT shared a similar 
structure. This was confirmed by electrophoretic separation of various cross-linked 
moieties (Gill et a l, 1981). It has also been reported that LT-I and CT catalyse similar 
reactions, share 79% sequence homology and recognise the same host cell receptor 
(Holmgren, 1973; Moss and Richardson, 1978; Dallas and Falkow, 1980). Each of 
these points will be expanded upon later in this report. In addition, both CT and LT 
are potent immunogens. On contacting mucosal surfaces they can stimulate 
production of both secretory IgA and systemic IgG and when administered along with 
another antigen they can act as adjuvants, stimulating the response to that antigen 
(Dougan, 1994).
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These similarities allow the classification of LT and CT as 'cholera-like toxins', 
however, differences do exist. LT had been shown to be plasmid-encoded by Smith 
and Halls (1968) whilst Vasil et al. (1975), by a series of conjugation experiments, 
showed that CT is chromosomally-encoded. Location of the toxin is also a point of 
difference. Whilst both De (1959) and Dutta et al. (1959) had demonstrated the 
presence of CT in culture-free filtrates, it was only when Richardson (1969) showed 
that cell lysis did not increase its activity that secretion of the toxin into the external 
environment was confirmed. In contrast, Clements and Finkelstein (1979) had shown 
that LT-I was not present in supernatant fluid of carefully prepared cultures, suggesting 
that it was cell-associated. Hirst et a l (1984a) proved that it is periplasmically located 
by demonstrating release of toxin on sphaeroplasting of cells (i.e. rupturing of cell 
walls with lysozyme whilst maintaining the integrity of the plasma membrane).
Structure of LT-I
The earlier-mentioned difficulty in purifying LT-I made characterisation of the toxin 
problematical (an account of purification methods is given on page 48). Prior to 
definitive purification by Clements and Finkelstein (1979), reported Mr's showed 
variations indicative of the lack of purified material, however, it is now known that LT- 
I is assembled from heavy and light subunits.
The heavy 'A' subunit and the light 'B' subunit are transcribed from a di-cistronic 
mRNA, translated, and processed to mature proteins of 240 and 103 amino acids 
respectively (Dallas and Falkow, 1980). The A subunit has Mr of 28000 whilst the B 
subunit has Mr of 11400, with LTp-I being larger due to minor amino acid variations 
(Hofstra and Witholt, 1984; Leong et a l,  1985). These relative masses correspond 
closely with those reported for CT (Lonnroth and Holmgren, 1973). A comparison of 
subunit Mr of CT, LT-I and LT-II is shown in Table 4.
The A subunit can be proteolytically nicked by tryptic digestion in vitro to yield Ai and 
A2 peptides (Mr of 22000 and 5500 respectively) which remain joined by a disulphide 
bond between a C in each of the two fragments.
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Toxin Holotoxin A subunit Al
fragment
A2
fragment
B subunit
CT 85000 27000 22000 5500 11600
LT-I 88000 28000 22000 5500 11400
LT-II 83000 28000 21000 7000 11800
TABLE 4 : Relative masses of components of cholera - like toxins
After Gyles, 1992.
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Gill (1976) predicted from results obtained on polyacrylamide gels that the CT 
holotoxin consisted of five B subunits bound in the form of a ring which facilitated 
binding of the toxin to the host epithelium while the enzymically active A subunits 
lay in the centre of the ring. He subsequently predicted this to be the case in LT-I also 
(Gill et a l ,  1981). X-ray crystallography has since confirmed the predicted 
conformation for LT-I to be correct with the holotoxin consisting of two subunits 
which, while functionally independent, are closely bonded. The A i portion is 
triangular and is hinged to the long a-helix that is A% by a disulphide bridge near to 
the carboxyl- terminus. The A2 a-helix lies along one face of the A] triangle and 
interacts extensively with it. The B subunits form a pentameric ring bonded by six 13- 
sheets at each intersection (three from each monomer) with the central pore of the 
ring lined with a-helices. The ring has a highly charged 'upper' surface with a flat 
appearance whilst the 'underside' is convoluted due to clefts between adjacent 
monomers. The carboxyl-terminal region of A2 passes through the pore in the centre 
of the five B subunits, interacting with those subunits and holding the Ai subunit 
above the 'flat' surface of the B ring (Sixma et a l, 1991 ; 1993; van Heyningen, 1991). 
Figure 3 is a schematic diagram of the B subunit pentamer showing the secondary 
structure features revealed by X-ray crystallography.
Export of LT to the periplasm
Hofstra and Witholt (1984), with a series of pulse chase experiments using (^^S) 
methionine, demonstrated that LT-I originates in the cytoplasm as pre-LT-A (Mr of 
29500) and pre-LT-B (Mr of 13500). Pre-LT-A and pre-LT-B were shown to have 
signal sequences of 18 and 21 amino acids respectively. Such sequences serve to 
target proteins across the cytoplasmic membrane into the periplasm, although they 
have no influence on whether or not they remain there (Hirst and Welch, 1988). The 
discovery of the LT signal sequence confirmed the conclusion that Dallas and Falkow 
( 1980) had drawn from a study of the amino acid sequence of LT. They had presented 
four lines of evidence that a signal sequence was present: (i) the lengths of the
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FIGURE 3 : Secondary structure of the B subunit pentamer
Structural features as revealed by X-ray crystallography include the a-helix-lined 
central pore formed by the five monomers (each differentially coloured). (After 
Sixma et al, 1991)
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putative signal sequences were consistent with those previously reported {ie. 
approximately 20 amino acids); (ii) the position of the cleavage point, after a glycine, 
was also consistent with others; (iii) the sequence resembled known signal sequences, 
especially in regard to its high hydrophobicity; (iv) LT was thought at that time 
(subsequently proven, see above) to be a periplasmic protein. Hirst et al. (1994) report 
that LT export is unaffected in mutants lacking either the Sec or GroEL 'chaperones' 
most frequently associated with export, suggesting that in this case another less well 
defined system is involved.
Hirst and Holmgren (1987a) have demonstrated that CT holotoxin is secreted from 
the cell in its complete form. In a further paper, (Hirst and Holmgren, 1987b) they 
used pulse labelling to confirm that monomeric B is exported into the periplasm, that 
it associates in around 1 minute to form pentameric B rings and that it is these intact 
rings which, after a pause, are secreted into the surrounding medium. From these 
results they concluded that folding of the proteins into their mature conformations 
must occur in the periplasm. This work thus confirmed that the secretion of CT was 
necessarily a two-stage process (cytoplasm to periplasm then periplasm to outside) 
and was thus typical of the general secretory pathway, (GSP) seen in several species 
of Gram negative bacteria {eg. Klebsiella, Pseudomonas, Erwinia) rather than the 
single-step, signal peptide-independent type secretion typified by E. coli a -  
haemolysin.
Genetic alterations influencing the three or four carboxyl-terminal amino acids 
profoundly affected the ability of the B subunit protein to assemble and secrete due to 
the effect this had on the ability to fold (Sandkvist et a l, 1990). That at least some of 
the folding is mediated by disulphide bonding was suggested by the work of Hardy et 
al. (1988) who demonstrated that the addition of dithiothreitol, which reduces 
disulphide bonds, to growing LT-producing cells arrested formation of B subunits. 
This finding was confirmed by Yu et al. (1992; 1993) who reported that di sulphide- 
bonding protein A (DsbA) was produced by both CT- and LT-producing strains. This 
protein, first described by Bardwell et al.{\99\), is an enzyme (Mi- of 21000) with
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thiol disulfide oxidoreductase activity and is thus a promoter of disulphide bond 
formation. Hirst et al. (1994) have shown that disruption of the dsbA gene causes a 
100-fold reduction in LT production.
Although single B subunits can spontaneously form pentameric rings independent of 
A subunit (thus forming the above mentioned choleragenoid), Hardy et al. (1988) 
showed that incorporation of A subunit can elicit a three fold acceleration in 
oligomerisation of B subunits and that, in solution, mature A subunits cannot 
associate with complete B pentamers. Orlandi and Fishman (1993), however, have 
shown that A subunit can associate with B pentamers which are membrane bound to 
form active holotoxin.
Secretion of cholera-like toxins from the periplasm
Extracellular secretion is relatively rare in E. coli, but much less so in Vibrio species. 
V. cholerae for example, is known to secrete a number of extracellular proteins 
including at least three types of protease (Young and Broadbent, 1982) as well as CT 
itself.
It was shown by Hunt and Hardy (1991) that LT could be released from the producing 
cell by growth in medium containing physiological concentrations of bile salts, an 
effect which could be increased by augmentation of the medium with trypsin. The 
conclusion drawn was that host factors may facilitate the release of LT by non- 
specifically permeabilising the outer membrane of the cell. Other reported results 
suggest that a more specific system is also involved. Firstly, Pearson and Mekalanos 
(1982) created the plasmid pJM17 by cloning the genes for CT (A and B) into 
plasmid pBR322. E. coli K12 strains carrying this plasmid produced CT, however 
94% of this normally exported toxin remained cell associated. Following on from 
this, plasmid-encoded LT holotoxin (Neill et al., 1983) and either the LT-A or LT-B 
subunit alone (Hirst et a l, 1984b) were expressed in V. cholerae. In these instances, 
the normally periplasmic LT was secreted, as was the B subunit; the A subunit alone 
remained cell associated. This suggests that there is a specific secretory apparatus in
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V. cholerae which recognises structural elements of the B pentamer. Further to this, 
Hirst and Holmgren (1987a) showed that no other periplasmic protein was released 
along with CT in this system.
Secretion of CT is therefore, most probably, a complex process, involving as it does, 
translocation of the proteins across both cell membranes. Subunits appear to cross the 
cytoplasmic membrane as monomers which then fold and form the mature toxin that 
will be secreted to the outside. The clear implication is that the failure of E. coli to 
secrete LT is primarily due to its lack of a mechanism for passage across the outer 
membrane, as it can be secreted without any modification by V. cholerae.
Overbye Michel et al. (1995) used pMMB68 (see page 45) and other plasmids to 
transfer the etxB gene (under the control of an inducible promoter) into a range of 
such Gram -ve species. On testing for the secretion of LT-B, only members of the 
Vibrionaceae m d  Aeromonaclaceae appeared capable of doing so (retention of (3- 
lactamase in the periplasm was also monitored to confirm that the outer membrane 
was intact). This result is reported as being consistent with an observed similarity in 
the amino acid sequences of the GSP proteins of V. cholerae and A erom onas  
hydrophila.
The GSP in V. cholerae is thought to involve accessory proteins. The gene coding for 
the first of these to be identified was named extracellular protein .yecretion {eps) E 
(Sandkvist et a l, 1993). Now, twelve such eps gene products have been identified and 
the suggestion is that they form a multi-protein complex that permits specific 
translocation across the outer membrane. Mutations in 6 eps genes, including epsE, 
have been shown to abolish translocation, as demonstrated by a build-up of CT in the 
periplasm. Further eps gene products have been shown to be necessary for export in 
other species and are likely to be so in V. cholerae also (Sandkvist et a l, 1995). The 
exact mechanism involved remains poorly understood, but it has been clearly 
demonstrated that it is specific to designated proteins; periplasmic proteins such as 13- 
lactamase or alkaline phosphatase are not concomitantly secreted. The location of the 
eps gene products is similarly uncertain: sequence data shows that epsE lacks both a
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leader sequence (suggestive therefore of a cytoplasmic location) and a long stretch of 
hydrophobic amino acids, capable of spanning a membrane (Sandkvist et a l, 1993). 
Thus it is probably membrane-associated, although not necessarily permanently so 
(Overbye Michel et a l, 1995).
This issue of secretion of LT-B by Vibrio species is further discussed on page 45. 
Host receptor for cholera-like toxins
The first breakthrough towards elucidating the nature of the host cell moiety to which 
the B subunit pentamer of cholera-like toxins bind came from van Heyningen et al. 
(1971) who showed that a mixture of gangliosides produced a blocking effect on CT 
action. Gangliosides are oligosaccharides linked to hydrophobic ceramide backbones. 
The ceramide anchors the ganglioside into the cell membrane leaving the 
oligosaccharide projecting from the cell and thus available for interaction with ligands 
(Moss and Vaughan, 1991). Holmgren et al. (1973) showed that cholera toxin bound 
with great avidity to the cell surface ganglioside Gmi (for structures of gangliosides 
see Table 5) then further showed that LT did likewise (Holmgren, 1973). It is now 
established that Gmi is the functional binding site for CT (Griffiths and Critchley, 
1991) with the CT recognising the terminal GalNAc - Gal sequence.
Holmgren et al. (1985) removed the lipid from human brush border membrane 
(BBM) and whole cell membrane. CT could no longer bind to such a membrane 
suggesting that it is almost completely specific for Gmi, however LT-I binding was 
unaffected. This suggested that, as well as ganglioside, LT-I was also able to bind to 
non-lipid (presumed glycoprotein) receptors. Holmgren confirmed this by showing 
that free CT-B subunit, which blocks the activity of CT, had no effect on the activity 
of LT-I bound to delipidised membrane, thus indicating that the glycoprotein is an 
actual receptor rather than simply a non-specific binding site. Free LT-B subunit 
blocked both CT and LT-I activity, presumably by blocking both ganglioside and 
glycoprotein receptors. Fukuta et al. (1988) demonstrated weak binding by CT and 
LT-I to Go lb, and by LT-I only to Gm2 and asialo Gmi, by immunostaining of thin
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G m i Gal - GalNAc - Gal - Glc - Ceramide
I
NANA
asialo-GMi Gal - GalNAc - Gal - Glc - Ceramide
Gm2 GalNAc - Gal - Glc - Ceramide
I
NANA
Güib Gal - GalNAc - Gal - Glc - Ceramide
I
NANA
I
TABLE 5 : Structures of gangliosides.
Abbreviations : Gal - Galactose ; GalNAc - N  - Acetylglucosamine ; Glc - Glucose ; 
NANA - sialic acid {N - acetylneuraminic acid)
3 6
NANA
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layer chromatograms. As the B subunits of CT and LT-I show 82% sequence 
similarity there is scope for different receptor recognition. Griffiths and Critchley 
(1991) used Wistar rat BBM to study binding to CT and LT-I. From this study they 
concluded that LT-I binding could be blocked by galactose and the galactose-specific 
lectin, ricin, suggesting that LT-I binds to BBM galactoproteins, these showing only 
weak affinity for CT. They also suggested that there are some 20 to 30 times more 
binding sites for LT-I than for CT in rat BBM, with strain and species differences in 
expression of these moieties. Holmgren et a l  (1985) reported no difference in 
numbers of LT-I and CT binding sites in human BBM.
With the holotoxins of CT and LT-I containing five B subunits, binding to receptors 
is multivalent with five potential binding sites per molecule. The fluid nature of the 
membrane and the flexible nature of the oligosaccharide extension probably facilitates 
this (Moss and Vaughan, 1991).
Orientation of bound pentameric rings
One of the most surprising aspects of the structure of LT, as determined by Sixma et 
al. (1991; 1993) was the finding that it was the convoluted underside of the B ring 
which presented to the membrane of target cells. This orientation places the A; 
subunit on the opposite side of the B pentamer from the host membrane which, given 
that the pore in the centre of the ring is too small to easily allow Ai to pass through 
(as originally predicted by Gill (1976)), poses a question as to how the Ai subunit can 
contact the membrane in order to insert. This arrangement was confirmed by Orlandi 
and Fishman (1993) who demonstrated that membrane bound holotoxin could still 
bind anti-AI subunit specific antibody and that intact holotoxin with anti-A | FAb 
fragments bound to it was not prevented from binding to a membrane. From these 
findings it was apparent that the Ai subunit of bound holotoxin must be oriented 
away from, and not towards the host membrane (see Figure 4).
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FIGURE 4 : Cholera-like toxin anchored to a membrane.
After Montecucco et a l, 1991. Attachment is via ganglioside molecules (shown in 
black). Note that the B subunit intervenes between the A subunit and the membrane.
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Binding of cholera-like toxins to GmI
Further crystallography was performed on CT and LT bound to both galactose and 
Gmi (Merritt et a l, 1994a; 1994b). The work on Gmi binding showed each of the five 
binding sites to be located almost entirely within a single B subunit, with only a 
single hydrogen bond to a moiety on an adjacent subunit. A schematic representation 
of the binding of Gmi in the cholera toxin pocket, taken from Merritt et a l (1994a), is 
seen in Figure 5.
Bonding ideally involves the terminal galactose and the sialic acid, with GalNAc and 
the second galactose playing a minor role and the glucose playing no role at all. It is 
worth noting that of CT is not conserved in LT. Being part of the binding site, it 
is possible that it accounts for the different range of gangliosides that each can bind 
to.
Binding is primarily to one subunit, with a single G being the only residue involved 
from an adjacent subunit. Hence, a toxin molecule can bind five Gmi molecules, one 
per subunit.Although sialic acid is a feature of all but the asialo-gangliosides, LT can 
bind to galactose, lactose or agarose alone with sufficient avidity to allow these 
sugars to be used as ligands in affinity chromatography, as discussed on page 48. 
Another outcome of these investigations (Merritt et a l,  1995) is of great interest. 
When investigating receptor binding of CT-B, B-subunit pentamers featuring a G33 
to D mutation were produced. These pentamers unexpectedly joined together by the 
insertion of a pentapeptide loop, (consisting of residues 10 to 14) of one, into the 
GM 1 -binding site of another. As each pentamer acted as both 'donor' and 'receptor' a 
lattice of conjoined pentamers was formed. The amino acids involved in this loop 
(AEYHN), bonded in a manner analogous to the natural receptor, with the imidazole 
ring of HI 3 both stacking over the indole ring of W88 and donating a hydrogen bond 
to E 51 in the manner of GMi (see Figure 5). Although no equivalent of the sialic acid 
portion of Gmi was seen, by being able to insert and bind in the receptor-binding site 
of CT-B, this peptide was therefore possibly mimicking Gmi-
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FIGURE 5 : Hydrogen bonding between CT and ganglioside GmI*
Residues in the CT binding pocket are shown in rectangles, solvent molecules as 
ovals. All of the binding pocket residues belong to B subunit 5, except for which 
is from an adjacent subunit.
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Enzymic effect of cholera-like toxins
Investigations into the way in which cholera-like toxins induced diarrhoea led to the 
finding reported by Field et a l  (1969) and Greenough et a l (1969) that CT had the 
same effect on rabbit intestine, and could be blocked by the same inhibitors, as 
chemical agents which caused an increase in the levels of cellular cAMP. Gill et a l 
(1976) showed that an increase in cAMP in pigeon erythrocytes when treated with the 
A l subunit of LT was due to NAD- and ATP-dependent ADP ribosylation of a 
regulatory protein of the host cell. Moss and Richardson (1978) subsequently 
demonstrated that Ai had NAD-glycohydrolase and ADP-ribosyltransferase activity, 
and thus could catalyse the reactions
N A D ---------------------> ADP-ribose + nicotinamide + H+
NAD glycohydrolase
NAD + arginine--------------------- > ADP-ribose-L-arginine + nicotinamide + H+
ADP ribosyltm nsfem se
Structure and function of G proteins
The regulatory protein affected by A% of CT and LT is a signal transducing guanine 
nucleotide-binding (G) protein which would normally function by coupling hormone 
and neurotransmitter receptors to their specific intracellular effectors. The particular 
G protein targeted by CT and LT-I for ADP-ribosylation is Gg. Adenylate cyclase 
activity is modulated by Gg (stimulatory) and Gj (inhibitory) proteins. G§, in common 
with other G proteins, is a heterotrimer which consists of three subunits termed a , (3 
and Y . It is the a  subunit which stimulates adenylate cyclase, while the p and y 
subunits exert an inhibitory effect on its activity. Gg, in common with other G 
proteins, is activated by the binding of GTP thus :
(1) Gg + G T P ---------------- > {Gg.GTP}
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(2) {Gg. GTP} + adenylate cyclase-------------------> {Gg.GTP.adenylate cyclase}
ATP-------------- >cAMP
The binding of GTP results in the dissociation of the a  from the p and 7 subunits. Gg 
does not remain in a state of permanent activation, however, as it is intrinsically a 
GTPase, an enzyme which catalyses the conversion of GTP into GDP, thus promoting 
reassociation of a , P and 7.
Hormones, on binding to receptors, would normally accelerate the release of GDP 
from Gg thus creating new binding sites for stimulatory GTP on the a  subunit. The 
intrinsic GTPase activity of the a , and the inhibitory nature of the p and 7 subunits 
would serve to modulate this activity (Neer and Clapham, 1988; Fishman, 1990; 
Moss and Vaughan, 1991).
Export and activation of cholera-like toxins
Although the nature of the binding of the B subunit to the cell and the enzymic 
activity of the A subunit are well understood, the specific mechanism that links the 
two processes is much less clear. After the binding of the B subunits to the 
ganglioside receptor, the A subunit of CT or LT-I must be internalised and activated. 
It is probably the insertion and activation events which account for the lag period 
observed between binding of the toxin to the host cell and the increase in cellular 
cAMP: with disrupted cells, no such delay occurs (Fishman, 1980).
In order to activate the enzymic subunit, it must firstly be nicked to Ai and A2 
subunits (Clements and Finkelstein, 1979). Although it had been suggested that 
cholera vibrios produce a haemagglutinin / protease which is capable of mediating 
this cleavage (Gill and Rappaport, 1979; Booth et a l, 1984), recent evidence suggests 
that host factors may be involved. Such cleavage is not, however, essential for 
secretion as both porcine and human LT were released from a genetically modified V. 
cholerae without being nicked (Hirst et a l, 1984b).
Gill and King (1975) were the first to show that the A] subunit of CT is enzymically 
active only after reduction of the disulphide bond linking it to the A% subunit. A i,
42
once activated, is enzymically functional in the absence of CT-B but is unable to 
penetrate target cells, therefore confirming that the B subunit is necessary for receptor 
binding. When this reduction occurs is not yet known.
The results from photolabelling experiments using liposomes suggest that, triggered 
by the reduction of the disulphide bond, the Ai subunit of CT is inserted into the 
target cell membrane with A% and the B pentamer remaining on the outer surface 
(Tomasi and Montecucco, 1981) The crystallography work of Ribi et a l  (1988) led to 
a similar conclusion. Using intact cells, however, Janicot et a l  (1988) found that on 
toxin insertion, whole toxin, subunit A and subunit B were no longer accessible to 
antibodies, and therefore proposed that the holotoxin molecule is taken up by 
endocytosis.
Any theory that seeks to give an account of events within the cell must explain the 
fact that, whilst the majority of Gg is located in the brush border (apical) membrane, 
adenylate cyclase is found at the opposite end of the cell, on the basolateral 
membrane. Based on work carried out using the epithelial cell line T84, Lencer et a l 
(1995a; 1995b, 1997) and W olf et a l  (1997) have suggested the following 
mechanism for CT.
Binding to the cell is at caveolae (invaginations) in specialised detergent-insoluble 
microdomains (DIGs), where Gmi is clustered. The toxin-GMi complex is drawn into 
an apical endosome, where it is activated by being nicked by a host serine / protease 
(when entering the cell via the basolateral membrane, this activation does not occur). 
The presence at the carboxyl-terminus of A2 of an 'address' signal (KDEL in CT, 
RDEL in LT), directs the complex through the Golgi to the endoplasmic reticulum 
and thence from apically recycling to basolaterally targeted membrane structures. 
Fusion of these vesicles to the basolateral membrane is at a site near the Gg - 
adenylate cyclase complex. Reduction of the disulphide bond between A; and A2, in 
this model, presumably occurs at the Golgi / endoplasmic reticulum stage of 
processing (Sears and Kaper, 1996).
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What is clear is that once in the target cell, the toxin is unable to intoxicate any 
adjoining cells and is thus sloughed off with the dying cell. This imposes self­
limitation on the extent of CT-mediated diarrhoeal diseases (Spangler, 1992).
Activation of Gs by cholera-like toxins
Once activated and in situ, A] catalyses the transfer of ADP-ribose from NAD to 
on the a  subunit of Gg. This promotes an increase in its sensitivity to GTP and loss of 
its GTPase activity thereby stabilising the G protein in its GTP bound form. As a 
result, GDP is released and binding of further GTP is promoted. Dissociation of the a  
subunit from the inhibitory p and y subunits is also irreversible. The production of 
cAMP is now activated in an unregulated manner as adenylate cyclase activity 
undergoes a several hundred-fold increase. It is this uncontrolled and irreversible 
increase in cellular cAMP which was thought to cause the loss of water and 
electrolytes symptomatic of V. cholerae or E. coli intoxication (Fishman, 1990; Lee et 
a l, 1991; Moss and Vaughan, 1991). Contributory to ADP-ribosylation are ARF's, a 
family of GTP-binding host proteins, (Mj- of -20000) that have been shown to 
stimulate the activity of CT and LT. In both cases the activity was directly associated 
with the Aj subunit, and therefore was not simply the acceleration of a physical 
function such as the release of Ai from A%. Exactly how these proteins fit in to the 
overall picture is still, however, unclear (Moss and Vaughan, 1991).
There does remain some doubt as to whether increased cAMP alone is responsible for 
all the observed physiological changes resulting from intoxication. It has been 
demonstrated that cAMP on its own does not cause fluid accumulation in ileal loops 
while prostaglandins (which show a marked increase in concentration during CT 
intoxication) can cause such accumulation. The suggestion is thus made that 
prostaglandins may also play a role in disease pathogenesis (Peterson and Ochoa, 
1989). The fact that two other G protein subunits, G;a and Gooc^  may also be ADP- 
ribosylated by CT (Rappuoli and Pizza, 1991) again suggests that the fluid
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accumulation effects seen in cholera-like intoxication are the result of a rather more 
complex series of events than originally envisaged.
PART 3 : LTB PRODUCTION, PURIFICATION AND 
ANALYSIS
In view of the detailed characterisation of its reaction with Gm i , LT was an ideal 
model system for testing phage display. A surface of purified, immobilised LT-B 
needed to be prepared for panning the phage display libraries.
Origin of B-subunit producer Vibrio 60
Initially LT was purified from isolated whole cells (see below). However, more 
recently recombinant expression systems have been developed in order to learn more 
about the processes of export and secretion in toxin-producing strains. Bacterial 
strains capable of over-expressing and/or secreting toxin subunits have uses in their 
own right.
Vibrio species can export a number of products out of the cell including LT-B, the 
etxB gene product (Hirst et a l,  1984b; see page 33). LT-B has been expressed by a 
modified marine strain. Vibrio 60 pMMB68, developed by Leece and Hirst (1992). 
Expressing LT-B in this strain, rather than V. cholerae, circumvents the problems of 
pathogenicity or simultaneous production of CT (Marcello et al., 1994).
Vibrio species 60 is related to Vibrio anguillarum  and was one of a number of 
baeteria collected from sites along the Pacific coastline of Japan in June 1977 during a 
study of haemagglutinin, an important virulence factor that gives Vibrio species 
adhesive properties (Oishi et a l,  1979). In common with most of the other strains 
analysed, species 60 produced a non-lethal exohaemagglutinin as well as protease, 
amylase and DNase (Ichige et a i,  1988). Analysis of a spontaneous streptomycin 
resistant mutant of this strain, MVT606, suggested that it secreted protease by a 
specific pathway. Treatment of MVT606 with N-methyl-V-nitro-A-nitrosoguanidine 
(NTG) created extracellular protein production (epr) mutants that were incapable of
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secreting protease, which remained in the periplasm. MVT606 and one of its epr 
mutants (MVTl 192) were used by Leece and Hirst for secretion of LT-B subunits.
The original source of the B subunit was a human ETEC, H74 - 114, from which 
Dallas (1983) purified two plasmids. From these he excised the etx genes by 
restriction with Pstl. This fragment was inserted into pBR322 yielding a plasmid,
.pWD600, that was used for mapping of the etx gene. Deletions from pWD600 were 
engineered via three internal restriction sites to yield further plasmids, which were 
transformed into E. coli hosts. One of these plasmids, pWD605, resulted from the 
deletion of four base pairs from the recognition sites of and had the phenotype 
e/xA+ etxB~ , whilst another, pWD615, the result of adding four bases to the middle of 
theXbal recognition site, was etxA~, etxB +.
Sandkvist et a l (1987) excised etx genes from both of these plasmids into a controlled 
expression vector, pMMB66EH. This was developed by Furste et al. (1986), who 
modified an IncQ replicon, RSFlOlO, by inserting a polylinker with an upstream tac 
promoter, a lacF ('super-repressor') gene and the bla (|3-lactamase) gene for selection.
IncQ replicons have a broad host-range and can be mobilised by members of the IncP 
group, (eg. the commonly used RP4) which can transfer genes between, and can 
themselves be maintained in, most Gram -ve bacteria.
A 0.59 kb EccRI / HindTLl fragment of pWD615 that carried the ribosome binding 
site and the entire coding sequence of the etxB gene as well as six codons, including 
the stop codon, from the 3' end of the etxA gene, was excised and inserted into the 
pMMB66EH polylinker, yielding pMMB68, in which expression of etxB was under 
the control of the tac promoter (see Figure 6).
Leece and Hirst transformed pMMB68 into E. coli S I7-1 which has RP4 integrated 
chromosomally, and thence mobilised the plasmid into the marine vibrios MVT606 
and MVTl 192.
Growth of Vibrio 60 pMMB68 in a standard broth, and induction with the lactose 
analogue, iso-propyl thiogalactopyranoside (IPTG), resulted in the expression of etxB 
leading to the secretion of intact B pentamers into the medium (Amin and Hirst,
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FIGURE 6 : Construction of plasmid pMMB68.
The 0.59kb fragment of pWD615 containing etxB was inserted into pMMB66EH 
yielding pMMB68 (Restriction sites : P, Pst I ; E, EcoRI ; H, iTmdlll ; Sa, S a d  ; C, 
Clal ; S, Smal ; Sp, S p d  ). After Sandkvist et a l, 1987.
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1994).
Purification of LT
As stated, the eai'liest attempts at purification of LT were hampered by its periplasmic 
location, and the presence of ST, giving results that were less than clear and 
occasionally contradictory. Generally, in excess of 20 litres of culture was grown in a 
fermentor, then centrifuged and filtered to remove cells. Supernatant fluids were 
concentrated by ultrafiltration and lyophilisation, then further purified by various 
combinations of ammonium sulphate precipitation, gel filtration and ion exchange 
chromatography, isoelectric focusing and preparative polyacrylamide electrophoresis 
(Moon et al., 1970; Dorner, 1975; Dorner et a l,  1976; Finkelstein et a l,  1976; 
Clements and Finkelstein, 1978b). Definitive purification was finally achieved by 
Clements and Finkelstein (1979) who processed whole cell lysate, cell free 
supernatant fluid and a concentrated, ammonium sulphate precipitate of a sodium 
chloride extract of whole cells. Each of these was precipitated with 60% ammonium 
sulphate, dialysed, concentrated by ultrafiltration, and then, exploiting the ability of 
LT to bind weakly to saccharides (see page 39), affinity purified on an agarose 
column. LT was eluted from the column with galactose, the eluate concentrated by 
ultrafiltration and finally purified by gel filtration chromatography. Approximately 30 
times more purified material resulted from the whole cell extract than from the other 
two sources. Around the same time, Kunkel and Robertson (1979) were purifying 
LT from 80 litres of culture by pH extraction of the whole cells, ammonium sulphate 
precipitation, affinity chromatography using hydrophobic and hydroxylapatite 
columns, and gel filtration. The Clements and Finkelstein method of LT purification 
remained favoured (eg. it was used by the University of Groningen group who first 
crystallised the LT toxin (Pronk et a l, 1985; Sixma et a l, 1991) ) until the advent of 
expression systems such as that described above.
The method by which Amin and Hirst (1994) separated LT-B, produced by Vibrio 60 
pMMB68, from other secreted proteins and from culture medium components was 
similai’ to those employed by Clements and Finkelstein (1979) and Kunkel and
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Robertson (1979) (see above), and involved ultrafiltration of 24h culture supernatant 
fluids, precipitation with ammonium sulphate and hydrophobic interaction 
chromatography. In a more recently published procedure, LT-B fusion products were 
purified by isolating material from culture supernatant fluid by differential solubility in 
20% and 60% ammonium sulphate and hydrophobic interaction chromatography 
(Loregian et a l, 1996).
A novel method was developed by Uesaka et a i  (1994), from an earlier technique of 
Clements and Finkelstein, who had bound LT to an agarose affinity column. The 
supply of the appropriate agarose being apparently inconsistent, Uesaka et a l  captured 
LT on commercially available, bead-immobilised galactose. They passed culture 
supernatant fluids from an E. coli strain that carried the LT genes through such a 
column, confirmed that it had bound, and then recovered the toxin by competitive 
elution with galactose solution. This method is similar in concept to that of Tayot et a l 
(1981), who had used a column of immobilised Gmi for affinity extraction of CT 
from V. cholerae supernatant fluid. Uesaka et al, however, report that the Tayot et a l 
method failed to work with LT whereas their method successfully purified both CT 
andLT.
Analysis of purified LT-B
The success of any protein purification protocol can be conveniently assessed by 
sodium lauryl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) (Laennnli, 
1970) and by testing the reaction of the product of purification with an antibody 
specific for the target protein. The antibody specificity of proteins separated by SDS- 
PAGE can be tested by Western blotting, in which the proteins on the gel are 
electrophoretically transferi’ed to more flexible, less fragile nitrocellulose membrane 
for processing. After blocking non-specific binding sites, the membrane is probed 
immunologically with a mouse monoclonal antibody and an anti-mouse antibody 
coupled to horse radish peroxidase (HRP). Detection of reacting protein is by the
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addition of an HRP substrate that results in a colour change. In the Gmi ELISA
technique of Svennerholm and Holmgren (1978), LT-B, specifically captured by plastic-
'coupled Gm i, can be subjected to identical immunological detection.
Protein concentration is traditionally estimated by the method of Lowry et al. (1951), 
based on alkaline copper labelling of the protein. However Markwell et al. (1978) found 
that this method was adversely affected when test samples had a high sugar or EDTA 
content. They reported that sugar-stability could be restored by increasing the
Immobilisation of LT-B for biopanning
As reported earlier, (see page 14), biopanning with phage display libraries has,
egg white. Although suitable in many applications, avidin is basic and may therefore bind 
proteins non-specifically. Its long carbohydrate chains may also interact with sugar- 
binding sites. Use of the avidin derivative streptavidin, a protein of Streptomyces
I
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concentration of copper tartrate. An alternative method of protein estimation is that of 
Bradford (1976), which detects the shift in the absorption maximum of Coomassie Blue 
(from 465nm to 595nm) on combination with protein.
traditionally, been carried out on biotinylated protein immobilised on streptavidin. In 
terms of effectiveness and convenience, this remains a method of choice.
Biotin, a small water-soluble vitamin, spontaneously bonds with avidin, a protein of hen
griseus, can circumvent these obstacles. The exact nature of the interaction between 
streptavidin and biotin remains unknown, although it is believed that the tryptophan rings 
of the streptavidin molecule are the tai’get for biotin attachment.
A protein such as LT-B can be rapidly coupled to biotin, which forms with streptavidin 
the strongest non-covalent bond in nature, by use of commercially available kits. 
Biotinylation is facilitated by the N-hydroxysuccinimide ester of biotinamido-caproic acid 
(BAC-sulfoNHS), which couples spontaneously to primary and secondary amines,
'including the amino acid lysine, by nucleophilic attack at the ester linkage. Biological 
activity is unaffected as this system allows for biotinylation in aqueous solution at neutral 
pH.
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The caproic acid arm of the BAG molecule acts as a spacer molecule, reducing steric 
hindrance between the protein and the biotin / streptavidin interface (see Figure 7). 
There are alternative methods of immobilisation for LT-B. For example, to do so via 
the specific ligand for LT-B, Gmj would be highly effective, and is indeed the basis of 
Gmi ELISA (described on page 82), however, it would not be an appropriate method 
when phage are sought that bear peptides that will occupy the Gmi binding site.
LT-B can also be immobilised by capture by specific antibodies. The anti-LT 
antibody 118.87 (see page 81) or a commercially-available anti-cholera toxin 
antibody, when attached to plastic, will both immobilise added LT-B without 
compromising the binding of Gmi and therefore, presumably, GMi-mimicking phage. 
Although antibodies will adhere directly to naked plastic, a more consistent coating 
can be obtained by binding them indirectly via Protein G. This Staphylococcal cell 
wall protein, first isolated by Bjorck and Kronvall (1984) will attach to a plastic 
surface by non-specific hydrophobic interaction and is capable of non-immune 
binding to most immunoglobulins .
PART 4 : SMITH HEXAMER LIBRARY
The first library tested against LT-BLotin, that of Scott and Smith (1990), displayed a 
hexamer fusion on protein III.
The Smith hexamer library
The Ff class are the phage of choice for display library work as they satisfy the 
principal criterion for phage propagation - they do not normally kill their host (see 'Ff 
class filamentous phage', page 3). Such phage, however, must be propagated by 
continual cycles of infection.
A new strain, fd-tet, was developed from phage fd by inserting the tetracycline 
resistance segment of transposon Tn/9 into the negative strand origin of replication,
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FIGURE 7 : Biotinylation of lysine residues.
(a) Direct coupling to lysine; (b) Coupling via an N-hydroxysuccinimide (NHS) ester 
of biotinamido-caproic acid (BAG). Nucleophilic attack by the lysine amino group is 
indicated by the dashed line.
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meaning that infected host cells could be propagated on tetracycline agar in bacterial 
colonies, in the manner of a plasmid, without the need for infection (Zacher et a l, 
1980; Smith, 1988a).
The Smith hexamer library was developed in a vector, fUSE5, that was based on fd- 
tet (see Figure 8). Firstly, gene III of fd-tet (A) was modified by the introduction, by 
oligouc 1 eotide-directed mutagenesis, of SfH restriction sites between the codons for 
and E^, to yield the phage vector fUSE5. Intracellular RE DNA (see page 8) of 
fUSE5 (B) was prepared from a 2 litre stationary phase culture by boiling and 
caesium chloride centrifugation. A 33 base pair degenerate Bgll fragment (C), 
prepared by polymerase chain reaction, and consisting of 32^ different nucleotide 
sequences was cloned into the Sfil site of fUSE5 (D) (the designation NNK will be 
explained in 'Biasing construction of an epitope library', below). The amino acid 
sequence of the amino-terminus of the mature form of pIII is shown in part E. The 
underlined portions are present in wild-type fd-tet and the part designated 
represents the random hexapeptide insert. The ligation product was electroporated 
into an E. coli host that was then used to inoculate 64 tetracycline-containing agar 
plates, on which only those that had taken-up phage could grow. After incubation, 
each plate contained around 3 million clones which were eluted and the phage 
precipitated and purified (Scott and Smith, 1990).
The final library consisted of 1.3 x 10^4 phage, representing 2 x 10^ different clones. 
Hosts infected with this phage under normal growth conditions give a yield of 
progeny that is around 25% of that seen when wild-type fd are used. However, in 
contrast to fd, yields cannot be increased by vigorous aeration in rich media. Host 
cells infected with fd-tet are resistant to tetracycline at a concentration of at least 
40pg m l'l but result in the production of near-invisible plaques. Enumeration by 
plaque number is therefore not feasible. Rather, transductant colonies are counted, 
these being host cell colonies that have been rendered capable, by fd-tet infection, of 
propagation on tetracycline-containing media (Smith, 1988a).
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A Wild-type gene II
S i g n a l  
p e p t i d a s e  
5 '  - TCC " GCT GAA ACT GTT GAA
A E T V E
B fUSES RF
Sfi\ Sfil
5 '  - TCG GCC GAG G 'T G  GCC TGG GCT G TG • GG GGG GAA AGT GTT GAA - 3  
3 '  -AGG GAA G 'T G  GAG GGG AGC GGA- GAG GG GGG GTT TGA GAA GTT - 5
Degenerate Bgl\ Fragment
GGGGT(NNK)gGGGGGGGGTG 
TGGGGGGA(NNK)gGGGGGGG
D Ligation product
5 '  - TGGGGGGAGG' GGGGT( NNK) gGGGGGGGGTG•GGGGGGAAAGTGTTGAA- 
3 ’ - AGGGGGG • TGCCGCGA( NNK) gGGGGGGC• GAGGGGGGGTTTGAGAAGTT-
E Recombinant pill
NH2 -  A D G A Xe G A A G A E T V  E
FIGURE 8 : Derivation of Smith hexamer library.
Adapted from Scott and Smith, 1990. See page 53 for explanation.
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Biasing construction of an epitope library
A basic element of phage display library construction is the insertion of random 
oligonucleotides into the DNA coding for a coat protein of the phage. However, 
within the genetic code there are not equal numbers of codons coding for each of the 
amino acids. As a result, nucleotide sequences consisting of genuinely randomised 
bases will not code for peptides featuring an equal distribution of the 20 amino acids, 
but will rather exhibit a bias in favour of those for which there are more codons. In an 
attempt to overcome this, both Scott and Smith (1990), and Cwirla et a l  (1990), 
produced phage display libraries carrying random hexapeptides by inserting the 
coding sequence (NNK)g, where N represents an equal mixture of the four bases A, 
C, G and T while K represents an equal mix of G and T only. This will produce single 
codons for 12 of the amino acids, two codons for 5 more and three codons for the 
remaining 3 amino acids as well as the amber stop codon, TAG. Thus in randomised 
hexapeptides produced under NNK biasing, amino acids encoded by three codons 
will be incorporated 3^ times more often than those with only one codon. This ratio 
increases threefold with each additional peptide included in the fusion {ie. 
heptapeptide, octapeptide, 3^;....em.). The full genetic code, the NNK abbreviation 
and codon frequencies are shown in Appendices 5 and 6 (pages 188 and 189).
Devlin et a l (1990), in their pentadecamer (15 amino acid) library used NNS with S 
representing C and G. Like NNK, NNS can yield only 32 of the possible 64 codons, 
and also codes for all 20 amino acids and only one stop codon. Kay et a l (1993) used 
NNB, with B representing C, G and T, to construct their library of 36 amino acid 
inserts. This particular bias allows 48 codons but as this still includes only one stop 
codon the frequency with which it should occur is less than that seen with NNK or 
NNS. A disadvantage of NNB is the disparity in amino acid representation eg. five of 
the possible codons are for S whilst M , E, Q, K and W are coded for only once 
meaning that S could appear 5*^  times more frequently in a 'random' hexapeptide
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library than those others. The number of possible combinations is, however, 
sufficiently high to ensure that each displayed peptide should be unique.
Another strategy is that employed by McLafferty et a l  (1993). Their gene III library 
phage carried 18 amino acid fusions, and had this somewhat unusual pattern: 
A E G X C X Y Y X C X S Y I E G R I V E T V E S  
where the insert is shown in bold letters. The variable part of the insert is described as 
being variegated rather than fully randomised, in that X is produced by NNT and Y 
by NNG. The result of this bias is that X can be any one of fifteen amino acids and Y 
can be any one of thirteen. Eight amino acids can appear in either position. The 
reported advantage of this bias is a reduction in the number of redundant codons, with 
8.55 X 10*^  different peptides resulting from only 1.68 x 10  ^ DNA sequences. By 
comparison, the NNK bias employs 64-fold more DNA sequences to produce only 8- 
fold more possible peptides. The obvious disadvantage is that not every possible 
peptide is coded for. The two C residues are placed to attempt to induce disulphide 
constraint (see page 71).
Other library construction strategies
A E (X X X )i5P6A E
Devlin et a l  (1990) employed a further tactic when constructing their library. The 
amino-terminal aiuino acids of the mature pIII produced was predicted to be -
Î
with first A and E being those seen at the amino-terminus of wild-type phage. They 
were included here to overcome the potential signal sequence processing difficulties 
mentioned earlier (see page 12). The second A E was included in order that, after the 
artificial insert, the wild-type pIII sequence would be present in an uninterrupted 
form. The poly-proline sequence was added as its rigid conformation might serve to 
distance the added peptide fusion from the rest of the protein, thus rendering it more
accessible to binding surfaces. This library was used to identify peptides which would 
bind streptavidin and was thus the first demonstration that libraries can include 
peptide mimics of non-protein ligands.
S
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Uses of the Smith hexamer library
In the original paper by Seott and Smith, two monoclonal antibodies (MAb's), 
specific for the DFLEKI hexapeptide epitope of the protein myohemerythrin, were 
biotinylated, immobilised and probed with a small library (2.3 x 10^ clones) that had 
been prepared alongside the major library. In three biopanning rounds, yields of 
eluted phage, relative to the number of phage originally applied, rose from 3 x lQ-5% 
in the first round to 1% in the third round. In sequencing the final round clones, 
DFLEKI did not occur, however, the most likely explanation for this fact is pure 
chance. In a complete NNK-biased hexamer library there are 32^ possible random 
nucleic acid sequences. However, only three of these will code for DFLEKI. 
Amongst the relatively small number of phage tested by Scott and Smith (only 23 
million clones) there was little possibility of the three sequences actually occurring. 
However, although DFLEKI did not occur, ELISA showed that the phage that were 
selected did bind to the MAb's as effectively as a phage manufactured to display that 
peptide. Inhibition by a peptide including the DFLEKI sequence also followed a 
similar pattern. By way of a negative control, original library material and 
preparations of non-binding phage showed no binding in similar assays.
Both Smith and Scott continued to apply the library in other applications, and in 1993 
used it to attempt to find agonists or antagonists of the S-peptide, one of the two 
products (the other is S-protein) of the partial digestion of ribonuclease (Smith et a l, 
1993). Although neither of the fragments is independently enzymic, when re­
combined activity is restored. This is due to the interaction of a 15 amino acid 
segment of the S-peptide with a cleft in the S-protein. Smith et a l  used the library to 
look for other peptides capable of modulating enzymic activity. Panning revealed a 
series of peptides with near-consensus sequences. One of these, YNFEVL, was 
shown to be capable of blocking the enzymic activation normally resulting from S- 
peptide/s-protein interaction, indicating its antagonistic quality.
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The use to which Scott et a l (1992) put the library is, perhaps, of more relevance to 
this project as they bound library phage to a ligand which does not naturally bind 
peptides. Their work involved Concanavalin A (ConA), a globular protein lectin of 
the Jack bean (Canavlia ensiformis) which, at neutral pH, consists of four identical 
monomeric units, each of which has a site specific for the binding of saccharides. 
These binding sites are most complementary to a-D-mannopyranosyl residues, which 
are thought to bind principally through hydrogen bonds. This high avidity, metal ion- 
dependent, attachment to the saccharide is thought to be part of a cell recognition 
system (Becker e ta l,  1976; Goldstein, 1976).
By use of the library in a standard panning experiment, they were able to identify 
peptides which bound at, or near, the sugar-binding site of ConA with an avidity 
equivalent to that of methyl a-D-glucopyranoside, a natural substrate for the lectin. 
Phage eluted by acid from the Con A surface were characterised in four ways : (i) 
Sequencing revealed a consensus motif (YPY); (ii) Phage selectively bound to ConA 
in ELISA assays; (hi) Phage could be captured by immobilised ConA and (iv) Phage- 
binding to ConA was inhibited by the addition of methyl a-D-mannopyranoside.
The most avidly binding phage, which carried the sequence M YW YPY, not only 
bound ConA with an affinity comparable with that of the natural ligand, but showed 
remarkable selectivity for ConA alone and not for related lectins.
Simultaneously with Scott e ta l ,  Oldenburg et a l  (1992) also reported the isolation of 
phage which bind to the sugar-binding site of Con A. Their work, utilising an 
octapeptide library, drew similar conclusions, and identified the same consensus 
sequence (YPY).
Other uses of phage display in non-protein systems
In a paper which is contemporary with Scott and Smith, Devlin et a l, (1990) (see 
page 56) were the first to demonstrate that phage display could be used to identify 
peptides which could mimic the binding of non-proteins. The library was exposed to 
blocked streptavidin, a protein that has no reported affinity for peptides, and binding
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phage were eluted. Phage stocks were prepared from 60 resultant plaques, then used 
in binding assays and in sequencing work.
The binding assay involved comparing ratios of selected phage and wild-type 
M13mpl9 phage eluted from a streptavidin surface after exposure to a mixture of the 
two. The results suggested that 56 of the 60 selected phage were enriched by a factor 
of 10 relative to wild-type M13mpl9. Adding biotin to the assay system to block the 
streptavidin surface significantly reduced this enrichment. Sequencing of 20 of these 
enriched phage revealed nine different peptide sequences, all of which contained the 
sequence HP, and seven of which contained HPQ at some point in the 15 amino acid 
random insert. This consensus was thus taken to represent the streptavidin-binding 
sequence. The authors point to the fact that both histidine and biotin contain carbon- 
and nitrogen- containing rings.
Hoess et al. (1993) investigated peptide binding to a monoclonal antibody, B3, which 
normally recognises the carbohydrate antigen, LewisY, which appears on the surface 
of adenocarcinoma cells. On sequencing twenty binding clones isolated from an 
octapeptide library, they were all found to contain a sequence, PWLY.
In a review of this branch of the subject Hoess (1993) suggests that the similarity of 
this sequence to that found in the Con A work may indicate that certain amino acids 
are best able to mimic specific sugars. His suggestion is that aromatic amino acids, 
with their cyclic structures, are able to mimic the saccharide rings, and that Y may be 
able, in addition, to establish hydrogen bonding through its -OH group. This theory 
concurs with an idea presented by Scott et al., (1992) who supported the proposal 
with evidence that the replacement of Y with A in ConA-binding peptides resulted in 
a -50%  reduction in inhibitory strength, and the fact that almost all of the selected 
peptides contained at least one residue which was aromatic and one which was 
hydroxylated. In a more recent report, it has been proposed by Phalipon et al. (1997) 
that P can serve to orient aromatic peptides in a manner similar to the branching 
naturally observed in carbohydrates.
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However, as the lab-work stage of this project neared completion a paper by the Scott
PART 5 :LUZZAGO CONSTRAINED NONAMER
into pUC plasmids. The plasmids they chose all carried an ampicillin resistance gene 
and the gene that codes for synthesis of the a-peptide of (3-galactosidase (lacZ). 
Differentiation between the pUC vectors chosen for modification by Dente et a i  was 
dependent on the size and content of a polylinker sequence located within lacZ. 
Insertion of DNA into this polylinker resulted in inactivation of lacZ , and
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and Oldenburg group (Bonnycastle et a i, 1996) cast doubt upon their earlier finding, 
reporting that the peptide that had apparently mimicked the binding of a - D -  
methylmannoside had not reacted with the sugar-binding site, but rather with an 
adjacent site. In a paper produced after further study of the phenomenon, (Harris et 
al., 1997) they stated that true carbohydrate-mimicking peptides appear to be 
relatively rare. The reasoning behind and implications of these findings for this 
project are discussed on page 180. I
LIBRARY
pEMBL family of single stranded vectors
Dente et a l  (1985) sought to create a new family of single-stranded cloning vectors 
without the limitations of insert size that were a feature of the M l 3 phage derivatives 
prevalent at that time. In order to achieve this, they modified one of the widely 
available double-stranded plasmids to single-stranded DNA form, following the lead 
given by Dotto and Horiuchi (1981) and Dotto et a l  (1981), who had cloned into 
pBR322 the intergenic region of the Ff phage f 1 responsible for phage replication and 
packaging {ie. the origin of replication or fl ori). Replication of single-stranded phage 
involves the export of single-stranded phage genomes derived from the double­
stranded RF. By superinfecting cells carrying this modified pBR322 with fl phage, 
progeny virion capsids carrying either pBR322 ssDNA or fl ssDNA were produced at 
roughly the same frequency.
In order to create their family of cloning vectors. Dente et a l  chose to insert fl ori
recombinants could be easily identified by growth of the host cell on medium 
containing X-gal (5-chromO"4-chloro-3-indolyl-|3-D-galactosidase); clones producing 
p-galactosidase were blue, those in which lacZ was insertionally inactivated were 
white.
Dente et a l inserted the 1300 base-pair fl ori sequence adjacent to lacZ in four pUC 
plasmids. This insertion did not affect lacZ  function. The orientation of the insert 
determined which of the two strands of lacZ, from the pUC vector, were encapsidated 
in the virions resulting from infection of a bacterial cell. In pEMBL(+) vectors, the 
antisense strand of lacZ was present, in pEMBL(-) vectors, the coding strand. One 
such phagemid, pEMBL19+, was used by Felici et al. to create the vector with which 
subsequent pVIII libraries were produced.
Figure 9 shows a map of a generic pEMBL vector.
Construction of Felici et al. phagemid vector pC89
To create their own library, Felici et a/. (1991) isolated a 481 nucleotide section of the 
fl genome by restriction with SnaSl and Bsml. The 2 base extension left by Bsml was 
removed by Klenow treatment. This fragment contained DNA sequences for the 
entire gene VIII and the amino-terminus of gene III. This was inserted into 
pEMBL19+ at Sma I, one of the fourteen restriction sites in the poly linker that defines 
this member of the pEMBL family. Clones in which gene VIII was placed under the 
control of the ^lac promoter were easily differentiated as they formed blue colonies 
on X-gal. The residual gene III DNA was removed and gene VIII was joined directly 
to the gene for the a-peptide of p-galactosidase in such a way as to introduce an 
’amber’ stop codon (ie. TAG) between the two. The resulting plasmid (named pC83) 
could be distinguished from parent plasmids by its ability to form a blue colony in a 
supE or amber suppressing host, whilst forming a white colony in a sup° host. The 
pEMBL polylinker was removed and an Eco RI and a Bam HI restriction site 
introduced, these flanking a second amber codon, and phagemid vector pC89 was 
thus complete. A supE host carrying this
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3Ap'”
pEMBL 
~ 4000 bp
ori
lac Z'
polylinker
FIGURE 9 ; Map of a generic pEMBL plasmid.
Markers : Ap', ampicillin resistance; ori, ColEl origin of replication; lacZ', p -  
galactosidase; F l, origin of replication of phage f l  in its two possible orientations (+ 
and “). Family members are defined by the size and composition of the poly linker.
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phagemid, with its double-amber, would appear to be only a white to pale blue colour, 
as lower amounts of a-peptide would be produced in this case. However, 
oligonucleotide insertions at the Eco RI - Bam HI restriction site would remove the 
second amber (see Figure 10) codon so supE hosts carrying pC89 modified in this 
way would be an intense blue on X-Gal.
Felici et a l  created a phage display library by synthesising a double stranded 46-mer 
that included a random 26-mer oligonucleotide (produced by the adding equimolar 
quantities of each of the four nucleotides to the synthesis reaction) positioned 
between EcoBl and BamEll restriction sites. Restriction with these two endonucleases 
yielded a 32 base pair fragment with cohesive ends, suitable for ligation into gene 
VIII of a similarly digested pC89 phagemid. The recombinant phagemids were then 
electrotransformed into Escherichia coli cells and antibiotic resistant cells selected for 
on agar containing ampicillin. In this way, approximately 9.4 x 10  ^independent 
clones were generated, with around 40% of them giving the dark blue appearance on 
X-gal that indicated insertion of random oligonucleotide into the ^coRI - BamHl 
restriction sites of gene VIII. This process is summarised in Figure 11.
As pC89 only contained the genes for pVIII and the fl ori, a second so-called helper 
phage was required to produce infectious phage virions from these selected clones. 
Although wild-type phage can be used as a helper, (see the work of Dotto et al. 
above) it is preferable to use a packaging-deficient helper that encodes all the capsid 
proteins but lacks fl ori in order to promote complementation between phagemid and 
helper. Felici et al. used Fl IRI to co-infect plasmid-harbouring cells to produce 
infectious virions that carried both wild-type pVIII and the coat protein carrying a 
random amino-terminal peptide.
Luzzago constrained nonamer library
A library based on that prepared by Felici et al. was prepared by Luzzago and co­
workers by introducing a C codon at either end of the random oligonucleotide. The 
full implications of this addition are discussed on page 71.
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Wild type GCT GAG GGT GAC GAT CGC
A E G D D P
Eco RI Bam HI
Modified GCT GAG GGT GAA TTC TAG GAT CGC 
A E G E F stop D P
FIGURE 10 : Modification of the amino terminus of gene VIII in construction of 
pC89.
Restriction sites are italicised and cutting points indicated. After Felici et a l  (1991).
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GCCCACTTAAGNMNNNNNNMNNNNNNNNNNNNNNNNNCCTAGGGCG
C GGGTGAATTCNNNNNNNNNMMNNNNNNNNNNNNNNNGGATCC CGC 
GCCCACTTAAGNMMISINNNNNNNNNNNNNNNNNNNNNNCCTAGGGCG
AATTCNNNNNNNNNNNNNNÎSÎNNNNNNNNNNNG
GNNNNNNNNNNNNNNNNNNNNNNNNNNCCTAG
K t t a a g a t e
V.
AATTCNNNNNNNNNNNNNNNNNNNNNNNMJNGga t  c  
1 1  aaGNNNNNNNNNNNNWNNNNNNNNNNNNNCCTAG
FIGURE 11 : Strategy for construction of random nonamer library in pC89.
The oligonucleotide (i) consisted of 46 bases including the 26 randomly generated 
bases (N), and BainYll (underlined left) and EcoRI (right) restriction sites. The 
complementary strand was synthesised (ii) and the duplex digested with BamRl and 
EcoRI (iii). The vector pC89 was digested to produce compatible ends (iv). Finally, 
the oligomer was ligated into the plasmid to yield the library (v). Adapted from Felici 
et al. (1991).
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An oligonucleotide including a 27 base random sequence, flanked by the bases GCA 
(complementary to the C codon TGG) and including restriction sites for EcoKl and 
Bam Rl was synthesised, along with a complementary primer. After annealing, the 
primer strand was extended and the resulting duplex was digested with the 
appropriate restrictionendonucleases. The fragment was then inserted into pC89, to 
form the Luzzago nonamer library. This process is summarised in Figure 12.
The amino acid sequence of the final insert was therefore - E F C X9 C G », the 
additional glycine codon (GGG) being added in order that the restriction site for 
Bam El (GGATCC) would be present in all displayed peptides. This insert therefore 
yielded modified protein VIII with the sequence, from the mature amino-terminus,
A E G E F C X 9 C G D P A ....
Wild-type protein VIII has the sequence
A E G D D P A ....
D having been lost during the insertion.
:The library consisted of 1 x 10  ^ independent clones; plating on X-gal revealed that 
25% carried a productive insert. The helper phage M13K07 was employed to harvest i
phage virions. This helper, which is based on phage M l3, was developed by Vieira 
and Messing (1987) to package preferentially phagemid DNA ahead of phage DNA. ?
The complete absence of C residues from wild-type pVIII aided analysis of the thiol 
content of isolated clones. Of six that were chosen at random, five were displaying 
some peptides in cyclised form, indicating that the peptide was held as a rigid loop 
structure. Luzzago et al. used their library to investigate the selection of phage by 
monoclonal antibodies (MAb) against discontinuous epitopes. Others, including Scott 
and Smith (1990), Cwirla et al. (1990) and Felici et al. (1991) had previously shown 
that the sequence of the peptides selected by MAbs against linear epitopes were 
highly homologous to the original epitope. However, in another paper by Luzzago's |
group, (Felici et al., 1993) using the library described above, it had been shown that A
peptides that mimic a discontinuous epitope have no sequence homology with the 
original antigen. To investigate further the nature of the peptides selected by MAbs
.:K
1
(A) 5 ' ------GCTTTTGCTG GATCCCCGCAN?,7 GCAG AATTCACCCTCAGCAG
(B) CGTCTTAA GTGGGAGTCGTC
Insertion yielded the following sequence -
g g t  gAA TTC TGC XXX9 TGG GGG G a t c c c  
G E F C N 9 C G D P
FIGURE 12 : Oligonucleotides for construction of a constrained random 
nonamer library in pC89
Oligonucleotide (B) was annealed to (A), extended and the duplex digested with 
EcoRl and BamHl. The fragment was then ligated into pC89. The underlined codons 
flanking the N27 random segment are complementary to TGC, the codon for cysteine. 
After Luzzago et a l  (1993)
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against discontinuous epitopes, a MAb against human heart ferritin was panned with 
their cysteine-constrained library. From a first round application of 10^  ^phage, 10  ^
were eluted. At 10 4 %, this return was considered slightly low, although Smith 
suggests 10’  ^ % as a 'normal' return in the first round. Luzzago et a l  chose not to 
proceed to a second round of panning, in case of loss of low affinity phage, but rather 
screened the first round phage directly with a plaque assay. Approximately 10  ^
plaques were lifted onto nitrocellulose and probed with the anti-ferritin MAb. More 
than 300 gave positive signals. Thirty-eight of these positive plaques were eluted and 
sequenced. They were found to have 11 different sequences, corresponding to two 
major groups. Analysis of two phage types, both from the first of these groups, 
suggested that only one carried predominantly cyclised peptides.
In work of significance to this project, the Felici and Luzzago libraries have been 
subsequently employed in an attempt to produce mimics of carbohydrate antigens for 
antibody production (Phalipon et a l,  1997). The outcome is discussed on page 177. 
The Luzzago library is, of eourse, a gene VIII library, and it is worth considering 
what influence this may have on the work. In most reviews of the subject, gene III 
and gene VIII are accorded equal status as potential sites for the insertion of random 
DNA for display purposes, with little evidence being presented to suggest that either 
approach is more consistently successful than the other. In considering, therefore, 
why gene III has thus far predominated, the extraordinary generosity of George Smith 
in making freely available his bacterial and phage strains, his primers and vectors, 
and, of course his hexamer library, to research groups throughout the world, must be 
considered a major factor. Of a list of twenty-three published libraries given by 
Burritt et a l (1996), all but two featured fusion to protein III. Of these twenty-one, 
seven were produced using the Smith vector fUSE5, whilst a further four used fAFFl, 
a vector created by Cwirla et a l (1990) using strains and phage supplied by George 
Smith. The only two gene VIII libraries in the list were those of Luzzago and Felici. 
Smith and Petrenko (1997), in a list of fifty-nine published libraries do include 
sixteen different gene VIII libraries, however, it should be noted that eleven of these
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came from a single paper by Bonnycastle et a l (1996) and consisted of variations, in 
terms of insert length and the relative position of constraining Cs, on a single, type 88 
progenitor. The others were the Felici and Luzzago 8 + 8's, an 8 + 8 pentamer, a type 
88 20-mer and an octamer library, that Smith and Petrenko themselves had created 
and that represents the only listed example of a type 8 fusion.
Of course, the influence of George Smith does not entirely explain the pre-eminence 
of gene III. Whilst it is generally agreed that the high number of copies of protein 
VIII on the phage capsid (2700 or more) should favour its use, especially in 
comparison with the very low numbers of pIII molecules (5 or less), protein III 
function appears to be less easily perturbed by the addition of heterologous sequences 
at its amino-terminus. Problems with maturation of the capsid affect the consistent 
production of infective phage consisting exclusively of modified gene VIII product if 
the fusion is in excess of five amino acids in length (Greenwood et a l, 1991). Whilst 
Felici et a l  (1991) suggest that fusions of nine residues or more cannot be assembled 
at all, lannolo et a l  (1995) demonstrate that this assertion is broadly, but not 
absolutely correct. Various lengths of random insert were tested, 100 clones at each 
length, and the percentage that tolerated an insert of each length was tabulated. They 
confirmed that an insert of six amino acids was always tolerated, and that 40% of 
eight residue, 20% of ten residue and 1% of 16 residue inserts were also satisfactorily 
processed into phage. Suggested explanations for this are that the density of packing 
of pVIII in the capsid precludes further extension of the amino-terminus (Cesareni, 
1992) that certain fusions may be unable to be translocated to the host-cell membrane 
(lannolo et a l, 1995; Malik et a l, 1999) or that whilst large inserts may be tolerated 
by the pVIII in the body of the virion, they may prevent those at the distal or proximal 
ends interacting with pVII and pIX, or pVI respectively (Makowski, 1994).
Despite the suggestion of lannolo et a l that a hexapeptide insert would be tolerated in 
a fully polyvalent display, Burritt et a l (1996) could find no record of such a library. 
However, as mentioned above. Smith and Petrenko do report on their own library that 
features octapeptide extensions to every copy of pVIII (Petrenko et a l, 1996). To
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create this library, the authors simply accepted that, as lannolo et a l had predicted, 
only around 40% of their initial clones would tolerate the insert, and sought to use 
that portion in panning work.
By contrast, the amino-terminus of the pIII molecule, although pivotal in the infection 
process, suffers no such restriction on the size of insert.
Allowing that the advent of the two-gene systems (type 88 or 8+8) has overcome this 
limitation on the use of gene VIII, one might have anticipated that its natural 
advantage, ie. high copy number, would have promoted its wider use. However, this 
apparently advantageous position is undermined by reports that the 33 or 3+3 types of 
display can be used to produce monovalent pIII fusions, in which only one of the pIII 
molecules carries the fusion. This arrangement is reportedly more favourable than 
polyvalent display on pIII or pVIII because a reduction in the overall avidity of the 
phage apparently results in greater selectivity by the library, with binding to low- or 
moderate-affinity sites being greatly reduced (Lowman et a l, 1991; Hoess, 1993). 
Cwirla et a l (1990), in one of the earliest papers on phage display, reported the 
difficulty of selecting fusion peptides of anything other than moderate affinity, as 
such peptides will outnumber the high-affinity binders. The authors conceded that the 
selection of a wide range of phage in the first round of panning could eliminate non­
specific, 'background' phage, and that reduction of the concentration of the target 
molecule in subsequent rounds of panning could serve to eliminate the weakest 
binders, but concluded that some form of monovalent display would be ultimately 
desirable. McConnell et a l (1994) drew similar conclusions regarding monovalent 
display, but did not exclude the idea that the use of polyvalent display in the first 
round could provide potential leads. Barrett et a l (1992) using phage displaying fused 
peptides known to represent high and low affinities, demonstrated that the 
concentration of free peptide required to completely block binding of these phage was 
far in excess of the Kj of the peptide itself. They reasoned that the only explanation 
for this was that polyvalent display on the phage surface resulted in multi valent 
attachment, and therefore binding with higher affinity. Thus, very low affinity
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peptides, if poly valently displayed, could remain attached during washing and then be 
released in the acidic eluate. Bass et al. (1990), were the first to produce a monovalent 
pin display system by creating a phagemid that, in conjunction with a helper phage, 
gave capsids that generally carried no more than one fusion peptide alongside four 
wild-type pIII molecules.
Another suggested advantage in pIII fusion is the location of this protein. Burritt et al. 
(1996) speculate that the terminal location of pIII is better suited to anchoring the 
phage to the affinity matrix, but it would seem plausible that interaction between the 
matrix and several points on the capsid surface, a possibility with polyvalent pVIII 
display, could achieve binding of comparable stability. In any case, Burritt et al. 
suggest that this fact merely compensates for the low copy number of pIII, not that 
pin is an inherently more suitable site for the insertion of the fusion peptide.
Finally, an application for which polyvalent display on protein VIII is ideal, as 
highlighted by the work of de la Cruz et al. (1988) and Greenwood et a l (1991), is 
immunisation of animals, with the high number of fusion peptides ensuring maximal 
antibody responses. Despite the presence of wild-type pVIII, the latter group found 
that the antibody response to the fusion was far greater. They proposed two possible 
explanations for this: that the fusion was more immunogenic; that its size shielded the 
wild-type protein from the immune system.
Cysteine constrained libraries
The amino-terminus of mature pVIII, like that of pIII, is not fixed into a defined 
conformation and short peptides fused there are equally likely to assume a range of 
conformations, constrained only by their thermodynamic stability. As a result, the 
concentration of any one conformation may be low (Folgori et a l, 1994). In order to 
overcome this, constraint can be introduced into libraries by flanking the fused 
peptide with C residues. By spontaneously forming cyclic disulphides during phage 
assembly, these C's serve to stabilise and restrict the conformations adopted.
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Koivunen et a l (1994) report that a constrained peptide showed greatly diminished 
activity when the disulphide bond was reduced.
The first deliberate attempt to include C constraint in a phage display library was by 
O'Neil et a l  (1992). Their gene III hexamer library was created to study the 
glycoprotein integrin Ilb/IIIa, which was known to recognise the sequence motif 
RGD with greater affinity when it was borne within a cyclised peptide. The O'Neil et 
a l constrained library showed a 500 times greater amplification of selected clones, in 
the second round of panning, than a similar, but unconstrained, library.
The opposite effect was observed by McConnell et a l  (1994) who again tested 
parallel constrained and unconstrained libraries with a model system (a MAb against 
the peptide angiotensin All). In their case, however, it was the unconstrained library 
that yielded sequences known to feature within AIL The constrained library, however, 
identified 'mimotopes' - novel sequences bearing no relationship to the original 
epitope. The conclusion drawn from this result was that constraint rendered the 
natural binding motif unrecognisable, and it therefore was not selected from the 
library. To test this theory, an oligonucleotide was synthesised that coded for the 
consensus sequence of the peptides selected from the unconstrained library flanked by 
two C residues, and was cloned into a phage. The addition of the C residues reduced 
phage binding by 100-fold in comparison with the unconstrained phage. In light of 
this result, McConnell et a l  conclude that there is a possibility that, even if a library 
does contain the correct motif, panning may nonetheless fail to select it if constraint 
renders it unsuitable as a ligand for the material being tested. McConnell et a l go on 
to conclude that if the natural epitope is constrained, then an unconstrained library 
may either fail to recognise it at all or may reveal unrelated mimotopes.
In a review on the subject, Ladner (1995), highlights the usefulness of constraint for 
discontinuous epitopes and for receptor binding sites. He suggests that a constrained 
ligand will have a higher affinity for the site than a similar unconstrained one 
because, if the conformation of the unconstrained peptide can change on dissociation
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from the site, there will be a tendency for dissociation to predominate over 
reassociation that is absent in the constrained version.
An interesting final point on this subject is provided by Kay et al. (1993), who, in 
testing a 38 amino acid unconstrained library, discovered strong evidence of selection 
against C residues in selected peptide sequences. More interestingly, of those that did 
contain C, the number with an odd number was less than expected, whilst those with 
even numbers were at the expected frequency. The explanation given for this 
phenomenon in the original paper and expanded by Kay and Hoess (1996), is that 
single Cs may form disulphide bridges with C residues fused to other pIII molecules, 
or with those present in pIII itself (there are eight). Such bonds would, most probably 
disrupt the structure of pIII, thereby impairing infectivity by that phage.
PART 6 : SMITH PENTADECAMER LIBRARY
The third library tested was the Smith pentadecamer (15 amino acid insert) library. 
The library was obtained from Dr. Russell Thompson, Division of Virology, 
University of Glasgow, but was originally constructed by George Smith of the 
University of Missouri. As in the Luzzago library, inserts are fused to protein VIII 
(see page 68 for a discussion of the advantages and disadvantages of fusions into this 
protein), but unlike the libraries tested previously, it is a type 88 fusion.
Type 88 fusion phage
The type 88 strategy represents an alternative way of overcoming the limitation on 
insert size that is encountered when incoiporating fusions into protein VIII. Originally 
postulated by George Smith (1993), it has apparently failed to attract significant use; 
reviews that report type 88 (or its gene III equivalent, type 33) as an option always 
refer back to the Smith paper, and Burritt et al. (1996) survey twenty-three different 
libraries, of which none are type 88. For this reason, little information about the 
efficacy of this type of library is available, other than unpublished data from Russell 
Thompson who made it available for this project.
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One paper reports the use of type 33 and 88 systems: Corey et al. (1993) fused trypsin 
to either gene III or gene VIII that was carried by M13mpl8, a vector similar to the 
pEMBL phagemid vector used in the production of the Luzzago library (see page 60). 
The gene III fusions were tested by biopanning on a series of ligands. Although 
successful, the principle was not extended as far as the production of a library.
Smith pentadecamer library
The procedure for creating the pentadecamer library used in this work is reported in 
'Cloning of fUSE vectors (Edition of February 10th, 1992)’, the unpublished manual 
that was supplied by George Smith and was extensively used in the hexamer library 
work.
This type 88 phage, f88-4, carries the wild-type fd-tet genome, with all genes intaet. 
In addition however, Xhol and Nhel sites were created at either end of a 330-base pair 
non-coding region of fd-tet (bases 5649 to 5978 inclusive), and a second, synthetic 
gene VIII was inserted at these sites. This insert is shown in Figure 13. Although the 
wild-type pVIII amino acid sequence is encoded, alternative codons are used with 
high frequency. Being able to discriminate between the two forms of gene VIII in the 
genome was of particular value for sequencing - without the variation, any primer 
against the recombinant gene VIII would also anneal to the wild-type sequence, 
which would have led to the appearance of double signals on the autoradiograph. 
Figure 14 compares the wild-type and recombinant base sequences.
Modification of the wild-type sequence CTG TCT TTC GCT to CTA AGC TTT 
GCC, which still codes for LSFA, served to introduce the H indlll restriction site 
(underlined). To introduce the Pstl site, an additional codon (CCT coding for P) was 
introduced. Along with the modification of GCT to GCA (both code for A), the 
restriction site (CTGCAG) was created. The introduction of these sites allowed 
insertion of the randomised 45 bases (ie. 15 amino acids). The insert therefore had 
the sequence AGC TTT GGG (NNN) 15 GCT G C A ... coding for S F A X15 P 
A . . .  and, after cleaving by signal peptidase, the mature protein had the sequence
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base 5 6 4 8  
of fd -tet  
I Xho\
GC TCGAGCTTAC TGCCGA 
tac promoter
TCCC CCTGTTGACA ATTAATGATG GGCTCGTATA AGTTGTGGAA TTGTGAGGGG 
ATAAGAATTT C
gene VIII translation initiation region
TTAATGGAA ACTTCC
gene VIII
ATG AAA AAG TCT TTA GTT GTT AAA GCA TCT GTT GCT GTT GGG ACT 
M K K S L V L K A S V A V A T
CTT GTT CCT ATG CTA-AGC TTT GGG|AAC GTG|GGT G C A -GAA GGT GAT 
L V P M L S F A A N V P A E G D
GAC CCG GCT AAA GCT GCT TTT GAC TCT CTT GAG GCT TCT GCT ACT 
D P A K A A F D S L Q A S A T
GAA TAG ATG GGG TAC GCT TGG GGT ATG GTG GTT GTT ATC GTT GGT 
E Y I G Y A W A M V V V I V G
GCT ACT ATT CGC ATC AAA CTT TTC AAA AAA TTC ACT TCT AAA GGG 
A T I G I K L F K K F T S K A
TCT
S
terminator region Nhe\
TAAT GAACTCAGAT ACCCAGCCCG CCTAATGAGCGGGCTTTTTT TAAGCTAGCTT
FIGURE 13 : Sequence of the second copy of gene VIII in the type 88 vector, 
f88-4.
Gene VIII itself is shown as codons, with the amino acids marked underneath. The 
random pentadecamer was inserted between the Hindlll and Pstl sites, replacing the 
amino acids N and V, the first two bases of the mature pVIII. The site for cleavage by 
signal peptidase is indicated by A . The tac promoter and the terminator region are 
also shown.
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wild-type ATGAAAAAGTCTTTAGTCCTCAAAGCCTCCGTAGCCGTTGCTACCCTCGTT
synthetic ......................................... T . . T ........... A . . T . . T . . T .............G . . T . . T . . .
residue M K K S L V L K A S V A V A T L V
wild-type CCGATGCTGTCTTTCGCT   GCTGAGGGTGACGATCCCGCAAAA
synthetic . .T  AAGC . .T . . G (XXX) 15GCT . .A . .A  T . .C . .G . .T . . .
residue P M L S F A  N15 P A E G D D P A K
PRIMER TGACTTATGTAGCCGATGCGA^ '
wild-type GCGGCCTTTGACTCCCTGCAAGGCTCAGCGACCGAATATATCGGTTATGCG
synthetic . . T . . T .................. T . . T . . G . . T . . T . . T . . T ............C ............C . . G . . T
residue A A F D S L Q A S A T E Y I G Y A
wild-type TGGGCGATGGTTGTTGTCATTGTCGGCGCAACTATCGGTATCAAGCTGTTT
synthetic  T  G  T . . C . . T . . T . . T  T . . C  A . . T . . G
residue W A M V V V I V G A T I G I K L F
wild-type AAGAAATTCACCTCGAAAGCAAGC
synthetic . . A ...................T . . T ...........GTCT
residue K K F T S K A S
FIGURE 14 : Alignment of nucleic and amino acid sequences of wild-type and 
synthetic gene VIII from vector f88-4.
The 21-base primer synthesised for sequencing is also shown.
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X i5  P A  E G D . . .  The synthetic gene VIII was placed under the control of 
the tac promoter. This strong promoter is a hybrid between the lac promoter that 
featured in the Luzzago library vector and the trp promoter that in E. coli drives 
transcription of enzymes involved in the biosynthesis of tryptophan. The tac promoter 
is stronger than either of these {ie. it can sustain a higher level of transcription) and, 
like lac, is induced by the addition of IPTG. The original library consisted of 2 x 10  ^
clones and an amplification of a part of it was supplied for this work .
The result of creating a phage with two genes for protein VIII is that around 10% of 
the outer coat protein will carry the insert {ie. around 300 per virion) (George Smith 
in 'Cloning of fUSE vectors (Edition of February 10th, 1992)'). The presence of wild- 
type pVIII ensures that phage assembly and infectivity can proceed without hindrance 
by the large insert in the recombinant pVIII, whereas, in the absence of wild-type 
pVIII, inserts of greater than five to six amino acids cannot be easily packaged (see 
page 69).
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CULTURE AND MAINTENANCE OF STRAINS 
Vibrio 60 pMMB68
This strain, which excretes LT-B, was kindly supplied by Professor T. Hirst, then at 
the University of Kent. The organism was cultured in Luria Bertani High Salt (LBHS) 
broth or in LBHS agar (see Appendix 1, page 182), both containing lOOmg mT^ 
ampicillin. Incubation was at 30“C, the broth cultures with shaking at 200 revolutions 
minute-1. Stocks of the strain were stored at ~70°C in LBHS broth containing 12.5 % 
glycerol.
Escherichia coli K91kan
This strain, which was used to amplify phage from both Smith libraries, was routinely 
cultured at 37“C in Luria Bertani (LB) broth or agar (see Appendix 1, page 182)
containing lOOpg mpl kanamycin. Broths were aerated as above. Stocks of the strain
:were stored at -70°C in LB broth containing 12.5 % glycerol.
Escherichia coli XL-1
This strain, which was used to amplify Luzzago library phage, was routinely cultured 
in LB broth or agar (see Appendix 1, page 182). Broths were aerated and stocks 
stored in the same manner as E. coli K91kan.
Escherichia coli DHSF'IQ
This strain, which is recA  deficient (see page 150), was routinely cultured as 
described for E. coli K91kan (above). It was obtained from Life Technologies,
Paisley.
f
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EXPRESSION, PURIFICATION AND 
CHARACTERISATION OF LT-B
Correlation of Vibrio  60 pMMB68 growth cycle with LT-B 
production
A flask of 50ml of LBHS broth was inoculated with 1ml of an overnight culture, and
1ml samples were withdrawn at hourly intervals. After 2h, the absorbance at 600 nm
(Aôoo) having reached 0.1, IPTG (Sigma; Poole) was added to a final concentration of j
:100p.M. After measuring the A^oo of the 1ml samples, the supernate was clarified by
centrifugation and tested for LT-B content by Gmi ELISA (see page 82), using an 
initial dilution of 1 in 64 .
. .I
Preparation of Vibrio 60 pMMB68 supernate
A 2 litre conical flask containing 500ml LBHS broth was inoculated with 10ml of an 
overnight culture of Vibrio 60 pMMB68 of Agoo LO - 1.2 and incubated with shaking 
at 30°C until the A^oo was approximately 0.2 (around 2 to 4h post-inoculation). IPTG 
(as above) was added and incubation continued until lOh post-inoculation. The cells 
were separated from the supernate by centrifugation (8000 g for 20 minutes at 4“C).
The supernate was cleared by further centrifugation (31000 g for 20 minutes at 4“C), 
followed by passage through a 0.45pm  Acrodisc filter (Gelman Sciences; 
Northampton) and was stored at -20“C in 100ml batches until required.
Purification of LT-B from Vibrio 60 pMMB68 supernate
This was achieved using the immobilised galactose affinity chromatography method 
of Uesaka et al. (1994) discussed on page 48. A Pharmacia C l6 column containing 
15ml of Immobilised Galactose beads (Pierce and Warriner; Chester) was equilibrated 
with 30ml of O.IM sodium phosphate buffer, pH 7.2. Individual 100ml batches of the 
cleared Vibrio 60 pMMB68 supernate, prepared as above, were run onto the column 
by gravity from a 30 cm head. The column was washed with a further 30ml of the 
phosphate buffer. All eluates thus far were run to waste. Elution of the LT-B was
A
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achieved by running 30ml of 0.5M D-galactose in phosphate buffer through the column 
and collecting fractions of approximately 1ml.
Concentration of LT-B samples
Following analysis (see below), fractions from the affinity purification column 
containing pure LT-B were pooled, then concentrated by pouring into dialysis tubing, 
sealing and covering in dry polyethylene glycol with average relative mass of 10000 
(PEG 10000; Sigma; Poole). This was left at 4°C until the volume was sufficiently 
reduced. The tube was then rapidly rinsed with water to remove PEG from the surface.
ANALYSIS OF PURIFIED LT-B 
Gel electrophoresis
The electrophoretic properties of fractions from tlie immobilised galactose column were 
firstly established using SDS PAGE, adapting the method of Laemmli (1970). 
Concentrated, purified material, (lOOpl) was mixed with an equal volume of 
solubilising buffer (recipes and mixtures used ai*e listed in Appendix 2, page 183). The 
sample was then divided into aliquots, one aliquot being boiled for 5 minutes and the 
other being left at room temperature. Then, 30p.l of boiled and unboiled sample were 
applied to separate lanes of a 12.5 % mini-gel ( 10 cm x 6 cm) that was run for 
approximately 75 minutes at 150 Volts using an Atto gel tank and a Pharmacia ECPS 
3000/150 power pack.
Gel staining
The gel was stained by the Coomassie Blue staining method (Appendix 3, page 185). 
Western blotting
The cross reaction between the protein eluted from the affinity column and an anti-LT-B 
monoclonal antibody 118.87 (kindly supplied by Prof. T. Hirst, then of the University 
of Kent) was tested by Western blotting. Two lanes containing unboiled sample were 
run on an SDS-PAGE gel (as described above). The gel was then
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divided between the lanes, and one half was stained by the Coomassie method (See 
Appendix 3, page 185 for method). The other portion was soaked, along with a 
similarly-sized piece of Hybond C nitrocellulose membrane (Amersham Life Science,
,
Amersham, Bucks.) and two sheets of Whatman 3MM chromatography paper, in 
transfer buffer (for recipe see Appendix 4 page 186) for 30 minutes at room 
temperature. Then, the gel was sandwiched alongside the nitrocellulose membrane 
between the sheets of 3MM on the negative plate of a BioRad Transblot Semi-dry
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Electrophoretic Transfer Cell (Biorad, Hemel Hempstead), with the gel towards the 
plate. After blotting for 75 minutes at 15 volts, the membrane was probed with 5 ml 
of anti - LT-B antibody at a dilution of 1 in 400 in PBS-TWEEN. After 6 hours 
incubation at room temperature and a further three washes with PBS-TWEEN, 1 ml 
of HRP - conjugated goat anti-mouse IgG, at a dilution of 1 in 500 in PBS-TWEEN, 
was added. After 2 hours incubation at room temperature and three 10 minute washes 
in PBS, the membrane was developed. The developer consisted of 9.8 ml of a filtered 
(Whatman no. 1) solution of 0.05 % (w/v) diamino benzidine (Sigma, Poole) in PBS. 
Just before use, 0.2 ml of 1 % (w/v) cobalt chloride and 10 pi of hydrogen peroxide 
were added, and 5 ml was applied to the membrane. After 2 - 3 minutes the developer 
was poured off and the membrane was allowed to dry.
G m i ELISA
The Gmi ELISA method of Svennerholm and Holmgren (1978) was adapted for use 
with microtitre plates. Each well of an Immunolon 96 well microtiter plate (Life 
Technologies; Paisley) was coated by the addition of 250pl of 1.5pM ganglioside 
Gmi (Sigma; Poole) in PBS and incubated, at room temperature, overnight. Coated 
plates were stored for no more than one month at 4°C.
Before being used in an assay, plates were washed three times, for three minutes each 
time, with PBS. Non-specific binding sites were blocked by 30 minutes incubation, at 
37°C, with 200pl of PBS - BSA (for recipes see Appendix 4, page 186). Fresh PBS - 
BSA (316pl) was then added to each well. Then 84pl (40 pg) of purified LT-B was
added to the first well and a two-fold dilution series was generated by transfer of 
200pl. The plate was incubated for four hours at room temperature after which it was 
washed three times, for three minutes each time, in PBS - TWEEN.
An anti - LT-B mouse monoclonal antibody 118.87, supplied by Professor T. Hirst, 
was diluted to 1 in 800 in PBS-TWEEN containing 0.1 % (w/v) BSA and 150pl was 
added to each well. After 90 minutes incubation at 37°C and a further three washes 
with PBS - TWEEN, 150pl of HRP - conjugated goat anti-mouse-IgG (SAPU, 
Carluke), at a dilution of 1 in 200 in PBS-TWEEN plus BSA, was added and 
incubated at room temperature for 90 minutes. The plates were washed three times, 
for three minutes each time, with PBS and then developed. The developing solution 
consisted of 20mg of the peroxidase substrate O-phenylene diamine (OPD: Sigma; 
Poole) in 20ml O.IM sodium citrate, pH 4.2, to which 8pl hydrogen peroxide was 
added prior to use. A positive result with this substrate is a yellow coloration, the 
absorbance of which can be measured spectrophotometrically. Each well received 
lOOpl of this reagent. After 15 minutes incubation at room temperature A450 was 
recorded using an ELISA plate reader.
Protein estimation of purified LT-B 
Markwell et al. (1978) method
This method of protein estimation is based on copper labelling of the protein, as 
discussed on 50, and is reported to be unaffected by high sugar concentrations. 
Galactose stability
Stock solutions were Reagent A: 2 % Na2C03 , 0.4 % NaOH, 0.16 % Na tartrate, 1 % 
SDS, and Reagent B: 4 % CUSO4. Reagent C was freshly prepared, and consisted of 
100 parts Reagent A plus 1 part Reagent B. Bovine serum albumin (BSA: Sigma; 
Poole) was prepared to a concentration of 120pg ml"k Aliquots of 0.5ml of this were 
mixed with an equal volume of galactose solution at concentrations ranging from 200 
to lOOOmM (to give final concentrations of 100 to 500mM galactose) and with 
distilled water (i.e. OmM galactose). To these, 3ml of reagent C was added. After 10
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minutes incubation at room temperature, 0.3ml of a 1 in 2 dilution of Folin and 
Ciocalteau Phenol reagent in distilled water (Sigma; Poole) was added. After 
vortexing, these were allowed to stand at room temperature for 45 minutes, after 
which absorbance was read at 660nm against a water (OmM galactose) control. 
Bradford (1976) method
This method of protein estimation is based on recording the shift in the absorbance of 
Coomassie blue when bound to protein, as discussed on page 50.
Galactose stability
The reagent used was prepared by dissolving 50mg of Coomassie Brilliant Blue G- 
250 in 50ml of 95 % ethanol and then adding 100ml of 85 % phosphoric acid. 
Distilled water was added to yield a final volume of 1 litre. BSA was prepared to a 
final concentration of 60pg m pl in the same concentrations of galactose that were 
used with the Markwell method. Each lOOpl aliquot of BSA/galactose solution 
received 5ml of reagent. After 2 minutes incubation at room temperature A595 was 
read against a reagent blank containing no protein.
Protein estimations
Bradford reagent, prepared as above, was used to estimate the protein content of all 
biotinylated LT-B (LT-B^iociii) samples. In each case, 5ml of reagent was added to 
lOOpl of sample, and to lOOpl solutions of BSA containing 0 to 50pg of protein. 
After 2 minutes incubation at room temperature A595 was read against a reagent 
blank. Protein content was estimated with reference to the BSA solutions.
Alternative source of purified LT-B
A sample of LT-B was kindly supplied by Professor T. Hirst, then at the University of 
Kent. Like that described above, it was produced by Vibrio60, however, it was 
purified by the method of Amin and Hirst (1994). This sample (hereafter called 'Hirst 
LT-B') was used in the second and third biopanning experiments with the Smith 
pentadecamer library, described on page 96.
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BIOTINYLATION OF PURIFIED LT-B
Both the LT-B produced for this project and the Hirst LT-B were biotinylated to 
facilitate immobilisation via the bioitin - streptavidin bridge described on page 50. 
The protocol supplied with the Immunoprobe Biotinylation Kit (Kit no BK-101: 
Sigma; Poole) was followed exactly, except that in both cases, 200pl of BAC 
-SulfoNHS solution was added per ml of concentrated LT-B. Separation of the LT- 
g b io tin  from unreacted biotin was performed as recommended in the kit instructions 
using the Sephadex G-25M column provided. The LT-B^'oiin ^^s stored at -20°C in 
200pl aliquots.
Degree of biotinylation
This was calculated using the avidin-HABA assay, performed exactly as detailed in, 
and using the reagents supplied with, the Immunoprobe Biotinylation Kit described 
above. In this assay, the LT-B^iotin was degraded by pronase and exposed to avidin- 
coupled 4'-hydroxyazobenzene-2-carboxylic acid (HABA). Displacement of the 
avidin by biotin results in a colour change, detectable by spectrophotometry at 
500nm, which is proportional to the amount of biotin present. Subtraction of the value 
given by LT-B^ioiin from that obtained with a HABA control gave a corrected A500 
value from which the biotin concentration could be calculated. The molar extinction 
coefficient of biotin is 34000.
The manufacturer recommends that the molar ratio of biotin to protein should be in 
the range three to five. The LT-B prepared for this project and biotinylated shall 
hereafter be referred to as 'stock LT-B^iotin' distinguishing it from 'Hirst LT-
gb io tin '
GmI ELISA
Gmi ELISA was used to confirm biotinylation of the stock LT-B and to establish that 
biotinylation had not diminished its Gm i-binding capability . Stock LT-B^iotin was 
added to the plate at an initial concentration of 1 in 20 (lOpl added to 190pl of PBS-
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BSA) and doubling dilution effected by the transfer of lOOfil. Two such series were 
prepared.
The first was probed with the anti-LT-B monoclonal antibody 118.87. The method 
followed was exactly as described on page 82, except that 100 pi volumes were added 
throughout. A dilution series to which no LT-B had been added served as a control. 
The second series was probed with lOOpl of the HRP-labelled streptavidin, 
'Extravidin' (Sigma; Poole), at a dilution of 1 in 500 in PBS plus BSA. After 4h 
incubation at room temperature, these wells were washed three times, for three 
minutes each time, with PBS and then developed using O-phenylene diamine (OPD: 
Sigma; Poole) as for the anti-LT-B antibody. Again, a series to which no LT-B had 
been added served as a control.
SOURCE OF PHAGE LIBRARIES AND PROTOCOLS
Smith hexamer library
As well as the hexamer library itself, George Smith of the University of Missouri was 
kind enough to supply the bacterial strain used for propagation of library phage and a 
manual, 'Cloning of fUSE vectors (Edition of February 10th, 1992)' which served as a 
valuable reference for methods associated with biopanning.
Luzzago library
This was kindly supplied by Alfredo Nicosia, Instituto di Ricerche di Biologia 
Molecolare P. Angelletti, Rome. Methods used with the nonamer library were 
adapted from Luzzago et al. (1993) and Felici et al., (1991; 1993), with reference to 
the methods used for the Smith library (see above).
Smith pentadecamer library
Russell Thompson, of the Division of Virology, University of Glasgow kindly 
supplied this library, along with a biopanning protocol that is based on, but not 
identical to, George Smith’s.
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AMPLIFICATION OF LIBRARIES
Smith hexamer library
The sample provided was of insufficient volume for the work planned and therefore 
required amplification. Escherichia coli K91kan was grown overnight in LB broth, 
1ml added to 100ml of Terrific Broth and the flask shaken at 250 revolutions minute"^ 
at 37“C until the Agoo was 2.0. Shaking was then slowed to 30 revolutions minute'^ 
for 5 minutes. All of the Smith hexamer library (approximately 6p,l) was added, and 
the slow shaking maintained for 15 minutes. The entire content of this flask was then 
added to 1 litre of pre-warmed LB broth containing 0.2pg mk^ tetracycline, and 
incubation at 37“C, with 250 revolutions minute'^ shaking, was continued for 35 
minutes. After the addition of tetracycline to a final concentration of 2 0 ^ ^ m k ^  the 
incubation continued for 16h.
Cells were removed by two 10 minute spins at 20000g and solid polyethylene glycol, 
10000 Da (Sigma, Poole) was added to the supernate to 15% (w/v). Precipitation was 
left to proceed, on ice, for 16h. The precipitate was removed from suspension by 
centrifugation at 20000g for 40 minutes at 2“C.
The phage pellet was dispersed with gentle agitation for 30 minutes, in 30ml of TBS 
and then spun for 10 minutes at 20000g to remove insoluble material. The supernate 
was mixed by 100 inversions with 4.5ml (ie. 0.15 volumes) of PEG / NaCl (see 
Appendix 4, page 186) then left on ice for 1 hour. Precipitated phage were harvested 
by centrifugation for 15 minutes at 20000g, then re-dispersed by gentle agitation for 1 
hour (to soften the pellet) followed by vortexing for 2 minutes. Insoluble material was 
removed by centrifugation at 20000g for a further 10 minutes. The supernate was 
mixed with 0.15 volumes (1.5ml) of PEG / NaCl then incubated on ice overnight.
The precipitated phage were harvested as before and re-suspended in Iml of TBS, by 
Ih gentle agitation and 2 minutes vortexing, and were then stored at -20°C as the 
'Amplified Library Stock’.
1
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Luzzago and Smith pentadecamer libraries
Sufficient library having been provided, amplification was unnecessary.
PHAGE INFECTIYITY 
Smith hexamer library
The infectivity cycle of E. coli K91kan with Smith hexamer library phage was 
investigated thus : from an overnight culture of K91kan in LB broth, 200p.l was used 
to inoculate 20ml of Terrific Broth (see Appendix 1, page 182). The flask was 
incubated with shaking at 250 revolutions minute"^ at 37°C. At 30 minute intervals, 
from 6h onwards, aliquots were removed and the Agoo was measured. At 30 minute 
intervals from 6.5h onwards, a second aliquot was removed, left static for 5 minutes 
to allow for regeneration of pili, then mixed with lOOpl of such a dilution of the 
'Amplified Library Stock', that 1 x 10^ phage were added (phage numbers having 
been established by the method reported on page 97). After incubating at 37“C for 30 
minutes to allow infection of the K91kan cells, 1ml of LB broth containing 0.2pgmk* 
tetracycline was added. After shaking at 37“C for one hour to allow expression of the 
tetracycline resistance genes, lOOpl was spread onto LB agar containing 100p.g mk^ 
kanamycin and 40pg mk^ tetracycline. Plates were incubated overnight at 37°C and 
colonies were counted.
Luzzago library
The phage library was serially diluted ten-fold to 10"'  ^ and lOpl of each dilution 
added to lOOpl of a four hour culture of E. coli XL-1 in LB broth. After incubation at 
37°C for one hour, all llO p l was spread on LB agar containing lOOpg mk^ 
ampicillin.
As a control, uninfected cells were plated directly onto LB agar plus ampicillin.
tube received 1ml of TBS alone. In both cases, the elution agent was left in the tube 
for 1 hour.
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BIOPANNING
Smith hexamer library 
First round of biopanning
Prior to con^ncement of the work, the streptavidin concentration and diluting buffer, 
as well as the brand of plastic tubes used had been optimised in an ELISA-style assay.
Streptavidin coating o f tubes
Streptavidin (1ml of a 0.8mg mk^ solution in 0.05M sodium phosphate buffer, pH 
8.0), was added to 3 Maxisorp tubes (Life Technologies; Paisley), left for 6h at 4°C 
then discarded and replaced with 2ml of a blocking solution consisting of 5mg mk^
BSA, 0.1 mg mk^ streptavidin and 0.02 % NaNg in O.IM NaHCOg. After reaction for 
1 hour at 4°C, the tubes were washed 6 times, for 1 minute each time in TBS- 
TWEEN, then upturned and 'slapped' down onto dry tissue to remove all residual 
fluid.
LT-B coating o f tubes
,Immediately after washing, 1ml of a 1 in 500 dilution of the stock LT-B^'otm solution 
in TBS-TWEEN, was added to the tubes, which were left overnight at 4°C. Then, 
lOpl of lOmM biotin solution was added and incubation at 4“C continued for a further 
hour before washing 6 times as before.
Panning and elution
Each tube received 1ml of TBS-TWEEN and lOOpl 'Amplified Library Stock'. After 
4h at 4°C, the tubes were emptied, drained and washed ten times as before. Bound
! :phage were eluted from the first tube with 1ml of acid elution buffer (Img mk^ 
bovine serum albumin in O.IN glycine-HCl, pH 2.2). This was removed after 30 
minutes and neutralised with 187.5pl of IM Tris, pH 9.1. Elution from the second 
tube was with 7pl of 1500pM Gmi, diluted in 1ml of TBS-TWEEN, whilst the third
J|l
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Portions of all eluates were immediately amplified (see below) with the remainder 
being frozen for further use.
Amplification and purification o f phage 
A  culture of E. coli K91kan was prepared by inoculating 20ml of LB broth and 
incubating, without shaking, for 16h at 37°C. A 20ml flask of pre-warmed Terrific 
Broth (see Appendix 1, page 182) was then inoculated with lOOpl of this culture, and 
incubated with shaking (250 revolutions minute"^) at 37“C until A^oo was between 
1.25 and 2.5. Shaking was slowed to 30 revolutions minute" ^  for at least 5 minutes 
and the culture was used for phage amplification within 1 hour.
To amplify, lOOpl of eluted phage were added to lOOpl of the Terrific Broth culture, 
mixed gently, and allowed to stand at room temperature for 30 minutes. This was 
added to 20ml of pre-warmed LB broth containing 0.2pg ml"^ tetracycline, and 
shaken at 37°C and 250 revolutions minute"^ for 60 minutes. Tetracycline was added 
to a final concentration of 20pg m pi and the flask left to incubate overnight. Then, 
the culture was poured into a 50ml Oak Ridge tube and the supernate clarified by 
centrifugation at 20000g for firstly 5, and then 10 minutes before being added to 3ml 
of PEG / NaCl. After mixing by 100 inversions, this was left on ice overnight to 
precipitate the phage. These were pelleted by centrifugation at 20000g for 15 minutes, 
then resuspended in 1ml of TBS, vortexed, and centrifuged for 1 minute at 25000g.
The supernate was added to 150pl of PEG / NaCl and left on ice for 1 hour. After 
microfuging for 10 minutes, pelleted phage were resuspended in 200pl of TBS, 
clarified once by brief centrifugation and the supernate (i.e. first round amplified 
phage) stored at -20“C until required.
Second and third rounds of biopanning 
Reaction o f phage with LT-B
lOOpl of amplified phage, from the previous round, was mixed with 2pl of stock LT- 
gbiotin in microfuge tubes and left to react overnight at 4“C
Si
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Panning on streptavidin and elution o f bound phage
Three Maxisorp tubes were coated with streptavidin and blocked in exactly the same 
manner as for the first round of biopanning. The overnight phage/LT-B mixes were 
then added to blocking solution in the appropriate tube and left at room temperature 
for one hour. This protocol, termed PL + S (phage and ligate plus streptavidin) 
contrasts with the P + LS strategy used in Round one. Elution was carried out exactly 
as described for round one, as was amplification and purification of eluted phage. 
Fourth rouud of hiopauuiug
This was carried out in an identical manner to rounds two and three through to the 
elution stage. However, eluted phage were not amplified; they were used to infect 
cells which were plated out to single colonies, each colony comprising identical cells 
arising from infection with a single phage. To obtain single colonies, lOOpl of 10“  ^
and 10“2 dilutions of each eluate were added to lOOpl of E. coli K91kan Terrific 
Broth culture and left for 30 minutes at room temperature. This mixture was added to 
1ml of pre-warmed LB broth with 0.2pg of tetracycline, and shaken at 37°C and 250 
revolutions minute"^ for 60 minutes. Then, lOOpl was spread onto LB agar 
containing lOOpg mpl kanamycin and 40pg mk^ tetracycline. Plates were incubated 
at 37°C overnight and were stored at 4°C until required for sequencing.
Purificatiou of phage 
Single colonies arising from round four eluates were picked at random, inoculated 
into 1.7ml of LB broth and incubated overnight at 37“C , with shaking at 250 
revolutions minute" h Culture supernates were then clarified by microfuging for 5 
minutes at 25000g and 1ml was added to 150pl of PEG / NaCl. After mixing by 100 
inversions the tubes were left on ice overnight. Precipitated phage were spun down by 
15 minutes microfuging at 25000g at 4“C and the pellets dispersed in 500pl of TBS 
and stored at -20°C .
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Luzzago library 
First round of biopanning
Three Maxis orb tubes were coated with streptavidin and then with stock LT-Bbiotin 
exactly as described for the Smith hexamer library.
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Panning and elution
To each tube was added 400pl TBS-TWEEN, 4pl lOmM biotin and 2 pi phage from 
the Luzzago library. The tubes were incubated at 4"C for 4h then washed 10 times 
with 2 ml of TBS-TWEEN and eluted using 500pl of Acid Elution buffer, Gmi and 
TBS respectively (see page 89). Elution proceeded in each case, for 30 minutes at 
room temperature, after which, 93.5pl of IM Tris, pH 9.1 was added to neutralise the 
acid eluate.
Amplification and purification of phage
To 450pl of each eluate was added 450pl of an overnight culture of E. coli XL-1. 
After mixing, the tubes were left at 37“C for 1 hour. Then, lOOpl was spread onto LB 
agar containing 50pg mk^ ampicillin, nine plates per eluate, and the 27 plates were 
incubated overnight at 37°C.
Following incubation, 1ml of LB broth containing 50pg mk^ ampicillin was added to 
each plate and the cells suspended. The suspensions from each elution set were 
pooled and added to 250ml flasks containing 100ml of LB broth with 50pg mk^ 
ampicillin, to an Agoo of 0.05. The flasks were shaken at 37“C until Agoo had risen to 
0.2 then 1.6 x lOJi M13K07 Helper Phage (Promega; Southampton) were added and 
incubation was continued overnight.
Supernates were clarified by centrifugation at 20000g for 20 minutes and phage were 
precipitated overnight with 0.15 volumes of PEG / NaCl (see Appendix 4, page 186) 
at 4°C. Phage were harvested by 40 minutes centrifugation as above, and resuspended 
in 10ml of TBS. A further 1.5ml of PEG/ NaCl was added and left on ice at 4“C for 1 
hour. The now-purified phage were harvested by centrifugation as above for 40
f
minutes, and resuspended in 500pl TBS. This final suspension constituted the First 
Round Amplified Eluate.
Second round of biopanning 
Reaction, panning and elution
In this case, 200pl of each First Round Amplified Eluate (acid, Gmi and TBS eluted) 
were mixed with 2pl of stock LT-B^iobig ^nd were left at 4°C overnight, before being 
increased to 1ml by the addition of TBS. This was added to tubes coated with 
streptavidin (as before), which were left 1 hour at room temperature, then washed 10 
times with 1ml each time of TBS-TWEEN. Elution was carried out as in round 1 (see 
above), except that 1ml of eluting agent was added. The acid eluate was thus 
neutralised with 187.5pl of IM Tris, pH 9.1.
Amplification and purification of phage
The processes of plating, harvesting, amplification and helper phage addition were 
performed exactly as described for round 1 (above), as was the PEG/NaCl 
purification of the resultant Second Round Amplified phage.
Third Round of biopanning 
Reaction, panning and elution
These stages were performed as in round 2, with only minor exceptions.
To increase the selectivity of the process, 200pl of each second round amplified 
phage was added to only 0.5pl of stock LT-B^iotin After overnight incubation at 4°C, 
this was increased to a volume of 500pl by the addition of TBS and was added to 
tubes coated with streptavidin in the previously described manner. Incubation, 
washing and elution were carried out as before, with 500pl of elutant being added. 
Isolation o f single clones
To lOOpl of each of the three eluates was added lOOpI of an overnight culture of E. 
coli XL-1. After gentle mixing and Ih incubation at 37“C, ten 20pl aliquots were 
spread onto LB agar containing 50pg mk^ ampicillin (i.e. 30 plates in all) and 
incubated at 37°C overnight. Each single colony was a clone of a single phage- 
infected cell.
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From each set of plates (i.e. acid-, Gm i- and TBS-eluted) twenty randomly selected 
colonies were picked onto fresh agar (for archiving purposes) and were inoculated 
into 2ml LB broths that were incubated, with shaking, at 37“C overnight.
Smith pentadecamer library
The Smith pentadecamer library was the most extensively studied in this project, 
being used in three separate three-round panning experiments.
First panning experiment
Biopanning was carried out in Nunclon Delta plates (Life Technologies; Paisley) that 
consist of six, 50mm wells of 1cm depth, results obtained from a series of 
experiments with a variety of proteins in the Division of Virology having indicated 
that binding was satisfactory for the purpose of biopanning.
First round of biopanning 
Streptavidin coating o f wells
Streptavidin (20pg in 2ml of O.IM unbuffered NaHCOg) was added to one well of a 
Delta plate and was agitated gently, overnight at 4“C. The solution was then discarded 
and replaced with 5ml of a blocking solution consisting of 5mg mpl BSA, and O.lmg 
mpi streptavidin in O.IM NaHCOg. This solution was gently agitated for two hours at 
room temperature. The well was then washed 3 times, for 30 seconds each time, with 
5ml TBS-TWEEN, being ’slapped’ onto dry tissue between washes to remove residual 
liquid.
Reaction, panning and elution
Library phage (30pl) were mixed with lOpl of stock LT-B^iotin a microfuge tube 
and left overnight at 4“C. The reaction mix was diluted by the addition of 1ml of 
TBS-TWEEN and added to the streptavidin-coated well, which was agitated at room 
temperature for 20 minutes. Unreacted phage were discarded and the plate washed ten 
times, for 1 minute each time, with 1ml of TBS-TWEEN. Elution, which was by acid 
only, was effected using 500pl of Smith acid elution buffer (see page 89) containing 
O.lmg mpl phenol red, which acted as an indicator. No more than 2 minutes after the
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addition of the elution buffer, 90 to lOOpl of IM Tris/FICl, pH 9.1 was added, a 
change in the colour of the indicator from yellow to rosé, indicating neutralisation. 
Eluates were retained at -20“C.
Amplification and purification o f phage
This was carried out exactly as for the Smith hexamer library, with one important 
variation. Having infected an E. coli K91kan culture with Round One phage, and sub­
cultured into LB containing tetracycline as before, IPTG was added to a final 
concentration of ImM. This served to induce, via the tac promoter, production of the 
synthetic pVIII that carries the fusion. Subsequent incubation and processing then 
followed an identical protocol to the Smith hexamer work.
Second round of biopanning 
Reaction, panning and elution
In this round, 30pl of amplified phage from the previous round was mixed with only 
8pi of LT-Bbiotii^ in a microfuge tube which was then left overnight at 4°C. The 
overnight phage/LT-B mix was processed as in the first round (see above). The phage 
were also titred as described below in 'Enumeration of eluted phage'.
Third round o f biopanning
Once again the amount of LT-B^iotin reacted with the phage was reduced, to 6pi that 
was added to 30pl of the second round phage. Although the eluted phage were not to 
be amplified, it was still necessary to mix them with K91kan cells, and to add this 
mixture to a 5ml volume of LB broth plus tetracycline, in order that the titre could be 
assayed by the same method as that previously employed.
Purification of single phage
When titering the third round eluates, an LB (plus tetracycline) agar plate containing 
single clones was produced. Colonies, picked from this plate, were processed as 
described on page 98.
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Second panning experiment
A further three parallel three-round biopanning experiments were carried out using the 
Smith pentadecamer library and Hirst In this case, phage-infected bacteria
were assayed by a ‘colony-lift’ assay (for method, see page 102).
In the first round, 20 pi of the phage library in 5 ml TBS were added to wells of a Delta 
plate coated with streptavidin bound LT-B (prepared by adding 10 pi of LT-B i^otiJi to a ^}
plate coated with streptavidin and blocked exactly as described on page 94); with 
blocked streptavidin only (again prepared exactly as described on page 94); and with 
blocked plastic (5 ml of 25% BSA in TBS were added to an empty well, left at room 
temperature for 6 hours and then washed out with TBS).
Elution with acid elution buffer, amplification and purification of phage was carried out 
as before (see page 94). Enumeration was by direct counting of colonies as described 
below (page 98). Two further rounds of biopanning were carried out using an identical 
method, with phage eluted from each surface in one round being exposed to that same 
surface in the subsequent round. The plates by which the third round phage were 
enumerated were retained for the ‘colony-lift’ binding assay described below.
Third panning experiment
In order to eliminate the possibility of streptavidin-binders predominating in eluted 
phage, three panning rounds were carried out in which Hirst LT-B was immobilised 
using Protein G and an anti-cholera toxin antibody.
To one well of a 96-well microtitre plate was added 200pl of 5pg per ml Protein G 
(Sigma, Poole) in unbuffered O.IM sodium bicarbonate. After overnight incubation, 
the well was blocked by 6 hours exposure to 200pl of a 1% solution of BSA in TBS.
Then, the well was washed thoroughly with TBS-TWEEN and 200pl of a 1 in 100 
dilution of anti-cholera toxin antibody (Sigma, Poole) in TBS was added. This was 
allowed to react for 1 hour, before the well was again washed with TBS-TWEEN.
At this point a mixture consisting of 2p,l of lOpg per ml LTB and 30p.l of library phage 
that had been allowed to react for 5 hours before dilution with 168pl of TBS
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was introduced to the well. After 90 minutes incubation at room temperature, the well 
was emptied and was washed with TBS-TWEEN.
Elution, amplification and purification of binding phage was accomplished exactly as 
described above.
At this stage, in an attempt to reduce the number of phage that may specifically bind 
to the immobilising agent, 200pl of the amplified first-round phage were introduced 
to a well coated, as above, with Protein G and anti-cholera antibody. After 1 hours 
incubation at room temperature, the contents of the well were removed and retained 
as 'backchecked 1st round phage'. Those phage that had bound during incubation 
were eluted as before and were retained for testing as '1st round eluted phage'.
A further round of biopanning was then carried out using the backchecked phage 
from round 1. The protocol followed was exactly as described above, with the 
amplified selected phage again being backchecked and the phage eluted at 
backchecking again being retained for testing. A third round of panning then 
followed, producing further backchecked and eluted phage.
Numbers of phage produced at each stage were determined by the enumeration 
method described below.
ENUMERATION OF PHAGE 
Smith hexamer library
The number of phage in the original library was estimated by preparing a series of 
ten-fold dilutions in TBS-G and mixing 20|il with a similar volume of a Terrific 
Broth culture of K91kan cells with an absorbance at 600nm of between 1.25 and 2.5. 
After 30 minutes incubation at room temperature, 1ml of LB containing 0.2pg of 
tetracycline was added and incubation, this time with shaking at 37°C, was continued 
for a further 45 minutes. After this, lOOpl was spread onto LB agar containing 30p,g 
m l'i tetracycline and the plate incubated overnight at 37“C.
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Luzzago library
The plates used to select phagenaid-infected XL-1 cells prior to infection with helper 
phage (see above, page 92) also served the purpose of enumeration.
Smith pentadecamer library 
First panning experiment
The titre of the phage in each round was determined at the amplification stage by 
removing lOOpl of culture from the flask immediately after the addition of the 6.2p,l 
of tetracycline but prior to overnight incubation. This was spread on to LB agar 
containing 30pg mk^ tetracycline. The plate was then incubated overnight at 37°C, 
and the number of colonies was counted.
Second and third panning experiments
The number of eluted and amplified phage from all stages was estimated by following 
the method described above for the Smith Hexamer library,
PREPARATION OF SEQUENCING TEMPLATES 
Smith hexamer and pentadecamer libraries
Purified DNA was produced from frozen phage stock by phenol / chloroform 
extraction.
To 200pl of phage was added 200pl of water-saturated phenol. After vortexing, layers 
were separated by microfuging at 25000g for 1 minute, the aqueous layer being 
withdrawn and added to 200pl of chloroform containing 4.16 % amyl alcohol. 
Vortexing and centrifugation were repeated as above and 150pl of the aqueous layer 
added to 250pl of TE buffer (See Appendix 4, page 186). Then, 40pl of 3M sodium 
acetate, pH 6.0, and 1ml of ethanol, were added. After vortexing, samples were 
incubated for at least 30 minutes at -20“C then microfuged for 30 minutes at 25000g 
at 2°C. Supernates were aspirated and the tubes re-spun briefly to collect supernate for 
further aspiration. Pellets were washed twice, for 8 minutes each time, with 1ml of 70
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% ethanol and allowed to air dry before being resuspended in 6p.l of deionised water, 
and stored in sealed tubes at -20“C.
Luzzago library
Phagemid DNA was prepared from the overnight cultures using the Wizard 
Minipreps DNA Purification System (Promega; Southampton), following the protocol 
supplied with the system. This process produced 50pl of double-stranded DNA, that 
was denatured to single-stranded form by alkaline precipitation, as detailed in the 
protocol leaflet accompanying the Sequenase 2.0 sequencing system. The final pellet 
was allowed to dry at room temperature for 10 minutes, then redissolved in 7pl 
deionised water.
SEQUENCING PRIMERS 
Smith hexamer library
OLIGO 2303 (see Appendix 7, page 190 for base sequence) was prepared in the 
Division of Biochemistry and Molecular Biology at the University of Glasgow. For 
use, 360pl of stock was added to 40pl of 3M sodium acetate and 1.2ml of ice-cold 
ethanol added. This was vortexed, then left at -70“C for 15 minutes. Precipitated 
primer was harvested by centrifugation in a microfuge for 10 minutes at 4°C , the 
pellet washed with 1ml of ice-cold ethanol, dried at room temperature and finally 
resuspended in lOOpl of water to a concentration of 61 pM. This was diluted to a 
working stock of 3 pM.
Luzzago library
The -40 primer provided with the USB Sequenase Version 2.0 DNA Sequencing Kit 
(A m ersham  Life Science; A m ersham , B ucks.) has the sequence, 
GTTTTCCCAGTCACGAC, and recognises a site in the pUC19 portion of 
pEMBL19. It was provided at a concentration suitable for immediate use.
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Smith pentadecamer library
The sequencing primer for this library, shown in Figure 14, page 76, was synthesised 
and supplied by Russell Thompson and did not need dilution for use.
SEQUENCING PROTOCOL
The sequencing reaction was carried out according to the protocol, and using the 
reagents provided with the USB Sequenase Version 2.0 DNA Sequencing Kit 
(Amersham Life Science; Amersham, Bucks.). The labelled dATP Redivue [^^S] 
dATP, was also supplied by Amersham.
Sequencing gels were run on a BRL Model S2 sequencing system (Life 
Technologies; Paisley) using 30 cm by 40 cm glass plates separated by a 0.2mm 
spacer. The acrylamide/bis solution (Scotlabs; Coatbridge) was 6% (w/v) acrylamide, 
0.3% (w/v) bis/acrylamide, 7M urea, Ix THE, 70ml being polymerised by the 
addition of 140pl of ammonium persulphate (25 %, w/v) and 70pl of tetramethyl 
ethylene diamine (TEMED).
The gel was placed on the sequencing apparatus and 1 litre of single strength TBE 
running buffer added (see Appendix 4, page 186). As a pre-run to test the integrity of 
the wells and to warm the gel, 2pl of stop solution was added to each well and the gel 
run at 85 Watts for 30 minutes.
Samples to be sequenced were heated for 2 minutes at 75“C and 2pl added per well. 
Gels were run, using a Gibco BRL 2500 power supply (Life Technologies; Paisley), 
at 85 Watts constant power, with a surface temperature of approximately 65°C, for 
135 minutes. The gel was then transferred to Whatman 3MM chromatography paper 
and dried at 85°C for 2h on a Bio Rad 483 slab gel dryer. Dried gels were scanned 
with a Geiger counter to determine the level of radioactivity and then exposed to Fuji 
Medical X-ray film, type RX, for 2 to 10 days, depending on the signal obtained 
(typically, a gel giving around 80 to 100 counts per minute was left for 2 days, a gel 
giving less than 5 counts per minute for 10 days). Autoradiographs were developed in
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Kodak LX24 X-ray developer for 4 min, rinsed with running tap water, then fixed in 
Kodak Unifix for 10 min.
BINDING ASSAY
Smith hexamer library
The extent to which the phage isolated by biopanning bound to LT-B’^ ^^ '-^  ^ was
established in an ELISA-style assay.
Phage stocks used in sequencing were also used here with lOOpl being added to one 
well, and lOOpl of TBS being added to a second well, of a 96-well, flat-bottomed 
microtitre plate, which was left overnight at 4 “C The phage were removed and 
reclaimed for further use, but the TBS was discarded. Wells were blocked at room 
temperature for 2h with 360pl of TBS-G (See Appendix 4, page 186), washed five 
times with TBS-TWEEN, then 80pl of a 1 in 500 dilution of stock LT-Bbi«tin TBS 
was added. After overnight incubation at 4°C, both wells were washed five times with 
TBS-TWEEN, and 70pl of a 1 in 800 dilution of the monoclonal antibody 118.87 was 
added. Plates were washed and processed as described for Gmi ELISA, (page 82).
To confirm binding of phage to the plastic, selected wells were probed with a 1 in 250 
dilution of a rabbit anti-fd phage antibody (Sigma, Poole) and processed as above 
with HRP-conjugated anti-rabbit reagent.
Smith pentadecamer library
Microtitre plate assay for phage from first panning experiment
Recognition of LT-B '^°(^"  ^ and streptavidin by phage selected in the first panning 
experiment was tested in a binding assay carried out in Immunosorb' 96-well 
microtitre plates (Life Technologies; Paisley).
The phage produced for DNA sequencing could not be used in the binding assays as
they carried no recombinant pVIII. Thus, a second stock of around 10^2 phage was
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produced from the archived cultures prepared above. Again, the culture was 
inoculated into 10ml of LB broth and shaken at 37°C, but this time, when the A^oo
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reached 0.2, IPTG was added to ImM. Incubation continued overnight, and phage 
stocks were produced by PEG/NaCl precipitation as before.
To test for recognition of LT-B i^otin  ^ 200pl of 0.8mg mk^ streptavidin was added to 
eleven sets of four wells on the Immunosorb plate. After overnight incubation at 4“C, 
the streptavidin was removed and 400pl of the BSA/streptavidin blocker, as used in 
biopanning (see above), was added to all four wells of each set, and to a fifth well. 
After 90 minutes incubation at room temperature, this too was discarded. Then, a 1 in 
500 dilution of stock LT-B*^ i° ”^k in TBS-TWEEN, was added to wells 2 and 4 of each 
set. The plate was then stored at 4“C for two hours, to allow the LT-Bt>iotin bind. 
Unbound LT-B^ *®*^ ”  ^ was washed out with 400pl of TBS-TWEEN by five washes, 
each of thirty seconds duration. Phage from a single clone were now added to wells 1, 
2 and 5 of each set, 30pl per well. After overnight incubation at 4°C, and further 
washing, all five wells in each set were probed for binding phage. Firstly, 30pl of a 1 
in 500 dilution, in TBS-TWEEN, of rabbit anti-fd phage antibody was added to each 
well. The plate was then incubated at 37°C for one hour. After washing with TBS- 
TWEEN (as before), 30pl of a 1 in 500 dilution, in TBS-TWEEN, of HRP-conjugated 
anti-rabbit antibody (Sigma; Poole) was added. Finally, after five more TBS-TWEEN 
washes, the plate was developed and read as described on page 82.
‘Colony lift’ assay for phage from second panning experiment 
Colonies produced when enumerating the final round of biopanning against LT-B 
and blocked streptavidin in the second panning experiment were sub-cultured onto 
LB agar plates containing 30pg ml.’  ^ tetracycline and ImM IPTG that were incubated 
at 37°C overnight. The plates were then overlaid with 82 mm diameter, 0.45 pm 
cellulose nitrate membranes that were left in contact with the colonies on the agar for 
5 minutes. The alignment of these test membranes on the plates was marked. This 
process was repeated using a second membrane for each plate, these second ‘prints’ 
serving as controls.
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All membranes were soaked for 6 hours in 5 ml of a 25% BSA solution in PBS to 
block non-specific attachment and were then washed three times, for one minute each 
time, with TBS-TWEEN.
A fresh test membrane that had been exposed to the colonies infected with LT-B - 
panned phage was then transferred into 5 ml of TBS containing lOjil of 5 mg ml.'^ 
non-biotinylated Hirst LT-B and was left for 2 hours at room temperature. After 3 
washes with 10 ml TBS-TWEEN, 5 ml of a 1 in 500 dilution of anti-LT-B 
monoclonal antibody 118.87 was added. After a further two hours at room 
temperature, 5 ml of a 1 in 500 dilution of HR?-conjugated anti-mouse antibody in 
TBS-TWEEN was added. After two hours incubation, the membrane was developed 
(see below).
A second such test membrane was probed with 5 ml of 10 p.g ml.-l streptavidin in 
O.IM NaHCOg. After 2 hours at room temperature and 3 washes with 10 ml TBS- 
TWEEN, 5 ml of a 1 in 500 dilution of biotinylated peroxidase (Sigma, Poole) was 
added. After a further two hours at room temperature, the membrane was developed 
(see below).
A test membrane from the colonies infected with streptavidin - panned phage was 
also exposed to streptavidin, according to the protocol described above.
All control membranes were transferred into 5 ml volumes of a 1 in 500 dilution of 
anti-fd phage antibody in TBS and after two hours at room temperature and washing 
with TBS-TWEEN, 5 ml volumes of a 1 in 500 dilution of HRP-conjugated anti­
rabbit antibody were added. After a further two hours incubation, the membranes 
were developed.
To confirm that sufficient ligand was being added, samples of membrane spotted with 
5 p i of 1.5 pM Gm i (for LT-B) or neat Hirst LT-Bbioti" (for streptavidin) were
processed along with the test membranes.
All test and control membranes were visualised by the addition of 5 ml of a developer 
that consisted of 3 ml of a 3 mg m l'l solution (in methanol) of the HRP substrate 4-
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chloronaphthol to which 47 ml of PBS was added. The visualisation reaction was 
stopped by washing the membrane with PBS.
Microtitre plate assay for phage from third panning experiment
'Backchecking', exposing the amplified, eluted phage from each round to a surface of 
Protein G immobilised anti-cholera toxin antibody, had been introduced to the 
panning process to remove phage that bore peptides that reacted with this surface 
from the phage pool, thus allowing phage bearing LT-B-reactive peptides to 
predominate. Ten examples of backchecked final round phage and ten of those eluted 
from the well used for backchecking, were tested in an ELISA-based binding assay. 
Protein G could not be used in the binding assay ELISA because of its cross­
reactivity with immunoglobulin, therefore, plates were coated with LT-B alone and 
with anti-cholera toxin antibody alone as follows.
Each phage was tested in eight wells of an 'Immunosorb' 96-well microtitre plate. 
Hirst LT-B was added to three wells at concentrations of 1, 10 and lOOpg m l'l of 
TBS respectively. Anti-cholera toxin antibody was added to a further three wells at 
concentrations of 1/10, 1/100 and 1/1000 in TBS respectively. The plate was then 
incubated at 4°C overnight. The content of the wells was discarded and 1% BSA in 
TBS was added to all six, and to one previously unused well and was left for 6 hours 
at room temperature to block non-specific sites. After thoroughly washing all used 
wells with TBS-TWEEN (which was used for washing throughout this procedure), 
lOOpl of phage at a 1/100 dilution in TBS (approximately 10  ^phage) was added to all 
seven wells and to one more that was previously unused. One test set to which no 
phage were added served as a control. The plate was then left for one hour at room 
temperature and then washed.
As the anti-cholera toxin antibody was raised in rabbit, the enzyme system previously 
employed (rabbit derived anti-fd phage antibody followed by HRP-conjugated anti 
rabbit antibody) could not be used. Rather, lOOpl of a biotinylated anti-fd phage 
antibody at a dilution of 1/1000 in TBS was added to all wells and allowed to react 
for one hour. After washing, the HRP-labelled streptavidin, Extravidin' was added,
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again at 1/1000 in TBS and again reaction was for 1 hour at room temperature. 
Finally, the plate was developed and read as described on page 82.
In attempt to further characterise the phage under examination they were also tested 
by ELISA against a range of protein and detergent blockers.
The proteins tested were BSA, ovalbumin, gelatin and skimmed milk, each at a 
concentration of 1% in TBS. The detergents were Tween 20, Triton X-100 and 
Nonidet P40, each at a concentration of 0.5% in TBS.
Twenty-one series of test wells were prepared, each well in a series receiving lOOpI 
of protein or detergent. After overnight incubation at room temperature, the wells that 
contained protein were washed three times with TBS-TWEEN.
The same twenty phage used above were tested, lOOpl of each one being added to 
each well in a series. In addition, phage were also added to one previously unused 
well adjacent to the protein and the detergent wells. The twenty-first series received 
no phage and served as a control.
After 8 hours exposure, phage were removed from all wells. The protein and adjacent 
wells were washed with TBS-TWEEN, the detergent wells with the respective 
detergent.
Biotinylated anti-fd phage antibody, Extravidin and developer were then used as 
above except that washing was with the appropriate detergent. Finally the result was 
read at 492nm.
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RESULTS
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EXPRESSION, PURIFICATION AND 
CHARACTERISATION OF LT-B
Expression of LT-B
Correlation of Vibrio 60 pMMB68 growth cycle with LT-B production
The point in the Vibrio 60 pMMB68 growth cycle at which expression of LT-B was 
optimal was determined by performing Gmi ELISA (see page 82) on supernates of 
samples drawn at hourly intervals from a flask of growing cells. The titre was 
arbitrarily taken as the log2 dilution which produced an absorbance of 0.2. Figure 15 
shows these titres superimposed onto the Vibrio 60 pMMB68 growth curve as 
determined by absorbance readings at 600nm. A rapid burst of LT-B production 
followed the addition of IPTG at 2h, the concentration of which increased 
exponentially until 4h, after which it levelled off, becoming stationary, along with cell 
concentration, at 8h. As there was no subsequent decrease in LT-B concentration, 
culture supernate was routinely harvested in LT-B production runs at lOh post- 
inoculation for processing by affinity chromatography by the method of Uesaka et a i  
(1994) (see page 80).
Purification of LT-B
Five cycles of adsorption of Vibrio 60 pMMB68 10 hour culture supernate to the 
immobilised galactose affinity column and elution with galactose, provided material 
for initial analysis of the purified product.
A further 15 full production cycles were then completed to provide the material for 
biopanning work. The peak fractions from the fifteen runs, as determined by SDS- 
PAGE and Gmi ELISA, were pooled and then concentrated with PEG to 7ml.
Characterisation of purified LT-B
The presence of LT-B in the concentrated product of affinity-column purification was 
demonstrated by SDS-PAGE, Western blotting and Gmi ELISA.
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FIGURE 15 : Production of LT-B during growth of Vibrio 60 pMMB68
The Aôoo of samples from the growing culture and the relative concentration of LT-B, 
determined by Gmi ELISA, were measured. Titre indicates the log2 dilution at which 
the ELISA absorbance was 0.2. IPTG was added to the culture 2 hours post­
inoculation.
Aeoo ; titre.
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SDS PAGE
Figure 16 shows the result of SDS-PAGE with heated (100°C) and unheated samples 
of the column eluate. Both lanes showed only one band; in the sample the
band had an apparent M^ - of 41500, but in the heated sample the Mr was 14000. 
Thus it appeared that the protein eluted from the affinity column disassociated when 
heated in the presence of SDS and mercaptoethanol, but did not do so at room 
temperature. The observed Mr and pattern of dissociation were those reported for LT- 
B, as discussed on page 142.
Western blotting
The protein eluted from the affinity column was transferred from an SDS-PAGE gel 
to nitrocellulose membrane by Western Blotting. After probing with the anti-LT-B 
monoclonal antibody 118.87, and adding peroxidase substrate, the membrane showed 
a single band of high intensity that corresponded to the Mr = 41500 band revealed by 
Coomassie blue staining. The gel and membrane are shown in Figure 17.
GmI ELISA
Gmi ELISA was performed on the affinity column eluate, using the anti-LT-B 
monoclonal antibody as a probe. The result (Figure 18), demonstrated that the protein 
interacted strongly with Gmi such that at a dilution 1/4096, the greatest dilution 
tested, the ELISA A450 was still greater than double the background signal. The 
reduced A450 occurring at dilutions up to 1/256 may have resulted from steric 
hinderance (discussed on page 145).
Given that the eluted protein displayed electrophoretic properties characteristic of LT- 
B, a strong affinity with the anti-LT-B monoclonal antibody 118.87 as demonstrated 
by both Western blotting and Gmi ELISA, and the ability to bind to ganglioside Gm i ,
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FIGURE 16 : SDS-PAGE analysis of samples produced by galactose 
affinity purification from Vibrio 60 pMMB68 culture supernate.
Lane 1 contained SDS7 molecular weight markers (molecular weights in kDa shown 
to left); Lanes 2 and 3 contained protein eluted from the affinity chromatography 
column and added to solubilising buffer. The sample in lane 3 was heated prior to 
loading on the gel, that in lane 2 was left at room temperature.
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FIGURE 17 : Analysis of affinity column purified sample by SDS- 
PAGE and Western blotting.
Lanes 1 and 2 show the Coomassie blue stained gel of, respectively, SDS7 
molecular weight markers (molecular weights shown to left) and the affinity 
column fraction (unheated). Lane 3 shows the Western blot of this gel, probed 
with anti-LT-B antibody and HRP-conjugated second antibody, and developed by 
addition of an HRP substrate.
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FIGURE 18 : Characterisation of puriüed column fraction by GmI ELISA.
Doubling dilutions of the protein purified from the affinity column (—■—  ) and of 
PBS (—o ~  ) were made in the wells of a microtitre plate coated with Gm i - After 
absorption and appropriate washing cycles (see page 82) wells were probed with anti- 
LT-B antibody and HRP-conjugated second antibody before addition of an HRP 
substrate. The absorbance at 450 nm was measured.
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it was considered that the protein purified from the immobilised galactose affinity 
column was indeed LT-B.
Protein concentration of purified LT-B samples
Before analysing eluted material for protein content, it was necessary to ensure that 
the method employed would not be affected by the presence of varying concentrations 
of galactose in the eluted fractions.
Markwell et a l  method
Figure 19 (a) shows that aliquots of BSA, prepared to a constant concentration of 
60|ag mL^ in increasing concentrations of galactose, failed to give a consistent 
reading with this adaptation of the Lowry assay. Read against the OmM galactose 
sample, the absorbance was a full unit higher when SOOitlM  galactose was present. 
Bradford method
Figure 19 (b) demonstrates that the absorbances, when read against a reagent blank, 
remained constant regardless of increasing galactose concentration. All further protein 
estimations were performed using this method.
LT-B yields as determined by Bradford Assay
The fractions eluted from five purification runs with the immobilised galactose 
column, shown by SDS PAGE to contain pure LT-B, were pooled and tested for 
protein content. These pools had an average volume of 10.6ml (maximum 12.5ml, 
minimum 7.6ml), and an average protein content of 880pg (maximum 1025p.g, 
minimum 700pg). The pools were then individually concentrated with PEG 10000 to 
an average of 780pl total volume, (maximum 1050pl, minimum 600pl), each of 
which contained an average of 762pg of protein (maximum 960pg, minimum 670pg). 
The 7ml pool from the fifteen production runs contained 2.1 mg protein.
The Hirst LT-B was supplied at a concentration of lOmg per ml.
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FIGURE 19 : Assay of a fixed amount of BSA in the presence of increasing 
concentrations of galactose.
(a) Markwell adaptation of the Lowry method; (b) Bradford assay.
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Having established the protein content of the LT-B samples, they were then 
biotinylated.
Biotinylation of purified LT-B
Biotinylation of the stock LT-B, produced and assayed as described above, and the 
Hirst LT-B was performed with the Sigma Immunoprobe Biotinylation kit, as 
described on page according to the protocol supplied.
Degree of biotinylation
The degree of biotinylation of both batches of LT-B was determined using the method 
outlined on page 84.
Stock LT-^ B
By this method a corrected A500 of 0.032, equivalent to a final biotin concentration of 
9.41 nmoles mk^, was indicated. The biotin / protein ratio was calculated from the 
protein concentration (2.1 nmoles ml"l), yielding 4.48 moles of biotin per mole of 
LT-B.
Hirst LT-B
Using the method described above, the biotin / protein ratio of the Hirst LT-B'^'^tin 
was demonstrated to be 2.60 moles of biotin per mole of LT-B.
Analysis of biotinylated LT-B
G mi ELISA was used to confirm that biotinylation had not diminished the Gm i - 
binding capability of stock LT-B.
In Figure 20 (a) the ELISA was carried out using the anti-LT-B monoclonal antibody 
118.87. Starting with a 1 / 2 0  dilution, a further 7 doubling-diiutions were required 
to reduce the signal to control level. Figure 20 (b) shows the result obtained when an 
identical dilution series was analysed with HRP-labelled streptavidin (Extravidin).
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FIGURE 20 : Gmi ELISA of biotinylated LT-B.
(a) Probed with anti-LT-B monoclonal antibody 118.87. (b) probed with Extravidin.
A450 of PBS-only control ;■ A450 values for biotinylated LT-B.
116
Although in this case the initial absorbance was higher, it again took eight dilutions to 
reach background level.
These results confirmed that the biotinylated LT-B was capable of binding to Gmi-
Finally, biotinylation of LT-B did not affect the ability of the protein to interact with a 
monoclonal antibody specific for the native protein or to interact with ganglioside 
Gm i - The biotinylated LT-B (LT-Bb^° '^") was therefore considered suitable for use 
with the phage libraries.
SMITH HEXAMER LIBRARY 
Infectivity of E. coU K91kan
The optimum time in the E. coli growth cycle at which the maximum number of 
transformants could be produced following infection by phage was determined using 
cells removed from the culture at half-hourly intervals from 6 hours post-inoculation 
onwards. Figure 21 shows the variation in colony numbers (representing T.U.) over 
the test period and clearly confirms that the ability to infect K91kan is growth-cycle 
dependent, with peak infectivity occurring when the culture had an A^oo in the range 
1.5 to 2.5.
Selection of binding phage by biopanning 
Enumeration of eluted phage
The initial Amplified Library Stock’ contained 1.1 x 10^3 phage m b i , and lOOjil of 
this suspension (i.e. 1.1 x lO^^ phage) was panned against streptavidin-bound LT- 
Bbiotin. Three such experiments were conducted, being eluted with acid elution buffer, 
Gm i and TBS respectively. Phage eluted by each agent were amplified and retested in 
a further three identical panning rounds.
The numbers of phage applied to and eluted from the tubes in each round were 
determined and the percentage of applied phage which was recovered was measured 
to calculate the degree of enrichment achieved.
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FIGURE 21 : Number of transductants produced on infection of 
Escherichia coli K91 kan at different times in the growth cycle.
Escherichia coli K91 kan was grown in Terrific broth at 37"C . At 30 minute intervals 
from 6 h, A^oo was recorded and an aliquot of the culture was infected with stock 
Smith hexamer library phage. Infected cells were plated on LB (plus tetracycline and 
kanamycin) agar that were incubated at 37° overnight. Each tetracycline-resistant colony 
represented 1 transducing unit.
— A^ oo of the culture; 
of the culture.
number of transductants arising from infection
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percentage of phage recovered from the first round to the last.
different to this, PW PCAG. One (type iv) had a sequence, PLPLA G , that showed 
three amino acid differences from type i, but sufficiently strong similarities to justify 
inclusion in this group : ie. P in positions 1 and 3; repeated, hydrophobic amino acids 
in positions 2 and 4 (although aliphatic L in this case, as opposed to aromatic W in
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Table 6 shows the number of phage eluted in the first round, the numbers applied and 
eluted in subsequent rounds and the overall enrichment, defined as the increase in
I
Sequencing of selected phage 
Sequencing reaction
To determine whether the phage selected by biopanning carried consensus amino acid 
sequences, DNA inserts were determined for representative recovered phage. 
However, in attempting to read the sequences from the autoradiographs a major 
problem arose because a second sequence, identified as that of wild-type pIII gene
(i.e. unmodified by insertion), was present in the same lanes of the gel as that of the 
selected phage. A sample autoradiograph, highlighting the problem, is shown in
Figure 22. The wild-type sequence did not appear with consistent intensity, being in
'
some cases close to background levels but in other samples it was the predominant 
signal. In the latter cases, the slightly offset nature of the wild-type sequence meant 
that it could not simply be disregarded; in these cases the insert sequences could not 
be determined. A fuller explanation of the problem, and of the attempts made to 
overcome it, are discussed later (see page 148).
The sequences from 20 acid-eluted, 8 GMi-eluted and 11 TBS-eluted clones are
presented in Tables 7 (a), (b) and (c).
Acid eluted phage carried inserts which could be viewed as belonging to three distinct 
groups. Group 1 consisted of ten clones which carried three different fusions. Seven 
had the sequence PW PW LG, two of which (type ii) were translated from a different 
base sequence to the other five (type i); ie. they featured the codon CCG, as opposed 
to CCT, for the P residue in position 3. Two (type iii) had a sequence two amino acids
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WILD TYPE
5 ' TCTCACTCCGCT-----------------------------------------------------------------------------GAAACTGTT 3 '
S H S A G T V
GENERIC RECOM BINANT
5 ' TCTCACTCGGCCGACGGGGCTÎMEOSINKNNKNNKNNKNNKGGGGCCGCTGGGGCCGAAACTGTT 3 ' 
S H S A D G A X X X X X X G A A G A G T V(a)
GROUP 1
( i )   CCGTGGCCTTGGCTGGGT..........................................................
S H S A D G A P W P W L G G A A G A G T V
(ii)  CCGTGGCCGTGGCTGGGT..........................................................
S H S A D G A P W P W L G G A A G A G T V
( i i i )  CCGTGGCCTTGTGCGGGT..........................................................
S H S A D G A P W P C A G G A A G A G T V
( iv )  .................................................. CCGTTGCCTTTGGCGGGT.........................................................
S H S A D G A P L P L A G G A A G A G T V
GROUP 2
( i )   TGGTTTAATGAGCCGTTT..........................................................
S H S A D G A W F N E P F G A A G A G T V
( i i )   TGGTTTAATATTGTTTTT..........................................................
S H S A D G A W F N I V F G A A G A G T V
( i i i  ) .................................................TGGTTGAAGATGCTGTTT..........................................................
S H S A D G A W F K M L F G A A G A G T V
(iv)  ..................................................TGGGTTAATAGGTCGTTT..........................................................
S H S A D G A W V N R S F G A A G A G T V
( v) ..................................................TGTTTTAATATGCCGTTT..........................................................
S H S A D G A C F N M P F G A A G A G T V
GROUP 3
( i  )....... ..................................................TTGTTGAGTTGCTGGTTT..........................................................
S H S A D G A L V E L L F G A A G A G T V
( i i )  ................................................. ACTTCGCTGGTCCCGGCT.........................................................
S H S A D G A T S L V P A G A A G A G T V
( i i i  ) .................................................. CGTACGCCTAAGAATTCT .............................................
S H S A D G A R T P K N S G A A G A G T V
TABLE 7 : Nucleotide and amino acid sequences of inserts carried by 
clones from the Smith hexamer library.
The generic recombinant sequence is shown at the top of each page, followed by the 
nucleotide sequence and amino acid translation of each eluted phage (a - Acid eluted ; b
- Gm i  eluted; c - TBS eluted). The wild-type sequence is shown at the top of this page
for comparison.
Dots show identity to the generic recombinant sequence; dashes, indicating absent 
nucleotides, were introduced to maintain alignment.
Note that c (v) carries a tripeptide insert
1 2 2
GENERIC RECOMBINANT SEQUENCE
5 ' TCTCACTCGGCCGACGGGGCTNNKNNKNNKNNKNNKNNKGGGGCCGCTGGGGCCGAAACTGTT 3 
S H S A D G A X X X X X X G A A G A G T V
( b )
( i  )  TTTTTTATGTCTCGTTTT.......................................
S H S A D G A F F M S R F G A A G A G T V
( i  i  )  AGTAATTCGGTGAATGGG....................................................................
S H S A D G A S N S V N G G A A G A G T V
( i i i )  ...............................................................TTTCTTAATTTGCATCTT..................................................................
S H S A D G A F L N L H L G A A G A G T V
( i v )  .............................................................ATTGCGTTGTTGCATTTT....................................................................
S H S A D G A I A L L H F G A A G A G T V
( V  )  GGGGGGCGTCAGAAGCTT....................................................................
S H S A D G A G G R Q K L G A A G A G T V
( v i  )  GGTTTGCGTATTAGTTAT....................................................................
S H S A D G A G L R I S Y G A A G A G T V
( v i i )   AATACGAGTAAGGTGTTT....................................................................
S H S A D G A N T S K V F G A A G A G T V
( v i i i )   TCGTCTAGGATTTCGAAT...................................................................
S H S A D G A S S R I S N G A A G A G T V
( c )
( i  )  CATCTTCTGTATCCGAAT....................................................................
S H S A D G A H L L Y P N G A A G A G T V
( i i )  .............................................................TTGCAGGGTTTGATGTTT....................................................................
S H S A D G A L Q G L M F G A A G A G T V
( i i i )  ............................................................... TTGGGGCTGAGGGGGAAT..................................................................
S H S A D G A L G L R G N G A A G A G T V
( i v )  .............................................................CCTGCTGTTGTTCTTAAG....................................................................
S H S A D G A P A V V L K G A A G A G T V
( v ) ........................................................................TCGCTTGTT........................... ....................................................................
S H S A D G A S L V  G A A G A G T V
( v i )  .............................................................CGTCCTATGCATGCGATT....................................................................
S H S A D G A R P M H A Î G A A G A G T V
( v i i )  .............................................................. TTTGTGCGGGTGCGTAAT...................................................................
S H S A D G A F V R V R N G A A G A G T V
( v i i i )   TTTCCGATGGTTACTCGG.................................................................
S H S A D G A F P M V T R G A A G A G T V
: i x  ) ..............................................................CGGGTGGTTGCGGCTCCT...................................................................
S H S A D G A R V V A A P G A A G A G T V
( X  )  TCTGCGTCGGGGCTTTGG....................................................................
S H S A D G A S A S G L W G A A G A G T V
( x i  )  ACTACTACTTCTAGTGAG....................................................................
S H S A D G A T T T S S E G A A G A G T V
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types i and ii) and G in position 6. The A in position 5 of type iii, like the L in the 
same position in types i and ii, is aliphatic.
Group 2 consisted of seven clones, of five sequence types, all of which featured F as 
the last amino acid in the random insert. Four types (i, ii, iii and iv) had W as their 
first residue, four (i, ii, iii and v) had F as their second, four (i, ii, iv and v) had N as 
their third. In addition, two (iii and v) had M in the fourth position and two (i and v) 
had P in the fifth.
No alternate codons were observed for any of the amino acids in group 2, but of all 
the amino acids featuring more than once in the group, only P can be translated from 
an alternative codon.
Group 3 consisted of three sequences which bear no apparent relationship, with the 
possible exception that Group 3(i) may be related to Group 2(iii) via the residues L 
and F in positions 5 and 6.
Gmi elution yielded eight phage with inserts that showed only tenuous similarities. 
The most noteworthy are types i, iv and vii, each of which terminate with F, as did 
the Group 2 acid eluted phage, although in this case the other amino acids in the 
sequence bear no relationship either to these or to each other. A low degree of 
similarity is also observed between type iii (FLNLHL) and iv (lA LLH F), in that 
both feature LH in positions 4 and 5, as well as F and an additional L, but again, the 
dissimilarities outweigh the similarities.
TBS elution gave eleven unrelated phage, including one (v) that had a tripeptide 
insert.
Binding assays
To determine whether the phage selected by biopanning had been enriched because of 
their affinity for LT-B rather than streptavidin or plastic, phage prepared from each of 
the acid, Gm i and TBS-eluted clones were assayed. The phage were used to coat 
microtitre plate wells whilst control wells received TBS alone. Stock LT-Bbioti" was 
added to all wells and the extent to which it was ‘captured’ in the well was
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determined by measuring A450 after the addition of anti-LT-B monoclonal antibody, 
HRP-conjugated anti-mouse antibody and HRP-substrate.
Acid-eluted phage gave an average A450 of 0.053, Gmi eluted phage an average of 
0.062 and TBS eluted phage an average of 0.066. No well containing phage of any 
type gave a reading of greater than 0.08. When compared with the average for the 
control wells (0.052), it was apparent that no phage showed any evidence of ability to 
capture LT-B.
To demonstrate that this result was not due to inadequate phage-coating of the wells, 
bound G m i -eluted phage were tested by the addition o f  anti-phage antibody, HRP- 
conjugated anti-rabbit antibody and HRP-substrate. Control wells, which did not 
contain phage, were treated similarly. In this case, phage-coated wells gave A450 
readings in excess of 2.0, some 7.7 times the average of the control well readings, 
thus confirming that the plastic surface was efficiently coated with the phage under 
investigation.
LUZZAGO NONAMER LIBRARY
The Luzzago library expresses a constrained nonameric peptide on pVIII (see page 63 
for details), and a transformation assay with E. coli XL-1 cells indicated that the stock 
library contained approximately 2.5 x lO^^ phage ml"^ therefore amplification was 
unnecessary. Uninfected E. coli XL-1 failed to grow on the ampicillin agar used in the 
assay.
Selection of binding phage by biopanning 
First round of biopanning
Three 2pl aliquots (i.e. 5 x IGdl phage) from the phage library were individually 
panned against streptavidin-bound stock LT-B^iotin Bound phage were eluted with 
acid elution buffer, G m I  and TBS respectively.
Each eluate was mixed with XL-1 cells in LB broth and was plated onto nine LB agar 
plates containing ampicillin. After incubation, all twenty-seven plates were covered 
with around 1500 small colonies, which were scraped from the plate, resuspended in
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broth, infected with M13K07, and used to produce phage for the second round of 
panning.
Subsequent rounds of biopanning
Amplified eluates were mixed with LT-B^ioan ^nd panned in streptavidin-coated 
Maxisorp tubes. Bound phage were eluted with the same agent used in the previous 
round.
The second and third rounds of biopanning produced eluates that, when mixed with 
XL-1 cells and plated out, all yielded approximately 1500 small colonies per plate. 
Those produced from second round eluates were used to prepare phage virions for use 
in the third round. Some of the third round colonies were picked at random and 
sequenced.
Sequencing of phagemid DNA
The nature of the peptides expressed by 20 acid-eluted, 10 GMi-eluted and 10 TBS- 
eluted clones were determined by DNA sequencing. That there was a serious problem 
with the construction of the library was immediately apparent. In every case there 
were only 26 bases between the two TGC (C) codons that flanked the random insert, 
and a base was missing from the codon for of mature pVIII (CC instead of CCC). 
In addition, there was a base substitution in the codon for in the signal sequence 
(TCT for TCG). The expected and actual sequences are shown in Figure 23.
Also shown in this figure is a sequence characteristic of three of the TBS-eluted 
phage. Downstream of the codon for F^, these were as described above (ie. they 
lacked a C in the codon for and carried a random insert of 26 bases). Upstream of 
the codon for F^ the nucleotide sequence bore no relationship to that predicted.
Since the location of the missing base in the characterised inserts could not be 
identified, no inference could be made of the protein sequence carried on phage eluted 
in the final round of biopanning. Taking all sequences into account, C was the most 
prominent base in the random insert (approximately 35.5%); then G (24.6%); T (23.4) 
and A (16.1%).
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Nucleotide sequences of the 26-base pair insert from the three unusual TBS-eluted 
phage described above are shown in part (a) of Table 8, whilst those of five 
representative phage eluted by acid are shown in part (b).
SMITH PENTADECAMER LIBRARY
The Smith pentadecamer was originally constructed by George Smith of the 
University of Missouri who provided the hexamer library also used in this work. The 
viral capsid displays both wild-type and synthetic pVIII, the 15 base-pair insert being 
fused to the latter. This form of fusion, Type 88, is discussed on page 10.
Selection of binding phage by biopanning 
First biopanning experiment
The number of phage in the original library was ascertained to be 5 x 10^  ^T.U. m hk 
In the first biopanning round, 30 p.1 (1.5 x 10^  ^ phage) was mixed with lOpI stock 
prior to exposure to a streptavidin-coated plastic surface. Bound phage 
were eluted from the plastic with acid buffer. Amplified first round phage were used 
in a second identical round of panning (although 30 pi of phage were in this case 
mixed with 8 pi stock LT-Bbioti" ). A third panning round, using 30 pi amplified 
second round phage and 6 pi LT-Bbio^n ^^s then conducted.
The number of phage eluted at each round was as follows :
First round : => 1.2 x 10  ^T.U.
Second round : => 4.1 x 10  ^T.U.
Third round : => 1.4 x 10  ^T.U.
Sequencing of selected phage
Ten clones from the final round were chosen at random for further characterisation. 
The sequences of the inserts carried by each are shown in Table 9. In all but one of 
the clones the second codon is CAT, coding for H. In the other, clone number 8, CAT 
is the first codon. This represents the only occurrence of H in all sequences bar that of
1 2 8
a)
5 ' CTGC CCTA CCCT CGTC AAAG TTCA GC
TACG TAGT ACGA ATCT GACC CTCC GA
TGGG ATTG ACCC GTGT CCAC CTCA CC
b)
5 ' CCTG CCTG ACGC CCCT GCTG GTGA CT
CGTC GCGT CCAC TCTC TCGC TAGC AC
CTAA TGAT GTCC GGCC CGCC GGTC GG
CCTG CCTG ACGC CCCT GCTG GTGA TC
CATA CGAG AAGT CCTC CGGC CCTT CT
TABLE 8 : Sequences of random inserts carried by clones from the Luzzago 
library.
(a) Data from TBS-eluted clones with unusual sequences upstream of the codon for 
F^; (b) Sequences from representative acid-eluted clones.
Placement of the reading frame is unknown.
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1 TCA CAT AGG ACG CGC CGC CAA CGC CTT AGT TCG CTG GGC CGC CTA
S H R T R R Q G L S S L G R L
2 AAT CAT CGT COT TTT TCG TCG ACG CGC TCT CTT CAG GCT TTT GCT
N H R P F S S T R S L Q A F A
3 CAG CAT CGT TCT TTC CGC GGT GAT TGT CGC GGT AGG ATG TGT TCG
Q H R S L R G D C R G R M C S
4 AGO CAT CTG CGT GCT GGT CAG GGG TTT ATG GTT CCG TTT CTT TCG
R H L P A G Q G F M V P F L S
5 GCG CAT AGG CAG TCT CCG GCT GCT CCG ATG ACT AAT TTT ATG ACT
A H R Q S P A A P M T N F M T
6 AGG CAT GGT TTT ACT TTC ATG ACC CTA AAG CGC TTG CGC CTA CTG
R H G P T L M T L K R L R L L
7 CAG CAT ACT AGT TCG CGT CCG AAT CGC CGT CCG TCT ACT CCG CGT
Q H S S S R P N R P P S T P P
8 CAT AGG ATC ATT CTG CGC AGG TTC GGG ACG AGG CCG CTT ACT ACT
H T I I h P R L G T R P L T T
9 AAT CAT TGG GCT GCT TAC GAG GGT TAC TGC GAA TCG GTC TCC TTC
N H W A A V E G V C E S V S F
1 0 AGG CAT AAA TTC GCG CGT GCG GTT TCG ACT GCT CAT CAG CAG ATA
R H K F A R A V S T P H Q Q I
TABLE 9 : Nucleotide and amino acid sequences of inserts carried by acid- 
eluted clones from the Smith pentadecamer library after biopanning with LT-
gbiotin^
The first row in each case shows the nucleotide sequence, the second shows the 
amino acid translation.
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clone 10, where it also appears as residue 12. In seven cases, the H was immediately 
adjacent to R (preceding on three occasions, succeeding on four). The residues N and 
Q also each preceded H in two cases, with S and A preceding once each. Table 10 
presents a table of expected and actual occurrence of amino acids. The most 
frequently occurring was R , constituting 21 of the 150 codons that were 
characterised; it occurred four times in two of the sequences (1 and 3) and failed to 
occur only in clone 9. The next most common residue was S, which featured 17 
times, including 3 successively in number 7, which also was the clone that bore the 
least varied complement of amino acids, with five P, four S, and two R among its 
fifteen residues. The only amino acid that failed to feature at all was Y, with W and D 
appearing only once each.
Binding assay
An assay was devised to ascertain whether the phage isolated and sequenced as 
described above bound specifically to LT-Bbio^». Preliminary tests having indicated 
that they adhered to streptavidin rather than to a spot-check assay was
developed. In this assay, final-round phage were exposed in microtitre-plate wells to 
either streptavidin-bound LT-B^iocin or streptavidin alone. Those that bound were 
identified by successive additions of rabbit anti-phage antibody, HRP-conjugated 
anti-rabbit antibody and HRP substrate. The coloured product of the reaction was read 
at A450. The result of this assay is shown in Figure 24.
The anti-phage antibodies did not react with either streptavidin alone or with 
streptavidin-bound LT-B (wells 3 and 4 respectively in the assay format described on 
page 101), both of which gave background readings not recorded in Figure 24. 
Background-level results were also obtained from the binding of phage to blocker 
alone (well 5).
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AMINO
ACID
NOMINAL
FREQUENCY
NOMINAL
OCCURRENCE
OBSERVED
OCCURRENCE
A 0.065 9.75 10
C 0.032 4.8 3
D 0.032 4.8 1
E 0.032 4.8 2
F 0.032 4.8 8
G 0.065 9.75 9
H 0.032 4.8 11
I 0.049 7.5 3
K 0.032 4.8 2
L 0.098 14.7 15
M 0.016 2.4 5
N 0.032 4.8 4
P 0.065 9.75 13
Q 0.032 4.8 8
R 0.098 14.7 21
S 0.098 14.7 17
T 0.065 9.75 12
V 0.065 9 J5 5
W 0.016 2.4 1
Y 0.032 4.8 0
TABLE 10 : Expected and actual occurrence of amino acids in the clones from  
the Smith pentadecam er library.
The nominal frequency is obtained by dividing the number of codons for any amino acid by 
31, the number of coding triplets in the NNK genetic code. Nominal occurrence is derived by 
multiplying the nominal frequency by 150, the number of amino acids in the 10 pentadecamer 
inserts.
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FIGURE 24 : Binding of phage selected from the Smith pentadecamer library to 
streptavidin and streptavidin-bound LT-B.
Purified phage clones were exposed to microtitre-plate wells coated with streptavidin- 
bound (0 9  ) or streptavidin alone ( ^ ) .  Bound phage were identified by
the addition of anti-phage antibody, HRP-conjugated second antibody and HRP 
substrate that yielded a chromagen read at A450. Clone numbers are designated on the 
X-axis, with ’control' indicating results obtained with an aliquot of the original library. 
The horizontal line shows the background signal determined from this control.
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Figure 24 shows the binding of each of the ten selected phage, and an aliquot of the 
original library, to streptavidin alone and to streptavidin-bound LT-Bb'otin phage 
from the original library did not bind to streptavidin or at levels higher than
background. Binding of the selected phage can therefore be measured against this 
figure, which, in Figure 24, is indicated by a horizontal line.
Clones 2 and 3 bound to the highest levels, (readings of 0.4 to 0.55) with readings in 
wells coated only with streptavidin some 25% higher than those with streptavidin- 
bound LT-Bbiocin_ Clones 1, 5 and 7 gave moderate readings (0.2 to 0.3) - in each case 
values were around 15% higher in streptavidin-bound LT-BbNtin wells than when the 
wells were coated only with streptavidin.
Clones 4, 6 and 10 gave low readings (0.1 to 0.2), which were 16%, 6% and 14% 
higher respectively in wells coated with streptavidin-bound Values for
clones 8 and 9 were barely higher than background and showed little difference 
between coatings.
Second biopanning experiment
In view of the findings from the binding assay described above a second panning 
experiment, using an alternative source of purified LT-B (Hirst LT-B i^o^"""), was 
conducted as previously described for the Smith pentadecamer library.
To assess the possible effect of binding to the medium supporting the LT-B during 
the panning process, 20pl phage were also panned, in parallel series, against 
streptavidin only and BSA-blocked plastic respectively. Elution was with acid buffer 
in each case and two further identical panning rounds followed.
The number of phage in the original library was aseertained to be 3 x IQll T.U. mTk 
The number of phage eluted in each round, from each surface, was as follows :
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PANNING SURFACE
LT-B STREPTAVIDIN PLASTIC
First round => 1 . 0  X lO"^ 1 . 0  X 1 0 ^ 1 . 0  X 1 0 ^
Second round => 6 . 0  X 1 0 ^ 1 . 4  X 1 0 ^ 1 . 0  X 1 0 ^
Third round => 1 . 6  X 1 0 ^ 2 . 3  X  1 0 ^ 2.7 X lo'^
‘Colony lift’ assay
The agar plates containing phage-infected colonies that were the by-product of the 
enumeration of final round eluates in this panning experiment were used in an 
alternative form of binding assay. They were overlaid with nitrocellulose membranes 
so that phage associated with each colony would be transferred to the membrane. 
Membrane-bound phage from the LT-B^^°' ‘^*^-panning experiment were exposed to 
non-biotinylated LT-B and streptavidin; phage from the streptavidin-panning 
experiment were exposed to streptavidin alone. Captured ligand was visualised by the 
addition of an antibody against the ligand and HRP-conjugated second antibody (in 
the case of LT-B) or biotinylated peroxidase (for captured streptavidin). To ensure 
that sufficient ligand was added, membranes impregnated with Gm i (for LT-B) and 
biotin (for streptavidin) were simultaneously processed.
A second membrane was also overlaid on the plates and was used to confirm transfer 
of phage to the membranes by the addition of rabbit-anti-phage antibody, HRP- 
conjugated anti-rabbit antibody and HRP substrate.
LT-B - panned phage failed to capture any LT-B, the membranes remaining clear 
after substrate had been added. The Gm i-impregnated membrane darkened intensely. 
However, these phage did demonstrate a degree of affinity for streptavidin, as very 
faint spots appeared at positions that corresponded with colonies on the original agar 
plate. Streptavidin -panned phage demonstrated a similar, weak affinity. By contrast, 
the membrane spotted with LT-B^Ntin reacted strongly with streptavidin as expected.
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The control membranes that were probed with rabbit-anti-phage antibody and HRP- 
conjugated anti-rabbit antibody, gave a strong, positive reaction, the position of each ,,.4
colony being easily discerned. One such control is shown in Figure 25. I
The ‘colony lift’ binding assay therefore identified colonies that displayed phage 
capable of binding streptavidin but not LT-B. That there were sufficient phage bound 
to the membranes was confirmed by the result obtained when anti-phage antibody 
was used, whilst the success of the assay principle was confirmed by the strongly- 
positive reactions obtained with membranes impregnated with Gmi and LT-Bbioün 
This result confirmed that obtained with the microtitre plate assay. In that case, the 
A450 produced when phage were added to LT-B^’iotin never significantly exceeded that 
obtained when streptavidin alone was used. The inference is therefore that it was the 
streptavidin to which the phage were binding. This implications of this result are 
discussed on page 165.
Third biopanning experiment
The previous experiments having apparently yielded phage with an affinity for 
streptavidin, it was decided to conduct one further panning experiment in which 
measures aimed at eliminating such undesired binding were employed. Firstly, an 
alternative form of immobilisation of Hirst LT-B, via Protein G-bound anti-cholera 
toxin, was used. Secondly, as described on page 9 7 , amplified phage from each 
round were 'backchecked' by exposure to a well containing Protein G-bound anti­
cholera toxin prior to their use in each subsequent panning round.
The number of phage eluted at each round was as follows :
First round ; => 1.64 x 10  ^T.U.
Second round : => 1.94 x 10  ^T.U.
Third round : => 2.7 x 10  ^T.U.
1
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FIGURE 25 : Control membrane used in ‘colony lift’ binding assay.
A membrane filter was placed against colonies infected with phage selected by 
biopanning on an LT-B coated surface. Adsorbed phage were probed with rabbit anti-fd 
antibody and HRP conjugated anti-rabbit antibody. Result was visualised using the HRP 
substrate 4-chloro naphthol. The position of individual colonies is clearly apparent.
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The wells of Protein G-bound anti-cholera toxin antibody used in backchecking were 
afterwards treated with acid elution buffer to release phage that had been removed by 
the backchecking process for enumeration purposes. The numbers eluted from these 
wells at each round were :
First round : => 5.82x103 T.U.
Second round : => 8.03 x 10  ^T.U.
Third round : => 3.63x103 T.U.
Microtitre plate binding assay
Two groups of third-round phage from this experiment were tested in a binding assay 
- ten of those that did not bind at 'backchecking' ('B-type' phage) and ten of those that 
did bind and were subsequently eluted ('E-type').
Phage were exposed to three dilutions of LT-B, to three dilutions of anti-cholera toxin 
antibody, to blocked plastic and 'naked' plastic.
On exposure to LT-B or anti-cholera toxin antibody, none of the phage tested showed 
differential binding by increasing dilution, with all three dilutions returning similar 
signals. However, four distinct phage types did emerge based on the strength of these 
signals and those from the wells containing blocker.
GROUP 1 : Phage B-2, B-4, B-5, B-6, B-8, B-9, E-5, E-9
These gave a high absorbance (ie. greater than 0.6) in wells that contained LT-B and 
blocker and moderate absorbance (between 0.3 and 0.6) in those coated with anti­
cholera toxin antibody.
GROUP 2 : Phage B-LB-7
Both of these phage gave a low absorbance reading (less than 0.3) in the wells 
containing LT-B, blocker and anti-cholera toxin antibody.
GROUP 3 : Phage B-3, E-1, E-2, E-3, E-4, E-6, E-7, E-8, E-10,
These gave high readings with all 3 coatings 
GROUP 4 : Phage B-10
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This phage gave moderate readings with all 3 of these surfaces.
The otherwise empty wells to which phage were added gave a high signals in every 
case. The groups are presented graphically in Figure 26.
These same phage were further tested in wells coated with ovalbumin, gelatin, 
skimmed milk, Tween 20, Triton X-100 and Nonidet P40.
In this case, all Group 1 phage behaved in an identical fashion, giving moderate 
readings against ovalbumin, low against skimmed milk, and high , as did all in Group
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FIGURE 26 : Four groups of phage selected in the third Smith Pentadecamer 
panning experiment as revealed by binding ELISA.
The average absorbances obtained from exposure of each phage to three dilutions of 
LT-B, to three dilutions of anti-cholera toxin antibody, to one blocked plastic well 
and to one 'naked' plastic well were determined. Phage were then assigned to groups 
according to those averages. Each graph above shows the average of readings 
obtained from all phage in the group when bound to LT-B H  ; blocker B  ; anti­
cholera toxin antibody □  and naked plastic S  .
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EXPRESSION, PURIFICATION AND 
CHARACTERISATION OF LT-B
This section of the project focused on the need to produce quantities of highly 
purified material, to confirm it to be LT-B, to biotinylate it, and to ensure that this 
process had not perturbed the properties of the protein.
Purification of LT-B was simplified by using a recombinant expression system rather 
than a wild-type ETEC culture. The advantage of expression controlled by an 
inducible strong promoter such as tac, which allows a high rate of transcription, is the 
consequently high output of gene product. Osek et a l (1995), using such a system, 
have over-expressed CT to yield a staggering 800 mg litre" ^  in fermenter-grown 
cultures. The expression system used in this project, the marine strain. Vibrio 60 
pMMB68 (Leece and Hirst, 1992), is a well-tested system for expression of LT-B 
itself (Amin and Hirst, 1994) and LT-B fusions (Marcello et a l, 1994; Loregian et a l, 
1996).
The output of LT-B over time from this strain was monitored to determine the 
optimum time for harvesting the supernate. Production of LT-B started immediately 
upon addition of IPTG and closely mirrored cell density so that prolonged incubation 
of cultures was not necessary; in fact, the LT-B concentration in the supernate 
stabilised before the cells fully entered stationary phase (see Figure 15, page 108). 
This down-turn in the rate of LT-B production, despite continuing increase in cell 
number, may be due to the IPTG concentration in the medium becoming limiting. As 
IPTG induces the activity of lac and related promoters by binding to the repressor 
product of la d ,  thereby preventing it from binding to the operator site, free 
concentration of IPTG would therefore decline to zero once every molecule was 
bound to a repressor, meaning that cells generated after this point would remain 
repressed, and therefore unable to produce LT-B.
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Given the apparent stability of the LT-B in the medium, and the possibility of slower
growth rates in some cultures, cultures were routinely harvested at lOh post­
inoculation.
That the protein eluted with galactose from the affinity column was LT-B was 
demonstrated by SDS-PAGE, Western blotting and G m I  ELISA. The result of SDS- 
PAGE (see Figure 16, page 110) shows that the protein displays the unusual 
electrophoretic properties characteristic of LT-B. Firstly, as initially reported by 
Sandkvist et a l (1990), LT-B retains its pentameric structure in the presence of SDS 
and 2-mercaptoethanol at room temperature, disassociating to monomeric form only 
when boiled. Secondly, although the B subunit pentamer of LT has a theoretical Mr 
of 58000, it consistently appears otherwise on SDS-PAGE. First isolated by Hirst et 
a l  (1983), when the apparent Mj. was given as 49000, it has since been reported as 
“approximately 45 kDa” (Sandkvist et a l, 1990) and is seen in Amin and Hirst (1994) 
to run at an Mr of 41600. These same three sources show that the monomeric form 
has an Mj. in the region of 12500.
The protein isolated from the affinity column in this project demonstrated a similar 
stability in the presence of SDS and 2-mercaptoethanol, with the gel lanes containing 
boiled and unboiled sample each containing a single protein band (see Figure 16, 
page 110). The Mj. of these bands, 41500 (unboiled sample) and 13000 (boiled 
sample) were again as expected for the pentameric and monomeric forms of LT-B. 
Further confirmation that the eluted protein was LT-B was provided by Western 
blotting and Gm i ELISA (Figures 17, page 111, and 18, page 112, respectively). In 
both cases, an anti-LT-B monoclonal antibody was used and in both cases a strong 
reaction with the eluted protein was observed. In the Western blot, this reaction was 
with the 41500 kDa band (the antibody does not react with monomeric LT-B).
Thus, the protein purified by affinity ehromatography from Vibrio 60 pMMB68 
culture supernate gave, by SDS-PAGE, bands characteristic of LT-B, reacted after 
Western blotting with a monoclonal antibody to LT-B and was bound by Gmi, the
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ganglioside associated with LT-B binding. Thus biochemical and immunological 
properties unambiguously confirm the identity of the purified protein to be LT-B.
The LT-B was then biotinylated to facilitate immobilisation for biopanning. The 
biotinylation kit instructions required the addition of a known amount of protein 
therefore a protein concentration estimation step was necessary. It was possible that 
the galactose used in eluting LT-B from the affinity column could affect this assay (as 
discussed on page 50) and a variable amount of galactose could be present. Therefore, 
two protein estimation methods were tested, the Mark well et a l (1978) modification 
of the Lowry assay, and the method of Bradford (1976). The test used was based on 
the one that Markwell et a l themselves used to demonstrate the superiority of their 
technique over the original Lowry method. In their test, the BSA standard was diluted 
in 0 to 200mM sucrose; the readings obtained in their adapted method remaining 
stable whilst the Lowry method gave values that decreased. Using galactose, 
however, the Markwell et a l method performed poorly (see Figure 19, page 114), 
demonstrating a rise of 1 absorbance unit over the range 0 to 500mM, in contrast with 
the Bradford method, which gave stable readings and which was therefore used to 
estimate the protein content of the purified LT-B eluted from the column.
Initially, each 100ml of culture supernate applied to the column yielded between 700 
and lOOOjLig of purified LT-B, or 47 to 70% of the 14.8mg litre-i produced by Amin 
and Hirst (1994), using Vibrio 60 pMMB68 culture supernate and their own 
purification method (see page 48). This was considered an acceptable yield. However, 
after purifying 1500ml of supernate, the total produced was just over 2mg, or just 
10% of the yield of Amin and Hirst (1994).
SDS-PAGE analysis of every fraction eluted from the column showed the LT-B band 
intensity to have remained constant throughout the whole process, whilst the intensity 
of the LT-B band in the material which failed to absorb to the column did not 
increase. The possibility that the column eventually became saturated with bound 
material is thus ruled out. In practice, the column was regenerated with IM galactose 
after each run, and was routinely purged with 6M guanidine.
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The poor yield of LT-B may have arisen through proteolytic degradation. As 
discussed earlier, protease is exported by Vibrio 60 pMMB68. Loregian et a l  (1996) 
reported attempts to produce protease-deficient mutants of Vibrio 60 pMMB68, such 
is the interference of the enzyme in production of fusion proteins. Although the 
protease should be removed from the LT-B by the galactose affinity column, it would 
have been present in the initial 2 litre batch of Vibrio 60 pMMB68 supernate. This 
was stored as 100ml aliquots, at -20°C, until required. These aliquots were each 
processed by thawing and clarification by passage through 0.45p,m nitrocellulose 
filters before being run by gravity onto the affinity column. Each of these processes 
was carried out at room temperature and in all took around 2h to complete. By 
comparison, the initial tests were performed on 100ml batches specifically produced 
for the purpose. It is therefore likely that proteolytic degradation occurred at this 
point, giving the smaller than expected final batch of LT-B.
Another possibility, that the LT-B spontaneously bound to the dialysis tubing at the 
concentration stage, might also be considered. That proteins adhere to surfaces is well 
accepted but this is usually a problem at low concentrations and in the short exposure 
time, the removal of 80% of the total protein seems unlikely.
The stock LT-B was successfully biotinylated yielding 4.48 moles of biotin per mole 
of LT-B, which is within the range recommended by the manufacturers of the 
biotinylation kit. As this form of biotinylation preferentially attached the biotin to 
lysine residues, of which there are nine in the LT-B molecule (see Appendix 9, page 
193), including in a critical position in the binding pocket (see Figure 5, page 40) 
it was then essential to check that biotinylation had in no way corrupted binding 
ability. Gmi ELISA was therefore performed using, as probes, an anti-LT-B 
monoclonal antibody, to demonstrate that LT-Bbio^i" could bind to Gm i , and the 
biotin-binding, peroxidase-conjugated antibody, 'Extravidin', to demonstrate the 
presence of biotin in the bound material (See Figure 20, page 116). The finding that 
biotinylation did not affect the ganglioside-binding property of LT-B can be 
contrasted with that of Khine and Ling wood (1994). In their investigation into the
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internalisation of verotoxin (shiga-like toxin), they found that biotinylation of the B- 
pentamer, by sulfo-NHS, reduced binding to its ganglioside reeeptor (Gyg) and 
prevented internalisation of the toxin. The verotoxin B-subunit has 69 amino acids of 
which 5 are lysines, as compared with LT-B which has 103 residues including 9 
lysines, and it was concluded that biotinylation of one of these lysine residues, 
was responsible for the deleterious effects. Although the differences between the B 
subunits of verotoxin and LT reduce the relevance of Khine and Lingwood's finding 
to this project, it nonetheless highlights the need for an assay to confirm that no such 
problem existed here. Having proved this, Gmi ELISA, which gave a semi- 
quantitative result, was thereafter used to assay LT-B^i°(i".
Whilst it would have been expected that the highest concentrations of LT-B would 
have bound the greatest quantities of anti-LT-B, and that this would then have bound 
the most HRP-conjugated antibody to give the highest ELISA signal, the result of 
some ELIS As obtained in this project (e.g. that seen in Figure 18, page 112) 
suggested that this was not always the case. Rather, the wells containing the most 
concentrated LT-B gave readings which were sub-optimal in comparison with more 
dilute samples. Steric hindrance caused by local overcrowding at the assay surface is 
the most likely explanation for this phenomenon, with closely packed 118.87 
antibody being less available to HRP-conjugated anti-mouse antibodies than more 
widely-distributed immunoglobulins.
SMITH HEXAMER LIBRARY
The aim of this section of the work was to 'pan' streptavidin-immobilised LT-B^iotin 
with the Smith hexamer library, to elute off and eharacterise any phage that bound 
and finally to assay their binding specificity.
Cultures of E. coli K91kan grown to A^oo hi the range 1.25 to 2.5 proved optimally 
susceptible to infection (see Figure 21, page 118). Smith, however, reports infectivity 
of fd-tet-derived virions to be "not very reproducible from one experiment to the 
next". Since the assay is inconsistent, titering was performed only after the four
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rounds of panning were completed in an attempt to minimise this effect: all of the 
applied and eluted phage were enumerated in one experiment using a single batch of 
K91kan cells.
Use of the P + LS strategy (in which phage are added to streptavidin-bound LT- 
gbiotin^ in the first round was intended to ensure that the target molecule, a peptide 
capable of mimicking the conformation of G m I , was present at maximum density, 
facilitating recovery of a high number of binding phage. Subsequent rounds pursued 
the alternative PL + S strategy (in which phage are mixed with LT-B^iotin prior to 
exposure to streptavidin-eoated plastic). Biopanning with acid elution did show an 
805-fold enrichment (see Table 6, page 120), however, this is little more than 5 times 
greater than the 154-fold enrichment obtained when phage were eluted with TBS 
alone. These yields are clearly far below the 10^-fold enrichment in a single round 
reported when Scott and Smith (1990) used the same library.
The enrichment of phage eluted with TBS alone is probably due to two factors. 
Firstly, having started each round with the addition of between 10*^ and 1 0 ^  phage, 
it is not surprising that at least some remain behind in the tube, despite the ten washes 
employed. It is possible that, by increasing the stringency of the washing, all free 
phage could be removed, however to do so might be to risk losing some of those 
specifically selected but bound with low affinity. Compounding this problem are the 
properties of the peptides carried by the phage. If there is a limited number of phage 
in a library of billions capable of attaching, via their peptide fusions, to LT-B'^ ^®f"h it 
is probable that there are also phage which may bind to the tube for other reasons. For 
example, Devlin et at. (1990) have reported the isolation of streptavidin-binding 
phage and Adey et a l (1995) have isolated phage which bind to the plastic matrix 
from two separate random peptide libraries, one with a 36 and the other with a 22 
amino acid insert. The latter authors suggest that skimmed milk is a more effective 
blocking agent for plastic surfaces than BSA but it was not used here as it is known 
that lactose can occupy the Gmi-binding pocket on LT-B (Sixma et a l, 1992). In 
addition, phage carrying peptides with an affinity for sites on LT-Bbi° i^n other than the
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receptor-binding pocket may be eluted. Therefore phage which are acid- or TBS- 
eluted from sites other than the G m I -binding site will have been just as capable of 
being amplified, and therefore of being present in increasing numbers in subsequent 
rounds, as those which were sought specifically. It was for this reason that Gmi- 
elution was included, to provide a specificity lacking in acid and TBS, which will 
remove phage binding to the surface with very low affinity.
The binding assay, an ELISA-type test based on applying the phage directly to the 
plastic, was chosen in order to preserve the stocks of the phage for any further work 1
that may have developed had the results proved more satisfactory. By adding the S
phage first, unbound virions could be collected and later recovered uneontaminated, 
an option that would not have been available had the phage been added to 
immobilised LT-B^iotin the event, phage eluted by acid, Gm i or TBS proved 
unable to capture LT-B i^o^i" at levels in excess of controls.
Perhaps the most compelling explanation for the disappointing results obtained in this 
experiment relates to the library itself. When originally produced by Scott and Smith, 
it consisted of 1.3 x 10^^ phage. This is well in excess of the number required to 
guarantee that all possible hexapeptides are present, which is XV, where X is the 
number of codons available and y is the length of insert. In this case, that would be 
32^, or 1.1 X 10^. However, the material supplied by George Smith was an i
amplification of a portion of the original library. On receipt, this was amplified again.
The composition of the library stock, used in this work, may well have differed from 
that of the original Smith library due to this processing, as it is possible that each 
phage may be differently affected by the fusion peptide that it carries. Any phage with 
a fusion which slows infection rate or which inhibits growth of its host will be under- i
represented in the final amplification relative to those which grow at normal, or even
■jenhanced rates. Cwirla et a l (1990) examined this phenomenon. They produced their 
own random hexapeptide library, fused to pIII in fd-tet employing the NNK bias, 
using Smith's methods and cultures. However, on sequencing 52 randomly selected 
clones from the library, they found that there were around 50 % more G than T
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residues at the third position (59 % G versus 39% T). This may have arisen from the 
synthesis reactions which produced the random inserts. It might, however, be that 
phage carrying those amino acids that are produced from codons containing a G in the 
third position gained some form of growth advantage over those with codons ending 
in a T, perhaps for reasons associated with availability of the appropriate tRNAs (as 
discussed on page 12).
The possibility must therefore exist that the 'Amplified Library Stock' simply 
contained an insufficient range of different peptides, and that peptides which could 
bind to the receptor-binding site of LT-B were not present in the library.
The problem posed by the 'double-signal' must also be addressed. The super­
imposition of the wild-type sequence over the insert sequence made reading the 
sequences difficult (Figure 22, page 121 demonstrates this problem) and had an 
unknown effect on the whole conduct of the experiment. One explanation for this 
problem is infection of the K91kan stock by wild-type fd-tet prior to its use in 
amplifying the panned phage. This possibility can probably be dismissed, as protein 
V (see page 9) spontaneously coats any single stranded DNA in the cell and 'escorts' it 
to the membrane for assembly. Any single-stranded DNA entering the cell on super­
infection would be similarly coated and packaged, thus preventing it from making 
replicative forms (RF) and from being further amplified. In spite of these 
considerations, experimental evaluation of super-infection was pursued. Firstly, an 
overnight culture of K91kan was mixed with an equivalent amount of 'top' agar (0.5% 
agar in water) and poured over an LB agar plate. After incubation, no plaques were 
observed. Some of the overnight culture supernate was then mixed with PEG/NaCl, in 
order to precipitate any phage that were present. However, when spun down there was 
no visible phage pellet. A colleague, Calum McCafferty continued this work, by 
processing and sequencing the contents of this tube. No extension / termination 
products could be detected on sequencing gels.
In addition, a new K91kan stock was obtained from Russell Thompson, Division of 
Virology, Glasgow University. Running some simple panning experiments using this
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culture gave a similar result, confirming that the problem was indeed associated with
.i:the phage and not the bacterial host.
A second possible explanation is that wild-type phage were present in the library 
stock, dating from the time that the library was first made. This is possible but in 
order to appear so frequently among the sequences they would have to have been
selected and amplified through the biopanning procedure, contrary to the principle of 
affinity-selection of adhering phage. Additionally, host cells infected with the wild- 
type phage would then have had to contaminate each of the single colonies chosen for 
amplification prior to sequencing. Again this is unlikely.
Another idea that was explored was that the wild-type sequence was the result of
'recombination events leading to the excision of the insert sequence from some phage
during amplification in the host cell. Any wild-type phage produced by 
recombination, during the amplification stage between biopanning rounds, would be 
selected against in the next round. However, any that were produced during 
amplification of the fourth round single colony would be sequenced. The product of 
the gene recA is a protein of Mr 38000 that helps to modulate recombination by 
recognising and pairing homologous sequences between single-stranded and double­
stranded DNA, the process that results in the re-arrangement of DNA (Kurumizaka 
and Shibata, 1996). The possibility therefore existed that, during amplification, 
deletion of the insert occurred with sufficient frequency through recombination 
between flanking homologous sequences. This theory was tested by growing some 
fourth round phage in E. coli DH5FIQ , a mutant deficient in the recA gene, and in
'which cross-overs would occur with much reduced frequency. Amplification in 
DH5FIQ was carried out exactly as normally performed in K91kan. The resulting 
cultures were then spread to single colonies, which were individually picked, phage 
amplified and sequenced. The resulting data still showed the presence of wild-type 
sequences. It was therefore reckoned unlikely that recombination accounted for the 
double signal.
J
Regardless of the aiiomolies encountered in sequencing, evidence for positive 
selection of phage from the library was strong; as shown in Table 7, page 122, the 
sequences of the peptides carried by phage which were acid eluted showed one clear 
consensus and a number of other common features. Given the diversity of the peptide 
library, it is not surprising that phage with a specificity for one or more components 
of the panning surface were eluted. The identification of two separate base sequences 
coding for PW PW LG  rules out the possibility that they arose from a single clone 
which was propagated with high frequency. That there were three other clearly related 
clones (with two different sequences), served to reinforce this point.
Another aspect of the groups of peptide sequences relates to their chemistry : the 
Group 1 acid-eluted phage, for example, consist entirely of hydrophobic amino acids, 
without a single charged residue. Amongst clones classified as Group 2, residues 1, 2 
and 6 are invariably hydrophobic and base 3 is invariably charged (i, ii, iv and v are 
acidic; iii is basic). Only residues 4 and 5 show variation, with a mixture of acidic, 
basic, hydrophobic and hydroxylated species all appearing in these positions. The 
Group 3 amino acids are from unrelated families.
Further evidence for positive selection can be derived from a comparison of the actual 
occurrence of amino acids in the acid eluted phage groups 1 and 2 versus the 
occurrence expected if selection was completely random (see Table 11). Although the 
sample number is low, it is nonetheless obvious that F, P, and W are unequivocally 
over-selected, by approximately 3-fold, 4-fold and 7-fold respeetively and that T is 
underselected (no appearances when at least 6 were expected).
Despite the strength of the argument for specific selection, the binding assay gave 
little evidence to suggest that those phage enriched by biopanning could capture LT- 
B. It is also worth noting that they bore no resemblance to the AEYHN loop (reported 
by Merritt et a l, 1995) borne on LT-B and thought to be capable of interacting with 
the GMI-binding site of adjaeent pentamers (previously discussed on page 39). In faet, 
A and E are under-represented amongst the acid-eluted phage, Y and H are totally
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AMINO
ACID
NOMINAL
FREQUENCY
NOMINAL
OCCURRENCE
OBSERVED
OCCURRENCE
A 0.065 6.63 3
C 0.032 3.264 3
D 0.032 3.264 0
E 0.032 3.264 1
F 0.032 3.264 13
G 0.065 6.63 10
H 0.032 3.264 0
I 0.032 3.264 1
K 0.032 3.264 3
L 0.097 9.894 12
M 0.032 3.264 4
N 0.032 3.264 4
P 0.065 6.63 22
Q 0.032 3.264 0
R 0.097 9.894 1
S 0.097 9.894 1
T 0.065 6.63 0
V 0.065 6.63 2
W 0.032 3.264 22
Y 0.032 3.264 0
TABLE 11 ; Expected and actual occurrence of amino acids in the clones from 
the Smith hexamer library.
The nominal frequency is obtained by dividing the number of codons for any amino 
acid by 31, the number of coding triplets in the NNK genetic code. Nominal 
occurrence is derived by multiplying the nominal frequency by 102, the number of 
amino acids in the 17 hexamer inserts.
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absent and N is present in no more than the expected frequency. The phage selected 
from this library also fail to display the sequence characteristics (the consensus 
HPQ), published by Devlin et al. (1990), for streptavidin binding. As well as H, Q 
was absent from the 17 peptide sequences characterised representing notable under­
representation. It is more plausible that the acid-eluted phage are capable of direct 
interaction with plastic. Adey et a l (1995) described the defining characteristic of this 
property as being a high frequency of Y and / or W residues. Although Y is absent 
from the peptides selected by biopanning, W is over-represented by 6.7-fold 
(observed frequency/ expected frequency). However, Adey et al. comment that the 
presence of W or Y residues is not of itself indicative of a peptide potentially capable 
of binding to plastic and go on to report that the bulk of the Y and W residues that 
they observed were towards the amino-termini of their inserts. They suggest that this 
may reflect the reduced steric hindrance from pIII in this location. They also mention 
that they failed to observe plastic binding when hexapeptide or C -constrained 
octapeptide libraries were used, due, they supposed, to the short length of the 
hexapeptide and / or the artificially shortened length of the octapeptide under C- 
constraint. As further evidence for this theory, they also cite the absence of Cs from 
all of their plastic-binding clones. In relation to this, it should be noted that the W 
residues carried by Group 2 acid-eluted clones are all at the extreme amino-terminus, 
whilst in Group 1 peptides they are flanked by P residues. It is possible that such 
alteration of the conformation of these Group 1 peptides could equally 'present' the W 
to the plastic in such a way as to overcome any steric hindrance from pIII. It should 
also be noted that the plastic tubes used in this work were selected specifically 
because of their highly absorptive characteristic, whilst Adey et a l  used standard 
polystyrene or polyvinyl chloride microtitre plates. This therefore raises the 
possibility that a single, amino-terminally located, or two, 'proline-presented', W 
residues are able to bind the phage to a Maxisorp tube with sufficiently high affinity 
that acid is necessary to elute them.
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Set against this, however, is the presence of the PLPLAG and CFNM PF peptides in 
Groups 1 and 2 respectively. The absence of W from these otherwise obviously 
related peptides makes plastic binding, as defined by Adey et al. rather less likely. 
However, given that the Group 1 phage peptides consisted entirely of hydrophobic 
residues, attraction to the matrix remains a possibility.
Finally, there is little evidence in these results to suggest that the sequences obtained 
are characteristic saccharide mimics. Both Hoess (1993) and Scott et al. (1992) 
emphasised the potential of Y residues as mimics of saccharide rings. These residues 
were completely absent from peptides borne on the eluted phage.
LUZZAGO NONAMER LIBRARY
The Luzzago library was of interest as it provided a contrast to the Smith hexamer 
library in several ways. The randomised DNA was inserted into gene VIII as opposed 
to gene III, the insert was potentially constrained through the formation of a 
disulphide bond by the C residues present at each end of the random peptide and this 
library was based on a phagemid-borne copy of gene VIII and thus was of type 8 + 8. 
Although the library phage supplied by Alfredo Nicosia were clearly infective, 
allowing E. coli XL-1 to grow on agar including ampicillin, the results obtained from 
sequencing the resultant clones indicated that there was a problem in the construction 
of the library.
Panning produced substantial numbers of eluted phage at each round, although there 
was little evidence of the amplification expected if phage were being specifically 
selected. After the first two rounds all clones were collected, resuspended in broth and 
co-infected with helper phage to produce the phage used in the subsequent round of 
panning. After the third round, the clones were individually picked and plasmid DNA 
isolated and sequenced.
Analysis of the sequences showed that, in most cases the gene VIII sequence was 
substantially as expected outwith the randomised insert (see Figure 23, page 127). 
The substitution of a TCT for TCC at 8"^^ is silent. It is likely that the apparent
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deletion at position 19 of the mature peptide (CC instead of CCC) is a compression 
artefact : this is caused when areas of the DNA that are rich in a single base, 
particularly G or C, are not fully denatured by the electrophoretic process, resulting in 
the normally uniform spacing of bands on the gel being extended or compressed 
(Sequenase Protocols, 1994). On examining the autoradiograph in the area concerned 
(see Figure 27) it can be seen that the lower band is somewhat thicker than the upper 
thereby suggesting that a compression was present.
In analysing the randomised inserts, some of which are shown in Table 8 (page 129), 
it is less plausible to look to compression as an explanation for the fact that only 26 
bases could be seen in every clone examined. Although G and C are the most 
numerous bases, constituting 60% of the inserts, they lie in a variety of positions in 
the sequence; it would be expected that at least one of them would resolve correctly, 
particularly as runs of up to four C's, and six G's, both above and below the random 
insert, were consistently and satisfactorily denatured.
There were also three TBS-eluted clones that had a sequence, running from position 4 
of the mature protein back into the signal peptide, that bore no relationship to that 
predicted (see Figure 23, page 127). The actual departure from predicted sequence 
begins at the first base of the codon for residue four of the mature protein (AAA 
rather than G A A). This forms the 5' end of the inserted oligonucleotide, raising the 
possibility that these clones are derived from aberrant restriction / ligation events. A 
small part of the base sequence immediately adjacent to this site, covering codons -4 
to 4 on Figure 23, ( A A AAGGT AT CCG AGGCGGGGGG) was analysed using the 
database search tool 'BLAST' (Basic Local Alignment Search Tool), at the National 
Center for Biotechnology Information (reached through website address 
http:/www.ncbi.nlm.nih.gov/BLAST/ ). A search for the sequence and its 
complement revealed similarity to the origins of replication from various plasmids
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T c  G A
Possible band—compression
FIGURE 27 : Autoradiograph of sequencing gel prepared with clones from 
the Luzzago library.
A possible compression is labelled. Nucleotides are shown above the relevant 
lanes. The sequence of the random insert runs upwards from the dashed line.
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including ColEl. The Luzzago phagemid is a ColEl derivative. A comparison of 
some 70 bases of the ColEl sequence with that gathered from clones of the Luzzago 
library (see Figure 28) clearly shows complementarity.
The following conclusions about events during production of the library can be drawn 
from the sequencing and BLAST search results.
a) The randomised insert was correctly prepared, as the cohesive ends for ZscoRI and 
BamYil were present.
b) BamYil digestion of PC89 and ligation of the insert at that site proceeded as 
intended, as evidenced by the presence of the full recognition sequence for this 
enzyme (see Figure 23, page 127).
c) EcoRI digestion of PC89 did not occur as anticipated. The EcoRl cohesive end of 
the insert is not adjacent to the base G, indicative of insertion at the EcoRI restriction 
site, but rather lies within the ColEl ori. The actual position at which the ColEl ori 
was cut was between bases 417 and 418. The bases surrounding this cut were :
4 1 1 CAGGCGT / /  TTTTCCA 424 
however, they bear little resemblance to the restriction site of EcoRl suggesting that 
the cut was non-specific. The net effect was the elimination of a section of DNA that 
included three amino-terminal amino acids and the signal sequence of gene VIII and 
the lac promoter.
The mechanism of this error is summarised in Figure 29. That three of the thirty 
clones sequenced should carry this error indicates that it occurs commonly.
A report by Beekwilder et al (1999) is worthy of consideration at this point. They had 
manufactured a library of phage carrying variants of a protease inhibitor. On panning 
against trypsin, they failed to recover a single phage with any binding activity. On 
analysis, the phage in their amplified library proved to be carrying either deletions or 
amber stop codons. It seems that those variants that carried nonsense mutations in the 
gene encoding the peptides attached to pIII, were entirely favoured over all variants
Î
I
that carried an extended pIII. The authors attribute this phenomenon to differential 
growth rates; the nonsense-peptide-carrying phage being able to outgrow the others to
Iî
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(A).
plac C0IEI oh
PC 8 9 “ lacZ f1 oh
n on-EC0RI sp ec ific
FIGURE 29 : Origin of the unusual sequences identified in clones from the 
Luzzago library.
The random nonapeptide and its flanking residues should have been inserted at (A), 
between the EcoRl and BamRl sites. It appears that the actual insertion was between 
BamHl and a non-specific site in the ColEl ori. As a result the DNA designated (B), 
between the EcoRI-cut end of the insert and the non-specific site, was lost.
I
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such an extent that their numbers became insignificantly small in the amplified 
library, de Bruin et al (1999), when panning with a library of synthetic heavy and 
light chain variable regions, observed that incomplete inserts predominated after 3 
rounds. They suggest that these did not arise by deletion of full length inserts but 
rather that they were present in small numbers in the original library and were subject 
to a sufficiently favoured growth rate to allow them to overwhelm slower growing 
phage .
It could well be that a similar occurrence took place during the production of the 
Luzzago library, or during the amplification of the portion that I received, with phage 
carrying mutant inserts overwhelming correctly-formed phage. The fact that phage 
were produced despite this, and could be precipitated out in the absence of pVIII is 
easily explicable: employing the phagemid system, a 'wild-type' capsid could still be 
formed consisting entirely of helper phage proteins. Ampicillin resistance could be 
contributed by the phagemid regardless of a frame shift in gene VIII. Although 
attempts were made to address this issue, the data produced was ambivalent and the 
problem remains unresolved. In view of the deficiencies of this library, the question 
whether constrained peptides can effectively mimic carbohydrates unfortunately 
remains unresolved. It is worth noting, however, that Hoess (1993), in the section of 
his review of phage display that dealt with this topic, comments that none of the 
reported successes involved constrained libraries. On the other hand, Ladner (1995), 
suggests that constrained peptides are more suited as mimics of discontinuous 
epitopes than continuous : the complexity of the interaction between Gm i and LT-B 
is such that the carbohydrate moieties resemble a discontinuous epitope. It might be 
therefore imagined, in this context, that a constrained peptide could have some 
advantages over one in which conformation was not restricted.
SMITH PENTADECAMER LIBRARY
This Smith pentadecamer library represented a further variation on those already 
tested. Although, like the Luzzago nonamer library, it carried a fusion to protein VIII,
I
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in this case it was a type 88 phage, with two copies of gene VIÏI, one wild-type and 
one synthetic carried in the viral genome. Addition of IPTG was required to induce 
production of the recombinant gene VIII, as it was under the control of the tac 
promoter. The library, as supplied, was shown to contain around 5 x 10^^  transducing 
units. This represents only 1.5 xlO'^ % of the 3.28 x 10^  ^possible combinations of 15 
amino acids, assuming each clone to be unique, but each 15 amino acid insert will 
contain 10 different hexamers, or 13 different trimers, (see page 12) providing a 
compensating level of diversity.
The first biopanning experiment was carried out according to the methods 
recommended by Russell Thompson. Biopanning proceeded as expected, and 
amplification of the number of eluted phage was observed. Phage numbers were 
calculated using the rapid method recommended by Russell Thompson, which counts 
only the number of eluted phage, but not the number applied in biopanning. As a 
result, the percentage of applied phage that were eluted was not calculable. However, 
an increase in the number of eluted phage, from 10  ^ in the first round to 10  ^ in the 
third, was in line with the results routinely achieved with this method in the Division 
of Virology.
Sequencing of phage selected in this experiment presented none of the problems 
previously encountered with the Smith hexamer or Luzzago libraries. Aside from the 
H residues in position 2, the other most noteworthy features of the sequences 
produced are best seen when the characteristics of each amino acid are related to the 
position in which they occur in the insert. In order to do this, amino acids were 
grouped according to the properties of their side chains, as shown below. The value to 
the right shows the percentage of all peptides that each group would constitute, 
allowing for the differential in number of codons for each amino acid.
i Acidic side chain (D, E) 6.5%
ii Basic side chain (K, H, R) 16%
iii Uncharged polar side chain (C, N, Q, S, T, Y) 30%
iv Non-polar side chain (A, F, G, I, L, M, P, V,W) 47.5%
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The actual composition of the 10 peptides analysed here was as follows :
i 1.8%
ii 22.6%
iii 29.4%
iv 46.2%
Aside from under-representation of amino acids with acidic side chains and over­
representation of those with basic side chains, these figures do not provide any 
significant indication of a selective effect through biopanning. However, analysis of 
the distribution by position in the peptide reveals a quite different picture. Table 12, 
shows the distribution of each group of amino acids according to position. It is clear
from this table that the peptides selected by biopanning are predominantly basic at
■their amino-termini (residues 1 to 3). This is not only due to the presence of H; six of 
them also feature R, whilst clone 10 features both R and K. Hydrophobic residues are 
substantially under-represented in this region, appearing only once in the first 
position, not at all in the second and four times in the third.
The occurrence of amino acids in the second and third regions (residues 4 to 9) are, 
aside from the lack of acidic amino acids, more consistent with random distribution, 
suggesting that behind the charged amino terminus, the fusions to pVIII have an :
uncharged, predominantly hydrophobic core. Region four is different again, with 
more common occurrence of residues with polar side chains, and fewer hydrophobic 
amino acids. The final region is the most hydrophobic, least charged of all, with only 
two of the inserts encoding charged residues. Given that this is the region closest to 
the capsid body, and most closely associated with the native pVIII, perhaps this lack 
of charge minimises interference with the coat protein.
The most striking individual feature of all the inserts is the H in the second (or in one 
case, first) position of each of the clones sequenced. In all cases, as with the other H
that featured (at position 12 in sequence 10), the codon was CAT which, according to 
the codon usage table given in the phage display laboratory manual (Kay et a l, 1996),
i
RESIDUE REGION
TYPE 1 2 3 4 5
i 0 0 6 3 0
ii 60 17 10 20 6
iii 23 26 27 37 34
iv 17 57 57 40 60
TABLE 12 : Distribution of amino acids occurring in the inserts carried by 
clones from the Smith pentadecamer library.
The percentage ocurrence is shown.
Regions: 1, residues 1 to 3; 2, residues 4 to 6; 3, residues 7 to 9; 4, residues 10 to 12; 
5, residues 13 to 15. Residue type i, acidic amino acids; ii, basic; i i i , uncharged polar; 
iv, non-polar.
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features four times more frequently than CAC.
Obviously, the amino acid sequence of any peptide selected in this experiment will 
reflect its affinity for the panning surface. It is apparent from the results of the 
Microtitre plate binding assay that these peptides bound streptavidin rather than LT- 
g b i o t i n  Figures 24, page 133, and 25, page 137). The signal from the well coated 
with streptavidin-bound LT-B^’iotin was occasionally higher than that from the well 
coated with streptavidin alone, but in no case did the difference exceed 17% and in 
every case the streptavidin signal was practically double the background level. Were 
the phage specifically binding to LT-B, one would have expected signals from wells 
coated only with streptavidin to be at background levels. Given the high level of 
reaction to streptavidin, it must be concluded that it is to this that the phage were 
binding.
The results of the ‘colony lift’ binding assay confirmed those obtained in the 
microtitre plate assay. Phage selected by panning streptavidin-bound LT-B, once 
adsorbed onto a nitrocellulose membrane, showed no discernible affinity for the LT-B 
to which the membrane was then exposed. By contrast, a piece of membrane 
impregnated with G m I  and exposed to the same LT-B solution, bound anti-LT-B 
antibodies effeetively. When exposed to streptavidin solution and probed with 
biotinylated peroxidase these same phage revealed a very weak affinity for the 
streptavidin. A similar weak affinity for streptavidin was demonstrated by the phage 
seleeted by panning streptavidin-coated plastic. Again the effect was negligible, but 
the positions of the faint traces that were seen did correspond with those of colonies 
on the agar.
Thus phage selected by panning the pentadecamer library on streptavidin-bound LT- 
B demonstrated, in both binding assays, a weak affinity for streptavidin, but no 
affinity for LT-B.
To consider the nature of the streptavidin binders that were selected, it is useful to 
bring together the sequencing data with that from the microtitre plate binding assay. 
Phage 2 and 3 gave the strongest signals in the assay and both carry an uncharged
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residue (N and Q respectively) as their first amino acid, followed by H and R. The 
next-highest signals were obtained from clones 1 and 5, which carry S H R and A H 
R respectively, whilst the third moderate binder, number 7, like number 2, also 
commences N H, but in this case S, rather than R, is the third residue. Among those 
clones that gave weak signals, numbers 4, 6 and 10 all commence with R H, followed 
by a non-polar residue (L and G respectively) in the case of the former two, and by K 
in the case of the latter, and clone 9, like clones 2 and 7, commences N H, followed 
by W. Clone 8, which gave the weakest signal of all, had the sequence in which H 
was the first, rather than the second, residue.
Having established that low-affinity streptavidin-binding phage were selected, it is 
pertinent to compare the sequences carried by these phage with those previously 
identified as streptavidin binding motifs. This work, which has been briefly dealt with 
earlier (see page 58) includes that of Devlin et a l (1990), who deliberately set out to 
isolate streptavidin binding phage. In doing so, they provided the first evidence that
phage display technology could be used to identify amino acid sequences that 
recognised proteins with no previously known affinity for peptides. The peculiarities 
of their library were discussed earlier (see page 56), but, in brief, it was created in 
M l3 and consisted of NNS-biased pentadecamer fusions to pIII, that were extended 
away from the phage on a poly-proline linker. In the paper, they describe the inserts 
from twenty phage, carrying nine different sequences. These are reproduced in Table 
13. The most significant feature of these sequences is the HP motif that appears in 
each of the nine sequences presented, and which represents the core consensus. The
'amino acid Q is appended to this core in seven sequences, followed by N in three 
instances.
Drawing these findings together with my own, the most obvious similarity is in the 
appearance of H in each sequence. The residues P and Q which also feature strongly
among sequences reported by Devlin et a l were both over-represented in this study 
(see Table 10, page 132) and, indeed, five sequences featured all three of these amino 
acids distributed throughout the insert. In clones 2, 4 and 10 these amino acids fell in
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TSOT.ATE FREQUENCY___________ SEQUENCE
i ) 3 SDDWWHD HPQN LRSS
i i ) 1 MLWYSPHSFS HPQN T
i i i ) 1 SWWWLSW HPQN TKELG
i v ) 5 ISFENTWLW HPQF SS
v) 1 LC HPQF PRCNLFRKV
v i  ) 2 PC HPQY RLCQRPLKQ
v i i  ) 2 QPFL HPQG DERWYMI
v i i i ) 1 ALCCLSSP HPNG AIF
i x ) 4 LN HPMD NRLHVSTSP
TABLE 13 ; Amino acid sequences carried by twenty streptavidin-binding 
phage.
After Devlin et al. (1990).
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the order H PQ , but in no instance were they contiguous. In clone 10, the motif 
PH Q Q , in positions eleven to fourteen, may be significant. In clone 2, although H 
and P were close together (positions two and four), Q was in twelfth position. In 
clone 4, however, the residues appeared in the second, fourth and seventh positions.
Positional effects seem to be strong. In clones that were characterised, the amino 
terminal featured both H and Q and the former residue also appeared nine times in 
position 2. The fourth residue was P in two sequences and Q in one; the sixth 
position twice features P and the seventh features Q twice, and P. Overall, of thirty- 
two occurrences of the three amino acids, twenty of them are in the first seven 
positions. Although not highlighted by Devlin et a l, in six of their nine sequences 
there is a basic residue (R five times and K once) at one, two or three residues to the 
carboxyl-terminal end of the HPQx core. A major difference is in the position of the 
H, which in my sequences was always at the amino-terminus of the insert, but which, 
in the sequences described by Devlin et a l  is in any position from 3 to 11. They make 
particular note of the position of H in sequence ii), suggesting that the consensus 
motif may bind even when placed very close to the phage capsid. It must, however, 
be remembered that these inserts were succeeded (at the carboxyl terminus), by six P 
residues, thereby making H the eleventh amino acid from the capsid body in sequence 
ii), and between the twelfth and nineteenth in the others.
The appearance of H, P and Q in my sequences does not correlate with signals from 
the binding assay. Clone 3, which performed best in the assay, does not feature P at
■Iall, nor does clone 1, (intermediate signal strength). Clones 7 and 5 gave similar assay 
results to clone 1, yet caried H and Q in adjacent positions and one residue apart, 
respectively.
Further work on streptavidin binding was carried out by Kay et a l  (1993), who chose 
this protein to determine the utility of a library consisting of random 38-amino acid 
fusions to gene III. On sequencing the inserts from forty-nine of their phage, they
found thirteen different sequences, each of which featured the HP motif, followed by - 
Q or M and then by a non-polar residue. The most extreme carboxyl-terminal location
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for the H was, in a single case, six places from the capsid, but overall, only seven of 
the forty-nine carried H closer than twelve places from pIII. Six of these thirteen 
sequences, representing the inserts from twenty-nine phage, also carried the motif 
PG, in various locations to the carboxyl-terminal side of HP. Ten further streptavidin 
phage that were characterised carried two inserts that lacked HPQ and were otherwise 
dissimilar save for the PG motif. Finally, assays were performed to confirm that both 
the H P etc. and the PG  type phage were binding to the biotin-binding site of the 
streptavidin. A detailed comparison of my sequences with those of Kay et al. will not 
be necessary, given the similarities with the Devlin et a l sequences already discussed, 
except in regard to the PG motif. These residues appear in positions four and six 
respectively in my sequence 4, in positions six and ten of my sequence 8, but do not 
feature together in any other sequence. Unlike P, G is neither over- nor under­
represented among these sequences.
Streptavidin was also employed to select phage from the library of McLafferty et a l 
(1993). This gene III library (see page 56) included a 'variegated' (ie. not fully 
randomised) insert. As with Devlin et a l and Kay et a l , the motif HPQ was again 
revealed as a consensus sequence, featuring in all the fourteen binding phage that 
were tested, in each case followed by F. This motif was, in every case, placed 
between fixed C residues, on either side of which was an unrelated amino acid.
Devlin et al. conclude their paper by highlighting the similarity between the structures 
of biotin and histidine, suggesting that the shared nitrogen- and carbon-containing 
ring may account for the presence of this amino acid in all of their selected phage. 
Figure 30 demonstrates this similarity. Crystallography studies into the mechanism of 
the interaction of the HPQ peptide with streptavidin have been published (Weber et 
a l,  1992; Katz and Cass, 1997). The structure reported by Weber et a l, shown in 
Figure 31, involved the heptapeptide FSHPQNT. The H and Q residues bind, via a 
captured water molecule, to S, D and T, whilst the P facilitates this binding by 
controlling the local conformation of the peptide. No reaction with any other amino 
acids is shown, although both reports suggest, from electron density mapping, that
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FIGURE 30 : Comparison of the structures of biotin and histidine.
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FIGURE 31 : Binding of the heptapeptide FSHPQNT to streptavidin.
After Weber et a l, 1992. Streptavidin residues are shown boxed and the heptapeptide 
residues are circled. A captured water molecule is outlined (centre).
170
these do also play a part in binding to streptavidin. Weber et ah, in 1992, had 
suggested that a more stringent assay could reveal an extended consensus, but the 
subsequent investigations of Kay et a l  and McLafferty et a l  failed to reveal one. The 
binding assays emphatically indicated that the phage selected from the Smith 
pentadecamer library were streptavidin binders, even if they do lack consecutive H, P 
and Q residues.
In considering the absence of this established consensus from my results, the first point 
to bear in mind is the fact that all of the work that determined H PQ  was carried out 
using gene III libraries, as opposed to the gene VIII library employed in this phase of 
the project. The difference that this may make, in terms of monovalent versus 
polyvalent binding, and terminal versus central location, was discussed, starting at page 
68. Another possible, if less likely explanation for the lack of the HPQ triplet is that the 
libraiy simply did not contain inserts with the appropriate codons. There must remain a 
certain degree of doubt as to how many variants there were in the library as used; 
although initially produced from 2 x 10  ^ different clones, it must be assumed that a 
sample from this original library was amplified for distribution. As Russell Thompson 
did not receive his aliquot directly from George Smith, it is likely that a further 
amplification had been carried out before he received it. Allowing that the portion 
removed for amplification may not contain all the possible variants, there is clearly 
scope for loss of particular sequences. All possible amino acid triplets can be coded by 
8 X 1Q3 base sequences, {ie. 20^), and it would require a library of 2.6 x 10  ^unique 
nine-base sequences (ie, 64^, for 64 codons) to ensure that all triplets were present. 
However, due to the sliding reading frame, each 15 amino acid insert would include 13 
different triplets, thus, only 2 x 10^ different pentadecamer inserts would be sufficient 
to code for the entire tripeptide range and, as there are 16 different codons for HPQ, 
then it would seem unlikely that the library was completely depleted of these sequences 
encoding this peptide.
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G iven the similarities and patterns revealed when viewing the sequences in 
conjunction with the binding assay results, it may be the case that the nature of the 
first three amino acids at the amino-terminus of the sequence (which did, in every 
example, include H) are more significant for streptavidin binding than HPQ when 
considering fusions to pVIII.
Given that streptavidin-binding phage were apparently selected in the foregoing 
experiments, another strategy was sought. An alternative means of immobilising LT- 
B, using Protein G-bound anti-cholera toxin antibody (see page 51), was employed 
whilst an additional stage, namely 'backchecking', was added to the panning 
procedure. After each round of panning, eluted phage were amplified as usual and 
then exposed in a microtitre plate to the immobilisation agent. Only phage that did not 
bind at this stage were used in the next panning round. Final-round phage were 
similarly backchecked, with those that did not bind to the plate being retained as B- 
type phage'. Those that did bind were acid-eluted and were retained as 'E-type phage'. 
Representatives of these final round phage were then tested in plate assays against, 
firstly, LT-B, anti-cholera toxin antibody, blocker and naked plastic and then against 
a range of protein and detergent blockers.
The first assay showed that the 20 phage tested could be assigned to 4 groups based
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on their binding to LT-B, anti-cholera toxin antibody and blocker (all phage bound 
with similar efficiency to plastic).
Group 1 contained eight phage, six of which were B-type and two of which were E- 
type. These all showed remarkably similar binding to all four surfaces, giving a high 
reading against LT-B and blocker and a moderate reading against anti-cholera toxin 
antibody.
ï;.-
Group 2 consisted of two B-type phage that bound poorly to all three surfaces.
Group 3 contained phage that demonstrated good binding to all three surfaces. Eight 
members of this group were E-type and one was B-type.
Finally, Group 4 was a sole B-type phage that showed moderate binding to all three 
surfaces.
;?:■ 
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These groupings were illustrated graphically in Figure 26 on page 140.
The lack of round-on-round amplification during panning strongly suggested that no 
LT-B-specific phage had been isolated, and the assay results appeared to confirm this; 
no phage bound strongly to LT-B alone. However, the strength of binding of phage 
to a variety of coated surfaces suggested that some specific interaction was occurring. 
The same twenty phage were added to wells coated with the proteins BSA, 
ovalbumin, gelatin and skimmed milk, and to wells coated with, and washed during 
the assay procedure with, the detergents Tween 20, Triton X-100 and Nonidet P40. 
The results from these tests generally confirmed those obtained in the first ELIS As, 
with three groups reacting strictly to type. Group 1 phage gave strong signals in wells 
coated with ovalbumin or previously washed with Tween 20 and Triton X-100 and a 
moderate reading with Nonidet p40 and a low reading with skimmed milk. Group 3 
phage gave high readings with ovalbumin, Tween 20 and Nonidet p40 and moderate 
readings with Triton X-100 and skimmed milk. The Group 4 phage showed moderate 
numbers binding to wells coated with ovalbumin, Tween 20, Triton X-100 and 
Nonidet p40 and a low reading with skimmed milk.
Only the Group 2 phage failed to bind in a similar mannner. Both phage bound to a 
moderate degree to the wells blocked with ovalbumin and to a low extent to those 
which had been blocked with skimmed milk. Phage B-1 bound moderately to the 
three wells that had been washed in each detergent, however, phage B-7 bound poorly 
to these wells.
All phage bound poorly to the gelatin-blocked well.
Despite the lack of an increase in the number of phage eluted in each succeeding 
round the binding assay results clearly indicate that some selection did occur in 
panning, with four groups of phage identified that behaved in a similar manner. There 
is also evidence to suggest that backchecking did remove a specific sub-set of phage 
from the amplified pool, as eight of the nine phage that constituted Group 3 were 
eluted from the backchecking well.
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However, once again the one definite conclusion that can be drawn is that this third 
panning experiment did not promote the amplification of LT-B-binding phage.
OVERVIEW AND CONCLUSIONS
Background to the project
Fourteen years ago the first steps were taken in the development of phage display 
(Smith, 1985), eleven years ago the first paper outlining the basic methods was 
published (Parmley and Smith, 1988) and nine years ago the production and 
utilisation of the first phage display libraries was reported (Cwirla et a l, 1990; Devlin 
et a l,  1990; Scott and Smith, 1990). George P. Smith's original vision (Smith, 1996) 
was of an immunological tool, and displayed peptides have indeed been used to 
discover epitope-mimics ('mimotopes'), whilst the insertion of antibody genes into 
phage has resulted in the display of active antibody fragments, leading to the isolation 
of human antibody fragments with specificity against protein and non-protein 
antigens (Wint&v et a l, 1994).
Phage display has proved equally applicable in other fields. Devlin et a l (1990) 
described fusions that bound to streptavidin, a protein with no previously reported 
affinity for peptides, and Oldenburg et a l  (1992) and Scott et a l  (1992) 
simultaneously reported that displayed random peptides could bind to the lectin, 
concanavalin A, for which the natural ligand was a carbohydrate. Hoess et a l (1993), 
in discovering peptides that bound to the carbohydrate receptor site of a monoclonal 
antibody, appeared to confirm the existence of peptides able to mimic carbohydrate 
determinants. O'Neil et a l (1992) showed that phage-displayed peptides could mimic 
fibronectin in binding to the cell adhesion glycoprotein integrin, Ilb/IIIa, thus 
demonstrating that such peptides could specifically bind to natural receptor 
molecules.
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It was against this background that the idea of applying phage display to the study of 
toxin-receptor interactions was first conceived. The toxin chosen for analysis was LT- 
B, which had recently been crystallised, yielding a wealth of information on the 
interaction with its natural receptor (Sixma et a i,  1991; 1992; 1993; Merritt et a l, 
1994a; 1994b). That the gene for the binding subunit had recently been cloned into an 
expression system (Amin and Hirst, 1994), increased its appeal as a model system.
Overview of experimental procedure
Acid elution was employed when biopanning all the libraries tested. The resilience of 
bacteriophage to extreme pH makes this most stringent form of elution ideal and it 
has been the agent of choice in most display work since Parmley and Smith (1988) 
first recommended it. O’Neil et a i  (1992) did suggest that such non-specific elution 
used in the first panning round could promote domination by irrelevant phage. 
Indeed, they found no identifiable sequence motifs when using it at this stage, and 
recommended that a specific ligand should be used instead, to provide an initial pool 
of binders that could be refined by further rounds of panning. In accordance with this, 
Gm] elution of phage from LT-B i^®^”^  was attempted with the Smith hexamer library, 
however no clones that demonstrated LT-B- specific binding were isolated.
Recovery with TBS proved useful as a control, giving a measure of non-specific 
binding and elution, resulting from the use of such vast numbers of phage in the 
panning process. After ten washes, detectable numbers of phage remained, possibly 
associated with the plastic tube, or with the streptavidin or LT-B^io '^n These phage 
were not amplified to any extent from round to round, and would have been of little 
significance if a population of specifically eluted, amplifiable phage had been present.
Overview of results
Binding of phage-borne peptides was investigated using gene III and gene VIII 
libraries, representing display types 3, 8+8 and 88, with inserts of varied lengths 
(hexapeptide, nonapeptide and pentadecapeptide).
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The results with the Smith hexamer library were disappointing. Despite the fact that 
nucleic acid sequences that could be read over the interfering wild-type signal carried 
related inserts, eluted phage showed little evidence of amplification over four rounds 
and performed poorly in the binding assays. This suggests that they were associating 
with something other than LT-B^iotin Comparison with known streptavidin or plastic 
binding sequences failed to indicate relatedness.
Flaws in construction of the Luzzago nonamer library, revealed by sequencing meant 
that no useful data was generated by this part of the study. This was particularly 
unfortunate as this library had been employed to select carbohydrate epitope- 
mimicking peptides (Phalipon et al., 1997). When used to immunise mice, anti­
carbohydrate antibodies were raised against these selected peptides.
The Smith pentadecamer library panned and sequenced well, however, phage isolated 
at the final round failed to bind to LT-B^iotin. Some clones did, however, demonstrate 
specificity for streptavidin, and the sequences of the binding phage were internally 
consistent and bore elements of similarity, in respect of the residues H, P and Q, to 
those previously published (Devlin et a l, 1990; Kay et a l, 1993; McLafferty et a l, 
1993).
Therefore, using the heat-labile toxin of E. coli as a model system, the phage display 
technique failed to generate peptide mimics of the natural carbohydrate ligand.
In considering why this should be, it is valuable to compare Gmi with a -D -  
methylmannoside (the saccharide ligand of concanavalin A) and the LewisY antigen. 
These structures are shown in Figure 31. Although Gmj is by far the most complex, 
the galactose (1) component (refer to Figure 31 for numbering scheme) has a 
superficially comparable structure to the a-D-methylmannoside and the non- 
acetylated rings of the LewisY antigen. The other critical structures for Gmi binding, 
principally the sialic acid (5), and to a lesser extent the N-acetyl glucosamine (2) are 
much more complex, and it may be that peptides are simply unable to mimic these 
residues. Galactose alone is sufficient to bind LT-B (a property exploited in the 
purification process), however, the LT-B^’^ tin in the panning work possibly
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OCH a-D -methylmaniîoside
OHHO OH
HO HNAcHO
OHHO' OH
OH Epitope of Lewisy antigen
o
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OHHO'
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OH
OH
OH
OH
0 = Ganglioside GM l
FIGURE 32 : Comparison of the structures of a-D-methylmannoside, the 
epitope of the Lewisy antigen and GmI-
Rings comprising the Gmi are galactose (1); N-acetyl-glucosamine (2); galactose (3); 
glucose (4); sialic acid (5).
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carried bound galactose, and, while it was hoped that this would have helped select 
for peptides with higher binding affinities, it was equally a possibility that it served to 
prevent any of the peptides from binding. For that reason, ’Hirst LT-B’ produced by 
the alternative purification strategy of Amin and Hirst (1994) was used in the second 
and third biopanning experiments carried out with the Smith pentadecamer library. 
The results obtained from these two pannings and the subsequent binding assays did 
not suggest that the stock LT-B^iotin used in the earlier experiments performed any 
differently to that produced by Professor Hirst.
A second possibility that always exists in phage display work, is that the binding 
peptide was simply absent from the libraries tested. The Smith hex amer library, as 
originally produced, was calculated to contain 1.3 x unique clones, when only 
1.1 X 1Q9 {ie. 32^) were required to guarantee that all possible hexamers were 
present. However, it must be remembered that what was used here was not the 
original library, but an amplification of an amplified part of that. Initially, the library 
had 2 X lO^ "^  clones, representing around one millon copies of each unique insert. It 
would thus seem unlikely that substantial loss of diversity would have occured 
through repeated amplification However, this view depends upon each phage 
possessing an equal ability to amplify and infect; this is not necessarily the case. 
Burritt et al. suggest that dominance by certain phage may be due to possession of 
some characteristic, unrelated to binding specificity, that promotes proliferation and 
that, if amplification is carried out on solid medium, this imbalance can be reduced. In 
their review of phage display, Burritt et al. list thirty proven consensus sequences of 
which nineteen are less than six amino acids in length. The longest consists of twenty- 
two residues, although this includes many variable positions interspersed among the 
set amino acids. The longest sequences that are defined throughout are seven amino 
acids in length. The streptavidin consensus is HPQ, and, were the sequence sought 
here also this length, then the number of variants in the original library would have 
been perfectly adequate. Set against this is the observation of Weber et al. (1992), that
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amongst streptavidin-binding phage, the residues adjacent to HPQ are also involved 
in binding, suggesting that the consensus sequence for binding may well be much 
longer. Obviously, the pentadecamer library is far from complete - this would require 
3.28 X 10^9 independent clones - but, as discussed earlier, it will contain, within its 
inserts, many shorter peptides. Therefore, with a small consensus sequence there is a 
greater chance of its being present within the pentadecapeptide insert than within the 
hexapeptide.
The third possibility is that only conformationally-constrained peptides will bind to 
LT-B. The failure with the Luzzago library prevented investigation of this issue. 
Ladner (1995) suggests that discoveries of peptide mimics of protein-binding 
sequences are rare when unconstrained libraries are used. Set against this argument is 
the fact that the previous carbohydrate-mimicking peptides were discovered using 
unconstrained libraries - in fact, Hoess et al. (1993) actually tested constrained and 
unconstrained libraries and discontinued work with the former due to lack of success. 
A fourth possibility is that peptide mimicking of carbohydrate ligands is not actually 
feasible. It was certainly curious, against a background of mass acceptance of phage 
display (there were 246 papers in the Science Citation Index of the BIDS database for 
the year 1998) and its application in ever more areas, that in the first four years after 
the Scott, Oldenburg and Hoess papers first appeared, only three other such examples 
were reported. Two of these involved peptide mimicking of carbohydrate epitopes, 
along the lines of the Hoess et al. / LewisY antigen work, and the other was by 
Martens et al. (1995), in which E-selectin, a cell adhesion molecule, was panned with 
the Cwirla et al. hexapeptide library. The isolated peptides did not compete for 
binding with the natural ligand and were considered to be binding outwith the site 
recognised by the carbohydrate ligand, possibly to a protein.
A paper by Bonnycastle et al. (1996), from the group that reported peptide binding to 
concanavalin A, presented results from testing eleven pVIII libraries against a bank of 
antibodies. Two of them were specific for saccharide epitopes and in both these cases 
binding peptides {ie. carbohydrate mimics) were eluted. However, the authors also
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reported that their libraries failed to bind to any of a panel of ten animal and plant 
lectins. Further, they conceded that the peptide that had apparently mimicked the 
binding of a-D-methylmannoside, the concanavalin A ligand (Oldenburg et a l, 
1992; Scott et a l, 1992) had not, in fact, reacted with the sugar-binding site. Drawing 
together these results with those of Martens et a l, they conclude that although phage 
display peptides that undoubtedly react well with anti-carbohydrate antibodies (eg. 
the previously-discussed papers by Hoess et a l, 1993, and Phalipon et a l, 1997) they 
may well be unable to bind to lectins in a manner analogous to their native ligands. In 
a further paper (Harris et a l, 1997) the same group reported further success when 
peptides were reacted with anti-carbohydrate antibodies but repeated their earlier 
view that true carbohydrate mimieking by peptides was a reasonably unlikely 
prospect. The reason given for this was that antigenic mimickry by peptides is 
dependent on factors other than the peptide demonstrating chemical or structural 
similarity to the native antigen, such as the nature of the binding site of the anti­
carbohydrate antibody.
This same group have since begun investigations into the chemical and structural 
bases of antigen mimickry by phage displayed peptides (Craig et a l, 1998), however, 
at this stage they have yet to publish data relating to anti-carbohydrate antibodies.
Final conclusions
It is unfortunate that the Bonnycastle et a l paper was published so late in the course 
of the practical element of this work as, in the light of their findings, LT-I, appears to 
be an inappropriate model system for investigating phage display. However, based on 
the information available in 1994, when the project was first commenced, it was a 
legitimate choice.
Remembering that the whole intention was to investigate the potential use of phage 
display as a tool in the study of toxin-receptor interactions, then the firm conclusion 
that would have been drawn from these results, regardless of the Bonnycastle et a l 
paper, is that it had no role to play as far as LT-I was concerned. Now, in
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consideration of the Bonnycastle et a l  results and my own, that conclusion can be 
extended to cover not just LT-I, but any other toxin that specifically, or preferentially 
recognises carbohydrate receptors. These other toxins include LT-II and cholera 
toxin, C. perfringens 8~ toxin, shiga and shiga-like (vero) toxin, botulinum toxins, 
tetanus toxin and toxin A of Clostridium dijficile.
The potential use of phage display to discover previously unidentified toxin receptors 
is also limited. Whilst a positive result could be obtained if the receptor was a protein, 
a negative result could suggest that the receptor was possibly, but not definitely, a 
carbohydrate.
Of course, where phage display may still have a role is in conjunction with those 
toxins, such as diphtheria toxin, E. coli ST-I, and pertussis toxin that are known to 
have protein receptors. It would be of great interest to see if a peptide could be 
selected from a display library that would attach within the receptor binding sites of 
these toxins, either by imitating the original receptor or by establishing a novel 
binding strategy of its own. Such a peptide might ultimately prove to have therapeutic 
potential, thereby extending yet further the range of uses for George Smith's visionary 
idea.
?.1
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APPENDIX 1 : MEDIA RECIPES
Luria Bertani (LB) broth
To 950ml of distilled water add :
B actotryptone 10 g
Bacto Yeast Extract 5 g
Sodium Chloride 10 g
Shake to dissolve. Adjust pH to 7.0 with 5N NaOH (-0.2ml). Adjust to 1 litre
with distilled water. Autoclave 20 minutes at 121 “C
Luria Bertani (LB) agar
As for Luria Bertani broth with technical agar added to 1.2%.
Luria Bertani High Salt (LBHS) medium (for marine organisms)
To 950ml of distilled water add :
B actotry ptone 10 g
Bacto Yeast Extract 5 g
Sodium Chloride 15 g
Shake to dissolve. Adjust pH to 7.0 with 5N NaOH (-0.2ml). Adjust to 1 litre
with distilled water. Autoclave 20 minutes at 121 °C
terrific broth
In 900ml of water dissolve :
Try ptone 12 g
Yeast Extract 24 g
Glycerol 4ml
Autoclave as 90ml aliquots. Before use, add 10ml of separately autoclaved
phosphate buffer (2.31 g of KH2PO4 and 12.54 g of K2HPO4 dissolved and
made up to 100ml in distilled water).
1 8 2
APPENDIX 2 : SDS PAGE SOLUTIONS
Sample preparation
Solubilising buffer
Glycerol 5.0ml
20% SDS 2.5ml
p -  mercaptoethanol 0.5ml
0.5M Tris HCl, pH 6.8 2.0ml
Bromophenol blue (Img mb^) 0.5ml
Separating gel 8% 13% 14%
30% acrylamide, 0.8% bis 4.0 ml 6.5 ml 7.0ml
distilled water 7.0 ml 4.5 ml 4.0ml
1.5M Tris HCl, pH 8.8 3.75ml 3.75ml 3.75ml
20% (w/v) SDS 75.0 jul 75.0 pi 75.0 pi
TEMED 7.5 111 7.5 pi 7.5 pi
10% (w/v) APS 150.0 111 150.0 pi 150.0 pi
Stacking gel 6%
30% acrylamide, 0.8% bis 2.0 ml
distilled water 5.4 ml
0.5M Tris HCl, pH 6.8 2.5 ml
20% (w/v) SDS 50.0 p.1
TEMED 5.0 pi
10% (w/v) APS 100.0 pi
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Gel preparation
"I
Gel running
Electrode buffer_______________ (1 litre)
Tris 3.02g
Glycine 14.0 g
SDS 1.0 g
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I
Destain
Distilled water containing 40% methanol and 10% acetic acid. Gels were retained 
until photographed in distilled water.
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APPENDIX 3 : GEL STAINING
Coomassie blue 
Concentrated Stain
Coomassie blue R250 1.25 g
Methanol 200 ml
Glacial acetic acid 50 ml
Distilled water to 500 ml
Gel was soaked in concentrated stain for 20 minutes at room temperature, then 
transferred into destain. Destaining continued at room temperature, with frequent 
changes, until background was cleared.
I
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APPENDIX 4 : MISCELLANEOUS RECIPES
Western blotting transfer buffer
Tris 5.82 g
Glycine 2.83 g
SDS 0.0375 g
Methanol 200 ml
Distilled water to 1 litre
PEG /NaCl
To 475ml water add :
PEG 8000 100 g
NaCl 116.9 g
Phosphate buffered saline (PBS)
Dulbecco A tablets from Oxoid, Basingstoke were used, 1 tablet per 100ml of 
distilled water.
PBS-BSA
PBS containing 0.1% bovine serum albumin (Sigma; Poole).
PBS-TWEEN
PBS containing 0.5% Tween 20 (Polyoxyethylenesorbitan monolaurate; Sigma; 
Poole)
Running buffer for sequencing
TBE (0.09M tris borate, 0.002M EDTA, pH 8.0)
Tris 135.0 g
Boric acid 68.75 g
EDTA 4.65 g
Makes 2.5 litres of 5 X. Dilute to single strength for use.
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TE buffer
ImM EDTA in lOmM Tris/HCl, pH 8.0 
Tris buffered saline (TBS)
Dissolve one physiological saline tablet (Oxoid; Basingstoke) in 475ml distilled 
water. Add 25ml of IM Tris/HCl, pH 7.5.
TBS-TWEEN
TBS containing 0.5% Tween 20 (Polyoxyethylenesorbitan monolaurate)
TBS-G
TBS containing 0.2% gelatin.
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APPENDIX 5 : AMINO ACIDS - SINGLE LETTER 
CODING
Showing frequency of codon appearance in the full and NNK genetic codes
No. OF CODONS 
_____________________________________FULL CODE NNK
A Alanine 4 2
C Cysteine 2 1
D Aspartic acid 2 1
E Glutamic acid 2 1
F Phenylalanine 2 1
G Glycine 4
H Histidine 2 1
I Isoleucine 3 1
K Lysine 2 1
L Leucine 6
M Methionine 1 1
N Asparagine 2 1
P Proline 4 2
Q Glutamine 2 1
R Arginine 6 3
S Serine 6 3
T Threonine 4 2
V Valine 4 2
W Tryptophan 1 1
Y Tyrosine 2 1
Stop 3 1
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APPENDIX 6 : GENETIC CODE
Amino acids designated by single letters (see Appendix 5). BOLD codons constitute 
the NNK genetic code. (St. = stop codon)
T T T
T T C  
T T  A 
T T  G
C T T
C T C  
CT  A 
C T  G
A T T
A T  C 
A T  A 
A T  G
G T T
G T C 
G T A 
G T G
M
V
V
V
V
T C T S T A T Y T G T C
T C  C S T A G Y T G C C
T C  A s T A  A st. T G A st
T C G s T A G st. T G G W
C O T p C A T H C G T R
C G C p C A C H C G C R
C C A p C A A Q C G A R
C C G p C A G Q C G G R
A C T T A A T N A G T S
A C C T A AC N A G C S
A C A T A A A K A G A R
A C G T A A G K A G G R
G C T A G A T D G G T G
G C C A G A G D G G C G
G C A A G A A E G G A G
G C G A G A G E G G G G
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APPENDIX 7 : GENE III OF fd-tet
Base and amino acid sequences of protein III of phage fd-tet. The capitalised, 
underlined bases represent the annealing site of the primer OLIGO 2303.
SIGNAL PEPTIDE
a t g a a a a a a t t a t t a t t c g c a a t t c c t t t a g t t g t t c c t t t c t a t t c t c a c
M K K L L F A I P L V V P F Y S H
t c c
S
MATURE PROTEIN
g e t g a a a c t g t t g a a a g t t g t t t a g c a a a a c c t c a t a c a g a a a a t t e a t t t
A E T V E S C L A K P H T E N S F
a c t a a c g t c t g g a a a g a c g a c a a a a c t t t a g a t CGT TAC GCT AAC TAT GAG
T N V w K D D K T L D R Y A N Y E
GGC t g t c g t t g g a a t g e t a c a g g c g t t g t g g t t t g t a c t g g t g a c g a a a c t
G C L w N A T G V V V C T G D E T
c a g t g t t a c g g t a c a t g g g t t c e t a t t g g g c t t g e t a t e c c t g a a a a t g a g
Q C Y G T w V p I G L A I p E N E
g g t g g t g g c t c t g a g g g t g g c g g t t c t g a g g g t g g c g g t t c t g a g g g t g g c
G G G S E G G G S E G G G S E G G
g g t a c t a a a c c t c c t g a g t a c g g t g a t a c a c c t a t t c c g g g c t a t a c t t a t
G T K p p E Y G D T p I P G Y T Y
a t e a a c c c t e t c g a c g g c a c t t a t c c g c c t g g t a c t g a g c a a a a c c c c g e t
I N P L D G T Y P p G T E Q N P A
a a t c e t a a t c c t t c t c t t g a g g a g t c t c a g c c t c t t a a t a c t t t c a t g t t t
N P N p S L E E S Q p L N T F M F
c a g a a t a a t a g g t t c c g a a a t a g g c a g g g t g c a t t a a c t g t t t a t a c g g g c
Q M N R F R N R Q G A L T V Y T G
a c t g t t a c t c a a g g c a c t g a c c c c g t t a a a a c t t a t t a c c a g t a c a c t c c t
T V T Q G T D P V K T Y Y Q Y T P
g t a t e a t e a a a a g c c a t g t a t g a c g e t t a c t g g a a c g g t a a a t t c a g a g a c
V S S K A M Y D A Y W N G K F R D
190
t c c  g g c  c t t  g e t  a a t  g g t  a a t  g g t  g e t  a c t  g g t  g a t  t t t  g e t  g g c  t c t  a a t
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1i
t g c  g e t  t t c  c a t  t c t  g g c  t t t  a a t  g a g  g a t  c c a  t t c  g t t  t g t  g a a  t a t  c a a  
C A F H S G F N E D P F V C E Y Q
g g c  c a a  t e g  t c t  g a c  c t g  c c t  c a a  c c t  c c t  g t c  a a t  g e t  g g c  g g c  g g c  t c t  
G Q S S D L P Q P P V N A G G G S
g g t  g g t  g g t  t c t  g g t  g g c  g g c  t c t  g a g  g g t  g g c  g g c  t c t  g a g  g g t  g g c  g g t  
G G G S G G G S E G G G S E G G G
t c t  g a g  g g t  g g c  g g c  t c t  g a g  g g t  g g c  g g t  t c c  g g t  g g c  g g c  t c c  g g t  t c c  
S E G G G S E G G G S G G G S G S
g g t  g a t  t t t  g a t  t a t  g a a  a a a  a t g  g c a  a a c  g e t  a a t  a a g  g g g  g e t  a t g  a c c  
G D F D Y E K M A N A N K G A M T
g a a  a a t  g c c  g a t  g a a  a a c  g c g  e t a  c a g  t c t  g a c  g e t  a a a  g g c  a a a  c t t  g a t  
E N A D E N A L Q S D A K G K L D
t c t  g t c  g e t  a c t  g a t  t a c  g g t  g e t  g e t  a t e  g a t  g g t  t t c  a t t  g g t  g a c  g t t  
S V A T D Y G A A I D G F  I G D V
I
Î
S G L A N G N G A T G D F A G S N
t c c  c a a  a t g  g e t  c a a  g t c  g g t  g a c  g g t  g a t  a a t  t e a  c c t  t t a  a t g  a a t  a a t  
S Q M A Q V G D G D N S P L M N N
t t c  c g t  c a a  t a t  t t a  c c t  t c t  t t g  c c t  c a g  t e g  g t t  g a a  t g t  c g c  c c t  t a t  
F R Q Y L P S L P Q S V E C R P Y
g t c  t t t  g g c  g e t  g g t  a a a  c c a  t a t  g a a  t t t  t c t  a t t  g a t  t g t  g a c  a a a  a t a  
V F G A G K P Y E F S I D C D K I
a a c  t t a  t t c  c g t  g g t  g t c  t t t  g c g  t t t  c t t  t t a  t a t  g t t  g c c  a c c  t t t  a t g  
N L F R G V F A F L L Y  V A T F M
t a t  g t a  t t t  t e g  a c g  t t t  g e t  a a c  a t a  c t g  c g t  a a t  a a g  g a g  t c t  t a a  
Y V F S T F A N I L R N K E S  S t o p
Ï
APPENDIX 8 : GENE VIII OF fd-tet
Base and amino acid sequences of protein VIIÏ of phage fd-tet. 
SIGNAL PEPTIDE
a t g a a a a a g t c t t t a g t c e t c a a a g c c t c c g t a g c c g t t g e t a c c e t c g t t
M K K S L V L K A S V A V A T L V
c c g a t g c t g t c t t t c g e t
P M L S F A
MATURE PROTEIN
g e t g a g g g t g a c g a t c c c g c a a a a g c g g c c t t t g a c t c c c t g c a a g c c t e a
A E G D D P A K A A F D s L Q A S
g c g a c c g a a t a t a t e g g t t a t g c g t g g g c g a t g g t t g t t g t c a t t g t c g g c
A T E Y I G Y A w A M V V V I V G
g c a a c t a t e g g t a t e a a g c t g t t t a a g a a a t t c a c c t e g a a a g c a a g e t g a
A T I G I K L F K K F T S K A S S t o p
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Lysine residues (highlighted in bold type) are at positions 23, 34, 43, 62, 63, 69, 81,
1 A P QS IT E L CS  EYHNTQIYTI NDKILSYTES MAGKREMVII TFKSGATFQV
5 1  EVPGSQHIDS QKKAIERMKD TLR ITY LTE T KIDKLCVWNN K T P N S I A A I S  MEN
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IAPPENDIX 9 : AMINO ACID SEQUENCE OE LT-B
84 and 91.
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